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1. INTRODUCTION 
 
Normal microbiota is regularly found in specific areas of the body. This speci-
ficity is far from arbitrary and depends on local factors, such as pH, oxygen 
concentration, amount of moisture present, and types of secretions associated 
with each anatomical site (Cappuccino et al., 2000). The gastrointestinal tract 
(GIT) serves as an important reservoir of normal microbiota with about 500 
different microbial species have been described (Rautava et al., 2002; Noverr et 
al., 2004;  Caicedo et al., 2005; Mshvildadze et al., 2010a; Ogra, 2010;). More 
than 99% of cultivable faecal microbiota is represented by 30–40 bacterial 
species (Fanaro et al., 2003; Noverr et al., 2004). In the lower intestine and 
colon, 96% to 99% is composed of anaerobes such as the members of the 
genera Bacteroides, Bifidobacterium, Lactobacillus, Clostridium, and Strepto-
coccus, whereas 1% to 4% is composed of aerobes, including coliforms, entero-
cocci, and a small number of Proteus, Pseudomonas and Candida spp (Cappuc-
cino et al., 2000; Noverr et al., 2004) 
The mucosal surfaces especially GIT are dynamic ecosystems influenced by 
host, intrinsic, and environmental factors. Although the importance of the gut 
microbiota for human health has been increasingly recognized, early bacterial 
colonisation in the neonatal gut and other mucosal sites is not yet completely 
understood (Wall et al., 2009; Vaishampayan et al., 2010). The relative im-
portance of factors influencing mucosal colonisation is interacted and difficult 
to organize into a hierarchy. A better knowledge of the microbiota and the im-
pact of antibiotics and other risk factors will provide an essential step towards 
understanding the development of mucosal bacterial community (De La 
Cochetiere et al., 2007), contribute to improved infection control-strategies and 
eventually improved outcomes for critically ill neonates (Donskey, 2004; Mi-
randa et al., 2009). 
Antibiotic therapy has only emerged over the last 60+ years as a practical 
proposition and has become one of the pillars of modern medicine. By these 
years significant changes in patterns of microbial colonisation in human infants 
have been revealed, attributable in part also to the higher numbers of Caesarean 
and premature deliveries, introduction of formulas, essentially sterile food, and 
generally cleaner living environments (Kelly et al., 2007). Furthermore, advan-
ces in perinatal care have decreased neonatal and especially preterm mortality. 
For better outcome empiric use of antibiotics in neonatal intensive care units 
(NICU) has become a common though not problem-free practice.  
A combination of gentamicin with a beta-lactam antibiotic such as penicillin 
G or ampicillin is the most recommended treatment for early onset sepsis (EOS) 
(Schrag et al., 2002; Huang et al., 2004; Mehta, 2005). Ampicillin has greater 
activity against some Gram-negative bacteria than penicillin G and also has 
activity against enterococci, Listeria monocytogenes, Escherichia coli, and 
group A and B streptococci (Ambroise, 2009). Previous studies have suggested 
that broad spectrum antibiotics including ampicillin when used for the empiric 
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treatment of EOS leads to increased rates of potentially pathogenic Entero-
bacteriaceae, to overgrowth of Candida spp. and selects for antibiotic resistant 
strains (Bonnemaison et al., 2003; Donskey, 2004; Manzoni et al., 2008; Auriti 
et al., 2009). Narrow spectrum penicillins like penicillin G on the contrary, have 
the least potential of interfering with normal colonisation (Bennet et al., 2002). 
Still the number of comparative studies in the field is limited.  
Infants admitted to NICU are at great risk of sepsis risk factors which in-
clude preterm labour, premature rupture of membranes (PROM), indwelling 
catheters, feeding with total parenteral nutrition (TPN), prolonged artificial lung 
ventilation (ALV), and colonisation with potential pathogens (Bizzarro et al., 
2005; Srivastava et al., 2007; Samanta et al., 2011). Immaturity may predispose 
to bacterial translocation from GIT and other mucosa to systemic organs and 
tissues (Cartelle et al., 2004; Donskey, 2004; Graham et al., 2007; Miranda et 
al., 2009). In an effort to anticipate septic events and guide antimicrobial 
therapy, some studies attempt to identify potential pathogens before infection 
occurs by routinely culturing a variety of surfaces from different body sites 
(Evans, 1988; Choi et al., 2008; Smith et al., 2010). So far the data are still 
limited and do not permit a great success. 
In the Department of Microbiology of the Tartu University microbial eco-
logy of the GIT has been investigated for a number of years, including com-
parisons of the faecal microbiota in healthy and sick persons (Mikelsaar, 1992; 
Naaber et al., 1997; Bjorksten et al., 1999; Mikelsaar et al., 2004; Stšepetova et 
al., 2007; Mikelsaar et al., 2009) and characterization of its formation in 
different countries of the Baltic-Scandinavian region (Sepp et al., 1997; Sepp et 
al., 2000; Voor et al., 2005). Also, an association between maternal and neo-
natal microbiota (Mändar et al., 1996; Mändar et al., 2001) and antimicrobial 
resistance of invasive pathogens (Lõivukene et al., 2006; Sepp et al., 2009) has 
been evaluated. This thesis focuses upon the formation of the rectal and NP 
opportunistic microbiota in neonates at risk of EOS admitted to NICU, identi-
fies independent perinatal, neonatal, and environmental factors influencing the 
colonisation process; and defines the value of surveillance cultures in predicting 
late onset sepsis (LOS). Comparison of the clinical efficacy of ampicillin plus 
gentamicin vs penicillin and gentamicin in the empiric treatment of EOS is 
presented elsewhere (Metsvaht, 2010). 
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2. REVIEW OF LITERATURE 
 
2.1. The developing microbiota and importance  
of early neonatal colonisation 
 
At birth the neonatal intestine and other mucosa are sterile while no invasive 
procedures have been carried out on the mother and there is no PROM 
(Srivastava et al., 2007; Mshvildadze et al., 2008). During and after birth, in-
fants are exposed to microbes that originate from the surrounding environment 
and/or from the birth canal (Bettelheim et al., 1974b; Fryklund et al., 1992; 
Thompson-Chagoyan et al., 2007; Morelli, 2008; Mshvildadze et al., 2010a; 
Mshvildadze et al., 2010b; Ogra, 2010;). The newborn’s colonisation begins at 
the skin and mucous membranes and enters the intestinal tract (Haenel et al., 
1975; Garcia-Rodriguez et al., 2002; Levy, 2007; Reid et al., 2011). 
 
 
2.1.1. Early gut colonisation 
The formation of GI microbiota is a gradual process in which several stages can 
be distinguished. Bacteria usually start to appear in neonate’s faeces within a 
few hours from birth (Thompson-Chagoyan et al., 2007). In general, the first 
phase, described as initial acquisition phase, lasts for the first two weeks of 
postnatal age (PNA); the second phase is the remaining period of solely breast-
feeding; the third phase is the time between the beginning of food supple-
mentation and the cessation of breast-feeding; and the fourth phase is the period 
of conversion to adult biota patterns beginning after the completion of weaning 
(Sepp, 1998; Mackie et al., 1999). 
During the early postnatal period aerobic and facultative anaerobic oppor-
tunistic bacteria such as Enterobacteriaceae, especially E. coli and Gram-
positive cocci may reach high population levels in the intestine (Almuneef et 
al., 2001; Rautava et al., 2002; Hallstrom et al., 2004; Morelli, 2008; Enck et 
al., 2009; Ogra, 2010). Early colonisation by Gram-negative bacteria is ex-
plained by the fact, that fetal intestinal villi and crypt epithelial cells express 
Toll-like receptors 4 and adaptor molecules MD2, the key components of the 
lipopolysaccharide receptor (Levy, 2007). However, the proportion of pre-
dominant faecal colonisers by the end of the first week of life differs in different 
studies. For example, rates of neonates colonised by enterococci range from 
12% to 100%, enterobacteria from 50% to 83%, staphylococci from 35% to 
100% and streptococci from 1.2% to 45% (Rotimi et al., 1981; Blakey et al., 
1982; Sakata et al., 1985; Fryklund et al., 1992; Hallstrom et al., 2004; Adler-
berth et al., 2006). By using more modern techniques like 16S rDNA E. coli 
was found to be the largest taxonomic group on Day 6 of life (Park et al., 2005).  
Although these bacteria belong to potentially pathogenic species, it has been 
proposed, that the metabolism and oxygen consumption of these aerobic 
bacteria might be a positive factor in preparing the path to beneficial anaerobic 
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genera such as Bacteroides, Bifidobacteria and Lactobacilli (Srivastava et al., 
2007; Thompson-Chagoyan et al., 2007; Morelli, 2008). However, previous 
data are mostly based on infants who have been subjected to factors, which can 
have a profound disruptive effect on the natural colonisation process such as 
Caesarean delivery (Penders et al., 2006), use of antibiotics (Bennet et al., 
1986), or treatment in NICU (Hallstrom et al., 2004). The results of the only 
study in infants without any major medical or dietary intervention showed that 
bifidobacteria are one of the first gut colonisers (Eggesbo et al., 2010).   
Anyway, more recently some changes in the composition of the first colo-
nisers in industrialized countries have been reported with “classical” faecal 
bacteria like E. coli appearing late and staphylococci becoming more abundant 
than Enterobacteriaceae (Adlerberth et al., 2006; Kelly et al., 2007; Morelli, 
2008). In a study of Adleberth et al (2006) by Day 3 almost 99% of infants were 
colonised with CoNS, and it took 2 months until enterobacteria, traditionally the 
first colonisers, appeared in the gut in more than 90% of infants. This pheno-
menon has been explained by widespread antibiotic use, dietary changes, more 
stringent hygienic conditions during the delivery and short hospital stay (Noverr 
et al., 2004; Adlerberth et al., 2006; Kelly et al., 2007; Morelli, 2008). 
 
 
2.1.2. Early nasopharyngeal colonisation 
Studies, mostly published 30 to 40 years ago, have shown that immediately 
after birth the nasopharyngeal (Haanpera et al. 2008) area of 62% babies 
contains bacteria consistent with those found in their mothers’ vaginas or faeces 
immediately before delivery (Bettelheim et al., 1974a; Goldmann, 1981). 
Similar to gut colonisation the predominance of Gram-positive cocci has been 
demonstrated in the NP (Saiman, 2002). By the example of very low birth 
weight (VLBW) infants a rise of coagulase negative staphylococci (Silvestri et 
al.1999) colonisation from 12% on NICU admission to 75% by week 2 
followed by a decline to 30% by week 6 has been shown (Hall et al., 1990). 
These data are consistent with the results of Blakey et al (Blakey et al., 1982), 
showing the predominance of Staphylococcus epidermidis (17%) colonisation 
in preterm neonates on day 1–4, with further rise to 43% by day 9–10 and 
decline to 25% by day >20.  
Baltimore et al (1989) monitored the dynamics of Gram-negative bacterial 
carriage in normal infants from birth to 6 months of age and compared with 
colonisation in age-matched hospitalized infants (Baltimore et al., 1989). The 
prevalence of Gram-negatives in healthy infants in the first 72 hours of life was 
8% increasing to 29% during the first month. As the data were similar in 
hospitalized infants (overall prevalence 26%), they concluded the age of the 
infant to be the primary factor associated with Gram-negative microbial colo-
nisation. In both groups the most frequent colonisers were Klebsiella pneu-
moniae, Enterobacter cloacae and E. coli, but also Klebsiella oxytoca, Serratia 
marcescens, Pseudomonas aeruginosa and Acinetobacter spp. were present. In 
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a more recent study conducted in Sarajevo (Ljubovic et al., 2007) 37.3% of 
neonates in the NICU had rectal or NP colonisation by antibiotic resistant 
Gram-negatives in the first week of hospitalization. The most frequent NP and 
rectal colonisers were K. pneumoniae, Pseudomonas spp., Acinetobacter spp., 
whereas Serratia spp. was isolated only in NP samples.  
The common bacterial respiratory pathogenic colonisers are Streptococcus 
pneumoniae, Haemophilus influenzae and Moraxella catarrhalis and probably 
all humans are colonized with these microbes at least once early in life 
(Aniansson et al., 1992; Garcia-Rodriguez et al., 2002; Cardozo et al., 2006; 
Mackenzie et al., 2010). In the first two months of life colonisation rate of 5%, 
12% and 20% for H. influenzae, S. pneumoniae, and M. catarrhalis have been 
shown, respectively (Aniansson et al., 1992). Anaerobes are rarely colonising 
NP but may transiently occur during infection (Kononen, 2005).  
 
 
2.1.3. Importance of normal microbiota 
It is believed that indigenous microbiota plays an important role in the health 
and well-being of the host although scientific evidence of these interactions is 
still limited. Indigenous bacteria stimulate the development of host immunity in 
the intestinal tract and regulate the immune response outside the gut being the 
major stimulators for postnatal maturation of T cells, production of different 
cytokines and regulation of differentiation of dendritic cells (DC) in the 
intestinal mucosa (Kelly et al., 2000; Rautava et al., 2002; Noverr et al., 2004; 
Pietzak, 2004; Tlaskalova-Hogenova et al., 2004; Caicedo et al., 2005; Levy, 
2007; Wynn et al., 2009; Mshvildadze et al., 2010a).  
The lack or change of early microbial stimulation may result in aberrant 
immune response later in life (Kalliomäki et al., 2001a; Kalliomäki et al., 
2001b; Rautava et al., 2002; Noverr et al., 2004; Kelly et al., 2007). Consistent 
with the “hygienic hypothesis” of allergy, an inverse epidemiological relation-
ships between the rates of infection and autoimmunity have been described – 
while the rates of common infection have dropped in wealthy industrialized 
countries, the rates of allergy and autoimmune disease have risen (Levy, 2007, 
Kelly 2007, Maldonado 2007). For example, in healthy children greater faecal 
microbial diversity than in children with eczemas at ages 1 (mean Shannon 
index of diversity for healthy children = 0.75 vs 0.53 for exema patients; p = 
0.01) and 4 months (0.92 vs 0.59; p = 0.02) have been shown (Forno et al., 
2008). As Gram-positive and Gram-negative bacteria induce partly different 
mediators, the optimal balance between TH1 and TH2-like immunity may be 
changed (Bjorksten et al., 1999; Hessle et al., 2000; Bjorksten, 2001; Roilides 
et al., 2004; Bjorksten, 2006; Biasucci et al., 2010).  
In addition, normal microbiota plays an important role by providing a barrier 
for colonisation of pathogens, competing with them for nutrients, degrading 
their toxins, interfering with the adherence and growth, and secreting anti-
microbial substances (Sprunt et al., 1978; Lievin et al., 2000; Noverr et al., 
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2004; Pietzak, 2004; Caicedo et al., 2005; Manzoni et al., 2008; Wall et al., 
2009; Stecher et al., 2011). However, the specific members of the indigenous 
bacteria that are able to inhibit colonisation by pathogens are not known 
(Donskey, 2004). Infants with no detectable Bifidobacteria in bowel, have high 
numbers of clostridia and E. coli (Mackie et al., 1999; Kelly et al., 2007). Also, 
members of the normal microbiota, such as lactic acid fermenting bacteria, 
producing large quantities of biologically active short-chain fatty acids as by-
products of anaerobic fermentation, possess an anti-inflammatory function and 
thus may inhibit C. albicans colonisation on the epithelium of the GIT (Noverr 
et al., 2004).  
In NP resident viridans streptococci can antagonize colonisation by other 
streptococci, especially group A -haemolytic streptococci (Garcia-Rodriguez 
et al., 2002). In a study conducted more than three decades ago infants colo-
nised by Gram-negative enteric bacilli, S. aureus and S. epidermidis were more 
likely to develop clinical infections (18 of 115) compared to those with normal 
pharyngeal flora (predominated by alpha-streptrococci; none of 108) (Sprunt et 
al., 1978).  
Furthermore, due to immaturity of various barrier mechanisms bacteria may 
translocate from GIT or from other mucosal surfaces into systemic organs and 
tissues (Cartelle et al., 2004; Donskey, 2004; Graham et al., 2007; Miranda et 
al., 2009). See also chapter 2.4. Also, opportunistic bacteria may cooperate and 
protect each other. For example mixed-species biofilms of S. epidermidis and  
C. albicans may be particularly pathogenic to preterms as slime production by 
S. epidermidis may inhibit the penetration of fluconazole into mixed biofilm 
and C. albicans may protect staphylococci from the action of vancomycin 
(Adam et al., 2002).  
 
 
2.2. Factors associated with neonatal colonisation 
 
2.2.1. Geographic region and season 
The reported rates of bowel and NP bacterial acquisition and carriage vary 
extensively between different studies and geographical regions due to genetic 
background and socio-economic conditions including housing, access to health 
care, hygiene habits, family size, day-care contact, etc. (Mims et al., 2004; 
Noverr et al., 2004; Roilides et al., 2004). In industrialized countries routine 
hygienic procedures, aimed at reducing the spread of bacteria in maternity and 
neonatal wards, have strongly influenced the colonisation pattern of the new-
born infant (Noverr 2004; Morelli 2008). The 10- to 1000-fold higher counts of 
CoNS, enterococci, enterobacteria and lactobacilli in the intestinal microbiota of 
Estonian compared with Swedish neonates during the first week and also first 
month of life have been demonstrated in late 1990ies (Sepp et al., 2000). 
Significantly earlier colonisation especially by E. coli and streptococci in 
Guatemalan and Pakistani children, compared with Swedish hospital-born 
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children has also been described (Adlerberth et al., 1991; Orrhage et al., 1999; 
Fanaro et al., 2003). These differences are likely triggered by exposure to heavy 
bacterial loads already at birth in developing countries. Still, variations between 
different wards and hospitals of similar setting, likely triggered by the microbial 
load of the immediate environment, occur (Fanaro et al., 2003; De La Coche-
tiere et al., 2007).  
An environmental risk factor, often overlooked, is the seasonal variation in 
the incidence of neonatal hospital acquired infection (HAI). For example, higher 
rates of colonisation by enterococci and multidrug resistant strains during 
winter/spring as compared with summer/autumn months have been shown 
(Hufnagel et al., 2007). In Italy slightly higher rates of NP carriage of respira-
tory pathogens (S. pneumoniae, H. influenzae, Moraxella catarrhalis) in spring 
compared with autumn have been demonstrated (23.7% vs 19.5%, respectively), 
especially for H. influenzae (18.2% vs 13%; p>0.0001) (Marchisio et al., 2001). 
Factors such as warm climate have been associated with a rise in colonisation 
rates with Enterobacter spp. Increased humidity or increased environmental 
dew point during the use of nursery air conditioners propagates airborne disse-
mination of Acinetobacter spp; the latter associated with Acinetobacter-related 
bloodstream infections (BSI) (Srivastava et al., 2007). 
 
 
2.2.2. Neonatal intensive care unit environment and  
cross-colonisation 
In 1970s newborns were mostly colonised by strains spread by the hospital 
staff. Today we hope that better hospital hygiene interventions, such as proper 
hand and surface cleaning, better nutrition, adequate patient/nurse ratio, better 
ventilator management, use of coated urinary and central venous catheters and 
high-efficiency particulate air (HEPA) filters, have reduced such exposure. 
However, the last 15 years publications show, that NICU environment is still 
not problem-free as it can serve as a potential source of high pathogen loads 
(Curtis, 2008; Mshvildadze et al., 2010a). 
Microbes live on the hands of health-care workers, in air, water or environ-
mental surfaces (De Man et al., 2001; Toltzis et al., 2001; Lidsky et al., 2002; 
Hira et al., 2007; Mammina et al., 2007; Huang et al., 1998b). Medical devices 
such as central venous catheters (CvC), urinary catheters and endotracheal tubes 
commonly used in the NICU become frequently colonised with opportunistic 
pathogens like Enterobacteriaceae, staphylococci and yeasts (Mahieu et al., 
2001; O'grady et al., 2002; Srivastava et al., 2007). For example, association 
between intubation for more than 72 hours and frequent NP colonisation by 
Enterobacteriaceae and/or C. albicans and high rates of BSI in patients with 
CvC are well recognised (Harris et al., 1976; O'grady et al., 2002).  
In the NICU environment cross-colonisation followed by an outbreak of 
infection caused by opportunistic organisms has been described in numerous 
studies. The outbreaks have mainly been caused by K. pneumoniae, S. marce-
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scens, E. cloacae, Acinetobacter baumannii, and P. aeruginosa (Verweij et al., 
1995; Shi et al., 1996; Van Der Zwet et al., 1999; Pillay et al., 1999; Cartelle et 
al., 2004; Crivaro et al., 2007; Crivaro et al., 2007; Zarrilli et al., 2007; 
Mammina et al., 2007; Dalben et al., 2008; Cassettari et al., 2009; Sanchez-
Carrillo et al., 2009). The origin of these outbreaks has been intensively in-
vestigated and association with NICU environment confirmed in most cases. In 
Italy during an outbreak of P. aeruginosa over 24 months the predominant type, 
identified by pulsed field gel electrophoresis (PFGE), was responsible for 36% 
of infections and at least 35% of colonisation. The same PFGE profile strain 
was also isolated from one sink (Crivaro et al., 2009). In Scotland, during an 
outbreak of Serratia marcescens in two NICUs the outbreak strain was isolated 
from a laryngoscope blade and a sample of expressed breast milk (Jones et al., 
2000). In Sweden clonal similarity between E. cloacae, E. coli and S. lique-
faciens isolates, collected from the neonates with BSI and the NICU environ-
ment has also been demonstrated (Amaya et al., 2010). 
Longer hospitalization is associated with colonisation by opportunistic 
microorganisms including Candida spp. (Duman et al., 2005; Mammina et al., 
2007; Manzoni et al., 2008; Westerbeek et al., 2006). In a recent study every 
10-day increment of NICU stay increased the odds of being colonised and 
infected with methicillin-resistant Staphylococcus aureus (MRSA) by approxi-
mately 1.3 fold (Maraqa et al., 2011). By the end of the second week of life 
more than 95% of NICU patients have been shown to be colonised by Gram-
negative bacteria, primarily E. coli, Klebsiella spp., Enterobacter spp. and 
Citrobacter spp. (Almuneef et al., 2001). In addition, over the same period 
acquisition of resistant strains may also occur (Millar et al., 2008).  
Microbes acquired via horizontal transmission are frequently antibiotic 
resistant and are endemic in many hospitals (Donowitz et al., 1981; Ayan et al., 
2003; Gras-Le Guen et al., 2003; Bagattini et al., 2006; Huang et al., 2006a; 
Curtis, 2008; Millar et al., 2008; Mears et al., 2009; Cassettari et al., 2009; 
Simmonds et al., 2009). In an Italian study  55.2% of NICU patients were colo-
nised by multidrug-resistant Gram-negative bacilli (MDRGN), with coloni-
sation rate being associated with the length of NICU stay; in 72.4% a cross-
colonisation had occurred (Mammina et al., 2007). Also in Washington by 
molecular epidemiologic analyses clustering for 36 (78%) P. aeruginosa, 22 
(45%) of the E. cloacae, and 13 (59%) K. pneumoniae isolates – all of them 
were MDRGN – has been revealed (Anderson et al., 2008).  
In the Netherlands during an outbreak period multiresistant E. cloacae was 
transmitted via an electronic digital thermometer (Van Den Berg et al., 2000). 
In Turkey two outbreaks due to K. pneumoniae and one due to K. oxytoca with 
a mortality rate of 76.7% were caused by the same genotype strain obtained 
from an incubator (Ayan et al., 2003). Toltzis et al (Toltzis et al., 2001) 
investigated 10 antibiotic-resistant Gram-negative species most frequently 
isolated from NP and rectum by PFGE in a non-outbreak period. They found, 
that cross-colonisation occurred in 12% of all analysed isolates. In India and 
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Italy, extended spectrum β-lactamases (ESBL) producing K. pneumoniae with 
similar PFGE type and antibiogram were isolated from the clinical samples of 
neonates, and also from room surfaces, health-care workers´ hands, incubators, 
work surfaces, suction apparatuses, medicine trolley and sinks (Bagattini et al., 
2006; Tallur et al., 2000). In the USA and Korea transmission of these microbes 
via artificial nails and designated stethoscope has been described (Gupta et al., 
2004; Lee et al., 2004). 
Colonisation with nosocomial microbes may persist for more than a year, 
even long after the index case has left the hospital (Goldmann, 1981; Millar et 
al., 2008). In Australia over a 4 week period 86 samples from 36 toys of 19 
infants were studied. Almost all toys (98%) were contaminated by CoNS, 39% 
by streptococci; and 47% by S. aureus, while more than three quarters were 
carrying MRSA. Eight (42%) of the infants had positive blood culture results 
and 5/8 of the isolates were genotypically identical to those colonising their 
corresponding toy (Davies et al., 2000).  
Admitted neonates may also serve as a reservoir for cross-contamination 
within the ward. Frebourg et al (1999) have demonstrated the presence of a 
single strain of MRSA (identified by PFGE) isolated from 33 CvC – nasal 
cultures pairs. Anyway, over the last several years clonal transmission of 
MRSA has become an increasing problem in NICUs around the world (Shio-
jima et al., 2003; Regev-Yochay et al., 2005; Mcdonald et al., 2007; Anderson 
et al., 2008; Gregory et al., 2009; Heinrich et al., 2011), mostly imported into 
the unit by colonised parents or healthcare workers but also by contaminated 
breast milk and medical equipment (Boyce et al., 1993; Morel et al., 2002; 
Eckhardt et al., 2003; Behari et al., 2004; Fujimura et al., 2004).  
 
 
2.2.3. Maternal factors (maternal microbiota,  
premature rupture of membranes, mode of delivery) 
Maternal vaginal and intestinal flora is a well-recognized source of bacteria for 
newborns´ microbiota (Bettelheim et al., 1974a; Bettelheim et al., 1974b; 
Bettelheim et al., 1974c; Goldmann, 1981; Tannock et al., 1990; Penders et al., 
2006; Ogra, 2010). Recently Dominguez-Bello et al (2010) compared maternal 
skin, oral and vaginal microbiota sampled 1 h before delivery with neonatal skin 
and NP aspirate sampled <5 min, and meconium <24 h after delivery by using 
multiplex 16S rRNA gene pyrosequencing. They showed that the microflora in 
vaginally delivered infants resembled maternal vaginal flora while infants born 
via Caesarean section harboured bacterial communities similar to those found 
on maternal skin. The similarity rates of the maternal-neonatal microbial pairs 
vary from 85% (Bettelheim et al., 1976; Mändar et al., 1996) to 8% (Fryklund 
et al., 1992)  from study to study. Tapiainen et al (Tapiainen et al., 2006) 
documented, that the short- and long-term (6 months) effects of the maternal 
faecal flora on gut colonisation in hospital-born infants were less marked than 
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had been expected and the faecal flora of infants resembled both the faecal flora 
of the mother as well as the first nurse. 
Many studies have described the type of delivery as a crucial aspect in 
selecting the first colonisers in neonates (Goldmann, 1981; Hallstrom et al., 
2004; Pietzak, 2004; Morelli, 2008; Biasucci et al., 2010) although some 
controversies exist. Vertical transmission of the same phenotype of Entero-
bacteriaceae in 12% of vaginally delivered vs 0% of Caesarean section de-
livered neonates has been shown (Fryklund et al., 1992). In naturally delivered 
neonates within 24–72h from birth E. coli, streptococci, staphylococci, and 
enterococci can be detected in stool (Morelli, 2008). Vaginally born infants vs 
those delivered via Caesarean section harbour significantly more E. coli at the 
age of 3 (39% vs 9%) (Biasucci et al., 2010) and 14 days (14.7% vs 2.8%, 
p=0.012) (Hallstrom et al., 2004). However, no differences in bacterial counts 
seem to occur. Penders et al (2006) did not find any effect of the route of 
delivery on the overall intestinal microbial composition; E. coli counts were 
even somewhat higher in Caesarean section vs vaginally born infants; 9.59 vs 
9.09 log10 CFU/g, respectively. The analogous results have shown by Mshvil-
dadze et al (2010b) who evaluated the diversity of intestinal microbiota shortly 
after delivery and during hospitalization by using 16S rRNA pyrosequencing 
and found no significant differences in babies of mothers who had a Caesarean 
delivery vs vaginal route (diversity index 8.99 vs 8.13, respectively). 
Neonates born via Caesarean section also become colonised by E. coli but 
also with other members of Enterobacteriaceae, such as Klebsiella spp (Kelly 
et al., 2007). Compared to naturally delivered infants these neonates seem to 
have reduced numbers of anaerobes (Bacteroides spp., Bifidobacterium spp.), 
that may promote overgrowth of Clostridium difficile (Fanaro et al., 2003;  
Westerbeek et al., 2006; Kelly et al., 2007; Biasucci et al., 2008; Huurre et al., 
2008; Morelli, 2008; Adlerberth et al., 2009). For example, Caesarean-delivered 
infants are less often colonised with lactobacilli and bifidobacteria on day 4 (4% 
vs. 59% and 0% vs. 23%, respectively) and with bifidobacteria on day 30 (0% 
vs. 35%, p = 0.042) compared to vaginally delivered ones (Mitsou et al., 2008). 
Also, based on the results of denaturing gradient gel electrophoresis (DGGE) 
analyses Bifidobacterium spp was detected in 13 of 23 (56.5%) samples derived 
from vaginally delivered newborns but in none of the samples obtained from 
those born via Caesarean section (Biasucci et al., 2010). On the other hand 
Mshvildadze et al (2010b) evaluated the diversity of intestinal mictobiota 
shortly after delivery and during hospitalization by using 16S rRNA pyrose-
quencing and found no significant differences between babies born via 
Caesarean vs vaginal delivery. 
More virulent microbes such as MRSA may also be acquired from the 
mother. In Taiwan (Huang et al., 2006a) MRSA colonisation was detected in 
41% of infants admitted to the NICU. In nearly 90% of colonised infants, 
MRSA was detected in the first 2 (weekly taken) samples. As most of them 
(60%) were admitted in the first 24 hours of life, and the acquisition of MRSA 
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occurred very soon after hospitalization or even before the infants were ad-
mitted to the NICU, the authors suggest, that the infants might have acquired 
MRSA from the mother. Howerver, this conclusion might not be conclusive, as 
in NICU healthcare workers nasal carriage rate was 4.8%. Anyway, in USA the 
prevalence of MRSA anovaginal colonisation in pregnant women remained 
stable and low over the years 2005 to 2009 (0.5% to 0.6%), but the rise of the 
clone USA3000 (0 of 14 isolates in 2005 vs 12 of 18 isolates in 2009) lead to an 
increase in postpartum MRSA infections in both, women and their newborns 
(Top et al., 2010). Maternal vaginal colonisation has been shown to be a risk 
factor of neonatal colonisation and infection by Candida spp. One third of 
mothers delivering preterm were colonised with Candida and 15 of 25 strains 
(60%) isolated from the mothers and their neonates were similar (Xu, 1996; 
Mendiratta et al., 2006).  
Additionally, the composition of newborn microbiota and also infections in 
preterm infants may originate from uterus. The presence of microbes in the 
amniotic fluid without rupture of membranes in the second-trimester placental 
parenchyma has been demonstrated (Mändar et al., 2001; Onderdonk et al., 
2008; Mshvildadze et al., 2010a). In particular, intraamniotic bacterial in-
fections in relation to PROM may cause preterm birth followed by a serious 
threat of immediate postnatal infections (Asindi et al., 2002; Kenyon et al., 
2003; Simhan et al., 2005; Kirchner et al., 2007; Levy, 2007; Lafeber et al., 
2008; Veleminsky et al., 2008). For example, in the USA PROM affects over 
120 000 pregnancies annually, and is associated with significant neonatal 
morbidity and mortality (Simhan et al., 2005). In Saudi Arabia (Asindi et al., 
2002) association between microbes isolated from the endocervical swabs of 
mothers with PROM and their infants’ microbiota were found, and infection 
risk of colonised neonates was 14%. CoNS (24%) and K. pneumoniae (13%) 
were the predominant isolates in the mothers and the same microbes were 
frequent in infants. 
 
 
2.2.4. Maturity 
Comparing term and preterm neonates delayed bacterial colonisation with 
limited number of bacterial species has been demonstrated in the latter. For 
example, Mshvildadze et al (2010b) did not detect any microbial DNA in the 
first stool sample in 2 of the 23 very premature infants and lower GA (<30 
weeks compared with ≥30 weeks) was associated with lower diversity index 
(Simpson diversity index 6.20 vs 9.38; p=0.03). Another study found that the 
lower the birth weight (BW) the later the colonisation by Gram-negative 
opportunistic bacteria (r=–0.449; p < 0.01) (Almuneef et al., 2001). Increased 
similarity of the bacterial communities in hospitalized preterm infants in 
contrast to breast-fed full-term infants has been shown also by Schwiertz et al 
(Schwiertz et al., 2003). The microbes most commonly found in all preterm 
infants in this study were E. coli, K. pneumoniae and Enterococcus spp.  
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Westerbeek et al (2006) reviewed the results of six studies determining the 
intestinal microbiota in preterms, carried out 20–30 years ago. They concluded 
that gut colonisation with beneficial bacteria is delayed in preterm neonates, 
while the counts of potentially pathogenic bacteria are high. Unfortunately, no 
comparable data from term newborns were presented. Similar results were 
described by Gewolb et al (1999) in ELBW infants. By day 30, the predominant 
species were Enterococcus faecalis, E. coli, E. cloacae, K. pneumoniae, S. epi-
dermidis and, S. haemolyticus whereas Lactobacillus and Bifidobacterium spp 
were identified in only one infant. Significant association between LBW and 
colonisation with multidrug-resistant Gram-negative microbes has been 
demonstrated (Duman et al., 2005; Mammina et al., 2007). Also, the colo-
nisation rate by Candida spp is significantly higher in preterm compared to 
healthy term infants (Mendiratta et al., 2006), especially GA <32 weeks is 
associated with either C. albicans (OR=1.08; 95% CI 1.30–2.49) or C. pa-
rapsilosis (OR=2.87; 95% CI 1.79–4.58) colonisation (Saiman et al., 2001).  
 
 
2.2.5. Nutritional habits 
The neonate is also likely to obtain bacteria originating from the nipple and 
surrounding skin as well as the milk ducts in the breast (Heikkila et al., 2003; 
Morelli, 2008). Studies have shown that microbes may translocate into the 
breast milk from mothers’ GIT and bloodstream (Perez et al., 2007). So, ex-
pressed breast milk contains up to 109  microbes/L in healthy mothers (Mackie 
et al., 1999; Morelli, 2008).  
Whether and how feeding habits influence intestinal colonisation is still 
controversial. Some studies have found higher abundance of aerobic bacteria in 
the GI tract of formula-fed compared to breast-fed neonates (Noverr et al., 
2004; Pietzak, 2004; Ogra, 2010), others describe the opposite findings (Ge-
wolb et al., 1999) or no difference between breast milk and formula at all 
(Penders et al., 2006). 
Breast milk colonised by microbes, including staphylococci, streptococci, 
and lactic acid bacteria, may play a positive role and act as a natural “probiotic” 
(Neu, 2007; Perez et al., 2007). Martín et al (2007) suggested that also Gram-
negatives, enterococci, and S. aureus are normal inhabitants of human milk. 
Anyway, Bifidobacteria and Lactobacillus spp. are among the dominant micro-
organisms in breast-fed infants, outnumbering Enterobacteriaceae by 1000-fold 
(Pietzak, 2004), whereas formula-fed infants are colonised more quickly and by 
more diverse microbiota, including Bifidobacteria, Bacteroides, clostridia, 
enterococci, staphylococci, streptococci and especially Enterobacteriaceae  
(E. coli, Klebsiella spp) (Gewolb et al., 1999; Mims et al., 2004; Noverr et al., 
2004; De La Cochetiere et al., 2007; Ogra, 2010). This may be in part due to the 
iron in the infant formulas, which fosters the growth of more complex flora 
(Pietzak, 2004).  
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Although formula is expected to be sterile, possible contamination of milk 
bank or equipment used for enteral feeding should be considered. Outbreaks, 
caused by milk contamination by Pseudomonas aeruginosa (Gras-Le Guen et 
al., 2003; Sanchez-Carrillo et al., 2009) or Klebsiella spp. (Donowitz et al., 
1981; Berthelot et al., 2001) have been described. Furthermore, Hurrell et al 
(2009) isolated opportunistic organisms like E. coli, K. pneumoniae, Serratia 
spp., and also Pseudomonas spp. from 76% of nasogastric enteral feeding tubes. 
Also, an association between exclusive formula feeding and cross transmission 
of MDRGN rods (RR=1.8; 95% CI 1.1–3.5) (Mammina et al., 2007) and more 
frequent colonisation with E. coli (OR=2.90; 95% CI 1.22–6.89) has been 
described (Penders et al., 2006). Based on the expression of surface K1 antigens 
(virulence marker) and serum killing, E. coli strains differ in breast fed and 
formula-fed infants (Mackie et al., 1999).   
There are almost no studies describing the direct impact of TPN on coloni-
sation process. Recently Smith et al (2010) demonstrated an association 
between delayed enteral feeding and late rectal colonisation by Gram-negative 
bacilli. On the other hand, in neonates receiving TPN normal GIT structure and 
function is lost, villi become shorter, mucosal DNA is lost, protein content and 
enzymatic activity are reduced (Ben, 2008). As a result they have an increased 
risk of nosocomial infection by Gram-negative organisms and fungi (Clark et 
al., 2004; De La Cochetiere et al., 2007).  
Only a few studies have described the influence of feeding habits on NP 
colonisation. Baltimore et al (1989) reported, that breastfed infants had signi-
ficantly lower prevalence of Gram-negative rods in NP than non-breast-fed 
infants at the age >3 weeks to 2.5 months (40% vs 64%, respectively). They 
speculated that immunoglobulin A and lymphocytes found in breast milk may 
be important in determining the different rates of colonisation. On the other 
hand, breast feeding vs formula feeding has been shown to protect against otitis 
media (Garcia-Rodriguez et al., 2002) although did not have any substantial 
influence on NP colonisation with respiratory pathogens such as Streptococcus 
pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, and Moraxella 
catarrhalis (Kaleida et al., 1993; Garcia-Rodriguez et al., 2002).  
 
 
2.2. Antibiotic treatment 
 
Antibiotic treatment may influence colonisation either when given to the mother 
during the delivery (for intrapartum prophylaxis or treatment of perinatal 
infection) or to the neonate early after birth. However, due to methodological 
variations as well as the multifactorial nature of gut colonisation the data in 
literature contains some controversy. Changes in the composition of microbiota 
as a consequence of antibiotic treatment can result in the dysregulation of host 
immune homeostasis and an increased susceptibility to disease (Willing et al., 
2011).  
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2.3.1. Intrapartum antibiotic treatment of mothers 
Intrapartum antibiotic prophylaxis (IAP) to prevent EOS caused by group B 
streptococci (GBS) has been in use for more than a decade and as shown in 
several studies has decreased infection rate significantly. For example, over the 
17 years’ experience (1986–2002) in Ohio antepartum antibiotic prophylaxis 
decreased the number of GBS BSI cases from 41 (1986–1991) to 4 (1998–
2002) (Cordero et al., 2004) and over the 9 years’ experience (1993–2001) in 
Australia from a peak of 1.43/1000 live births to 0.25/1000 (Daley et al., 2004). 
Additionally, during the IAP era the decrease of GBS sepsis has led to a 
reduction in the overall incidence of EOS; in a Boston study from 3.70/1000 
live births in 1990–1992 to 1.59/1000 live births in 1997–2007 (Puopolo et al., 
2010).  
However, some worrying trends have been noted concomitantly. Admi-
nistration of antimicrobial agents may disturb the ecological balance between 
the host and the microorganisms and thus interfere with initial gut colonisation 
in neonates (Sullivan et al., 2001; De La Cochetiere et al., 2007; Tanaka et al., 
2009). As a result of IAP increased rates of neonatal mucosal colonisation by 
ampicillin resistant Enterobacteriaceae and increased risk of EOS caused by 
ampicillin-resistant E. coli in many (Mcduffie et al., 1993; Joseph et al., 1998; 
Schuchat et al., 2000; Almuneef et al., 2001; Stoll et al., 2002a; Laugel et al., 
2003; Cordero et al., 2004; Bizzarro et al., 2008), although not in all studies 
(Edwards et al., 2002; Jaureguy et al., 2004; Schrag et al., 2006a; Puopolo et 
al., 2010). Stoll et al (2002a) and Puopolo et al (2010) have shown, that the 
mothers of infants with ampicillin-resistant (AR) E. coli had significantly more 
likely received IAP with ampicillin than those with ampicillin sensitive strains 
(26 of 28 vs 1 of 5; p=0.01; and 36.9% vs 16.8%, respectively). On the other 
hand, Jaurgery et al (Jaureguy et al., 2004) compared the patterns of GIT 
colonisation in infants born with IAP (amoxicillin) and those without early 
antibiotic exposure and found no differences in colonisation by amoxicillin-
resistant enterobacteria (75% and 77%, respectively). 
The trends in invasive disease have been even more controversial. Namely, 
Bizzarro et al (Bizzarro et al., 2008) reported a significant increase in the 
proportion of ampicillin-resistant E. coli EOS in the VLBW population over the 
study period of 1976 to 2006. No cases of AR E. coli were observed from 1979 
to 1992, compared with 1 out of 4 during the risk factor based IAP period from 
1993 to 1996 and 12 out of 17 cases during the screening based IAP period 
from 1997 to 2006. Intrapartum ampicillin exposure was identified as a signi-
ficant risk-factor for AR (OR=17.91; 95% CI 1.59–202.37). In the Ohio study, 
IAP (penicillin G or ampicillin) increased E. coli blood isolates’ resistance to 
ampicillin/sulbactam from 45% to 73% over the period from 1996–1996 to 
1997–2002 (Cordero et al., 2004). However, Puopolo et al (2010) found no 
change in the incidence of infection with AR organisms overall or among 
VLBW infants. In Australia, using preferably penicillin for IAP, the decrease in 
EOS due to GBS has been accompanied by concomitant decrease in E. coli 
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sepsis (Daley et al., 2004; Tarnow-Mordi et al.2010), suggesting the role of the 
different choice of antibiotics applied in IAP.  
Unfortunately, direct comparisons of different antibiotic regimens, especially 
involving sufficiently long time periods to allow out-selection of resistance, are 
scarce. Edwards et al (2002) assessed whether ampicillin as a broader spectrum 
antibiotic vs narrow spectrum penicillin G for IAP affects the subsequent 
exposure of the neonate to AR Gram-negatives and found, that either antibiotic 
may promote neonatal exposure to AR E. coli and other Enterobacteriaceae. 
The rates of AR strains in maternal genital tract cultures obtained at study entry 
and 8–36 h postpartum were similar, with an increase in postpartum culture 
rates of AR E. coli and other Enterobacteriaceae seen in both groups.  
Alternately, case control and/or cohort approach applying multivariate ana-
lysis has been used. Schrag et al (2006a) found an association between IAP 
exposure to ≥2 doses of penicillin or ampicillin and invasive E. coli infection. 
However, comparing E. coli patients with uninfected controls while controlling 
for other risk factors, this association disappeared. This study highlights (1) the 
importance of adequate study design and statistical analysis to elucidate the true 
relationship between antibiotic exposure and resistant infections; and (2) the 
dangers of overinterpreting associations based on case patients’ data alone or in 
analyses not controlling for other major risk factors.  
 
 
2.3.2. Antibacterial treatment and colonisation  
by resistant microorganisms 
A number of studies have looked the effect of general antibacterial therapy on 
mucosal colonisation in terms of development of antibacterial resistance but 
only a limited number of studies have monitored the impact of short-term 
empiric antibacterial therapy of EOS (Table 1). In some studies the purpose of 
antibacterial therapy has not been specified.  
 
26
 
 Ta
bl
e 
1.
 T
he
 e
ff
ec
t o
f a
nt
ib
ac
te
ria
l t
he
ra
py
 o
n 
m
uc
os
al
 c
ol
on
is
at
io
n 
 S
tu
dy
 
Pu
rp
os
e 
of
 
tr
ea
tm
en
t
A
nt
ib
io
tic
s 
Fi
nd
in
gs
 
B
en
ne
t e
t a
l.,
 1
98
2 
G
en
er
al
 
G
en
ta
m
ic
in
 +
 a
m
pi
ci
lli
n 
vs
 u
nt
re
at
ed
  
E.
 c
ol
i d
om
in
at
ed
 in
 u
nt
re
at
ed
, a
nd
 K
. p
ne
um
on
ia
e 
in
 tr
ea
te
d 
ne
on
at
es
 
B
ur
m
an
 e
t a
l.,
 1
99
3 
G
en
er
al
 
am
pi
ci
lli
n 
vs
 c
ef
ur
ox
im
e 
vs
 u
nt
re
at
ed
 
In
 a
m
pi
ci
lli
n 
gr
ou
p 
co
lo
ni
sa
tio
n 
w
ith
 re
si
st
an
t s
tra
in
s t
o 
al
l 
br
oa
d 
sp
ec
tru
m
 p
en
ic
ill
in
s a
nd
 c
ep
ha
lo
sp
or
in
s o
cc
ur
re
d 
D
um
an
 e
t a
l.,
 2
00
5 
G
en
er
al
 
M
at
er
na
l: 
am
pi
ci
lli
n 
or
 a
m
ox
ic
ill
in
, 
ne
on
at
al
: A
B
 w
er
e 
no
t s
pe
ci
fie
d 
In
fa
nt
 a
nd
 m
at
er
na
l A
B
 u
se
 w
er
e 
ris
k 
fa
ct
or
s o
f c
ol
on
is
at
io
n 
w
ith
 E
SB
Ls
 
G
ew
ol
b 
et
 a
l.,
 1
99
9 
G
en
er
al
 
W
ee
k 
I: 
am
pi
ci
lli
n 
+ 
ge
nt
am
ic
in
 o
r 
ce
fo
ta
xi
m
e;
 la
te
r: 
va
nc
om
yc
in
 +
 c
ef
ot
ax
im
e 
In
ve
rs
e 
co
rr
el
at
io
n 
be
tw
ee
n 
A
B
 d
ay
s a
nd
 th
e 
nu
m
be
r o
f 
ba
ct
er
ia
l s
pe
ci
es
 a
nd
 th
e 
to
ta
l n
um
be
r o
f m
ic
ro
or
ga
ni
sm
s. 
Ja
in
 e
t a
l.,
 2
00
3 
G
en
er
al
 
U
ns
pe
ci
fie
d 
In
di
sc
rim
in
at
e 
us
e 
of
 II
I-
ge
ne
ra
tio
n 
ce
ph
al
os
po
rin
s m
ay
 b
e 
re
sp
on
si
bl
e 
fo
r t
he
 se
le
ct
io
n 
of
 E
SB
Ls
. 
M
am
m
in
a 
et
 a
l.,
 2
00
7 
G
en
er
al
 
A
B
 d
ur
in
g 
N
IC
U
 st
ay
 (u
ns
pe
ci
fie
d)
 
A
B
 tr
ea
tm
en
t w
as
 n
ot
 a
ss
oc
ia
te
d 
w
ith
 c
ol
on
is
at
io
n 
by
 
m
ul
tid
ru
g 
re
si
st
an
t G
ra
m
-n
eg
at
iv
e 
m
ic
ro
or
ga
ni
sm
s 
M
ill
ar
 e
t a
l.,
 2
00
8 
G
en
er
al
 
EO
S:
 p
en
ic
ill
in
 +
 g
en
ta
m
ic
in
;  
LO
S:
 d
iff
er
en
t A
bs
 
Ex
po
su
re
 o
f s
pe
ci
fic
 A
B
 is
 n
ot
 ri
sk
 fa
ct
or
 fo
r t
he
 c
ar
ria
ge
 o
f 
a 
st
ra
in
 re
si
st
an
t t
o 
th
at
 A
B
 
Pe
nd
er
s e
t a
l.,
 2
00
6 
G
en
er
al
 
A
B
 d
ur
in
g 
th
e 
fir
st
 m
on
th
 
A
B
 u
se
 re
su
lts
 in
 d
ec
re
as
ed
 a
m
ou
nt
 o
f b
ifi
do
ba
ct
er
ia
 a
nd
 
ba
ct
er
io
id
es
 
Sp
ru
nt
, 1
98
5 
G
en
er
al
 
A
B
 d
ur
in
g 
N
IC
U
 st
ay
 (u
ns
pe
ci
fie
d)
 
N
P:
 A
B
 –
 b
ac
te
ria
l o
ve
rg
ro
w
th
 o
f a
bn
or
m
al
 m
ic
ro
bi
ot
a 
A
lm
un
ee
f e
t a
l.,
 2
00
1 
N
S 
am
pi
ci
lli
n 
+ 
ge
nt
am
ic
in
, I
II
 g
en
er
at
io
n 
ce
ph
al
os
po
rin
s 
A
m
ou
nt
 o
f A
B
 u
se
 w
as
 a
ss
oc
ia
te
d 
w
ith
 in
cr
ea
se
 c
ol
on
is
at
io
n 
by
 re
si
st
an
t s
tra
in
s a
nd
 la
te
 c
ol
on
is
at
io
n 
Ta
na
ka
 e
t a
l.,
 2
00
9 
N
S 
A
B
 fr
ee
 v
s c
ef
al
ex
in
 in
 fi
rs
t 4
 d
ay
s v
s 
m
at
er
na
l c
ef
ot
ia
m
 h
yd
ro
ch
lo
rid
e 
 
A
B
 in
 th
e 
be
gi
nn
in
g 
of
 li
fe
 c
on
du
ce
s t
o 
ov
er
gr
ow
th
 o
f 
En
te
ro
ba
ct
er
ia
ce
ae
 a
nd
 E
nt
er
oc
oc
cu
s s
pp
. a
nd
 c
ru
sh
 d
ow
n 
bi
fid
ob
ac
te
ria
. O
cc
ur
re
nc
e 
of
 re
si
st
an
ce
 st
ra
in
s w
as
 n
ot
 
ob
se
rv
ed
. 
27
 
St
ud
y 
Pu
rp
os
e 
of
 
tr
ea
tm
en
t
A
nt
ib
io
tic
s 
Fi
nd
in
gs
 
To
ltz
is
 e
t a
l.,
 2
00
2 
N
S 
R
ot
at
io
n 
of
 A
B
s:
 g
en
ta
m
ic
in
 →
 p
ip
er
ac
ill
in
-
ta
zo
ba
ct
am
, →
 c
ef
ta
zi
di
m
e 
R
ot
at
io
n 
di
d 
no
t d
ec
re
as
e 
re
si
st
an
t s
tra
in
s 
A
ur
iti
 e
t a
l.,
 2
00
9 
EE
 
Tw
o 
vs
 a
 si
ng
le
 d
os
e 
of
 a
m
pi
ci
lli
n 
+ 
ne
til
m
ic
in
 in
 7
2 
ho
ur
s 
Th
e 
si
ng
le
 a
nd
 d
ou
bl
e 
do
se
 w
as
 e
qu
al
ly
 e
ff
ec
tiv
e 
 
B
on
ne
m
ai
so
n 
et
 a
l.,
 
20
03
 
EE
 
U
nt
re
at
ed
 v
s a
m
ox
ic
ill
in
 +
 n
et
ilm
ic
in
 v
s 
am
ox
ic
ill
in
 +
 n
et
ilm
ic
in
 +
 c
ef
ot
ax
im
e 
In
 th
re
e 
A
B
 g
ro
up
 th
e 
bi
od
iv
er
si
ty
 o
f i
nt
es
tin
al
 fl
or
a 
w
as
 lo
w
 
w
ith
 o
ve
rg
ro
w
th
 o
f s
ta
ph
yl
oc
oc
ci
 a
nd
 C
an
di
da
 sp
p.
 
C
ot
te
n 
et
 a
l.,
 2
00
9 
EE
 
D
iff
er
en
t r
eg
im
en
, f
re
qu
en
tly
 a
m
pi
ci
lli
n 
+ 
ge
nt
am
ic
in
 
Pr
ol
on
ge
d 
du
ra
tio
n 
of
 th
e 
in
iti
al
 e
m
pi
ric
al
 th
er
ap
y 
m
ay
 b
e 
as
so
ci
at
ed
 w
ith
 th
e 
ris
k 
of
 d
ea
th
 o
r N
EC
 
D
e 
M
an
 e
t a
l.,
 2
00
0 
EE
 
am
ox
ic
ill
in
 +
 c
ef
ot
ax
im
e 
vs
 p
en
ic
ill
in
 +
 
to
br
am
yc
in
 
B
ro
ad
 sp
ec
tru
m
 o
f A
B
 re
gi
m
en
 le
ad
s t
o 
co
lo
ni
sa
tio
n 
by
 
re
si
st
an
t s
tra
in
s 
EE
 –
 e
ar
ly
 e
m
pi
ric
al
 a
nt
ib
ac
te
ria
l t
he
ra
py
; A
B
 –
 a
nt
ib
io
tic
; N
S 
– 
no
t s
pe
ci
fie
d;
 N
EC
 –
 n
ec
ro
tiz
in
g 
en
te
ro
co
lit
is
 
28 
The results of studies focusing on risk factors of ESBL colonisation are some-
what controversial. While the majority of studies highlight prior use of third-
generation cephalosporins as an important risk-factor of the emergence of ESBL 
producing strains (Rice et al., 1990; Arlet et al., 1994; Wong-Beringer et al., 
2002; Jain et al., 2003; Glynn et al., 2005), the results of a study conducted in 
Taiwan (Chiu et al., 2005) have not confirmed this effect, though 34 of 76 of 
Enterobacteriaceae isolates from III level NICU patients were ESBLs. Duman 
et al (Duman et al., 2005) determined the rate of -lactam resistant bacteria in 
the commensal faecal flora of newborns and the risk factors of colonisation in 
Turkey. Colonisation with AR-resistant and ESBL producing microorganisms 
was found in 75.2% and 33.7% of 367 stool samples, respectively. Besides very 
low birth-weight, vaginal delivery and male sex, infant and/or maternal anti-
biotic use was identified as a risk factor related to colonisation with ESBL-pro-
ducing microorganism (infant antibiotics – OR=14.5; 95% CI 1.19 – 164.62 and 
maternal antibiotics – OR=3.81; 95% CI 1.07 – 13.50). Mothers were treated 
with ampicillin or amoxicillin in this study but infant’s antibiotic regimens were 
not specified. In another study the use of penicillin and amikacin but not third-
generation cephalosporins was identified as a risk factor for the acquisition of 
ESBL-producing K. pneumoniae (OR=12.3; 95% CI 3.66 – 41.2) (Cassettari et 
al., 2009).  
Rotation of antibiotics has also been suggested as a measure to reduce 
selection pressure. Toltzis et al (Toltzis et al., 2002) in USA tested the potential 
of antibiotic rotation in reduction of colonisation with resistant Gram-negative 
bacilli in NICU. In one team physicians chose antibiotics according to their 
individual practice, while in the other antibiotics were changed monthly as 
follows: gentamicin was followed by piperacillin-tazobactam followed by cefta-
zidime. For Gram-positive coverage, vancomycin or ampicillin were accepted at 
the discretion of the attending physician. This strategy deemed to be ineffec-
tive – a total of 10.7% infants in the rotation vs 7.7% in the control group were 
colonised by resistant Gram-negative bacilli.  
Apart from resistance selection attributed to antibiotics, the delay in normal 
intestinal and NP colonisation may facilitate introduction of environmental 
pathogens or overgrowth of potentially opportunistic organisms normally pre-
sent in small numbers (Bennet et al., 1982; Sprunt, 1985; Gewolb et al., 1999; 
Tanaka et al., 2009), especially promote intestinal colonisation with Candida 
spp. (Bendel, 2003; Bonnemaison et al., 2003; Donskey, 2004). Gewolb et al 
(1999) have shown an inverse correlation between the number of days on 
antibiotic treatment in the first month of life and the number of bacterial species 
(r=0.491; p=0.007) and the total number of organisms (r=0.482; p=0.008) in 
stool samples of ELBW infants on day 30. The association between the amount 
of antibiotics used and later colonisation has been confirmed in Yale by 
Almuneef et al (2001). They have also demonstrated the interplay of antibiotic 
use (ampicillin and gentamicin), development of gentamicin-resistance, and the 
spread of nosocomial Gram-negatives in the NICU setting.  
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Tanaka et al (2009) have monitored the influence of antibiotics admini-
strated to neonates (first-generation cephalosporins) or their mothers (second-
generation cephalosporins) for 4 days after delivery, on the development of 
intestinal microbiota. They showed a significant overgrowth of enterococci on 
day 3 and 5 and one month and arrested growth of Bifidobacterium on Day 3 in 
the antibiotic treated group as compared with untreated group. Also, after the 
first month, the population of Enterobacteriaceae was markedly overrepre-
sented in the antibiotic therapy group as compared to the untreated population. 
Furthermore, infants whose mothers received antibiotics for Caesarean section, 
sustained similar, although relatively weaker, alteration in the development of 
microbiota.  
 
 
2.3.3. Empiric antibacterial treatment of early onset sepsis 
A combination of gentamicin with a beta-lactam antibiotic such as penicillin G 
or ampicillin is recommended as the treatment of choice for EOS by most hand-
books and guidelines (Joung, 2008; Metha, 2005; Schrag et al., 2002) and are 
used widely (Table 1). However, some experts advocate antibiotics of wider 
spectrum of activity like third generation cephalosporins (Hall et al., 2011). 
Although, their use has remained limited because of increasing resistance 
(Yurdakok, 1998; De Man et al., 2000; De Hoog et al., 2005; Hakalehto, 2006; 
Ambroise, 2009), there may be a place for broader spectrum primary EOS 
therapy in special circumstances. Thrombocytopenia <94.5 X 109/L with con-
comitant need for vasoactive treatment; or white blood cells (WBC) below 
3.5 X 109/L or above 38.8 X 109/L; or blood glucose below 1.65 mmol/L within 
72 h of PNA all carry a more than 30% risk of a penicillin and gentamicin 
treatment failure in neonates at risk of EOS as highlighted recently by Metsvaht 
et al. (2009).  
Penicillin and ampicillin are in general considered as narrow spectrum anti-
biotics but ampicillin has higher activity against some Gram-negative bacteria 
(e.g. E. coli) than penicillin G and is also effective against entrococci, Listeria 
monocytogenes, and group A and B streptococci (Yurdakok, 1998;  De Man et 
al., 2000; De Hoog et al., 2005; Hakalehto, 2006; Schrag et al., 2006b; 
Ambroise, 2009). Aminoglycosides are bactericidal antibiotics used for broad 
spectrum coverage of most Gram-negative organisms. They work by inhibiting 
protein synthesis on 30S ribosomes (De Hoog et al., 2005; Ambroise, 2009). 
A limited number of studies have looked at the effect of short-term empiric 
antibacterial therapy of EOS on mucosal colonisation in the era of resistance 
and no final conclusions can be drawn. De Man et al (2000) compared the effect 
of amoxicillin plus cefotaxime with penicillin plus tobramycin on the emer-
gence of resistant Enterobacteriaceae in two NICUs in the Netherlands over a 
period of six months. They found an 18.8% colonisation rate with bacteria 
resistant to initial antibiotics with the first regimen compared to only 1.3% with 
the second regimen. Still, the study did not clarify whether the differences 
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between the two antibiotic regimens were triggered by amoxicillin or cefo-
taxime or both.  
In a French study Bonnemaison et al (2003) compared the impact of two 
antibiotic combinations (amoxicillin + netilmicin and amoxicillin, cefotaxime 
and netilmicin) on the faecal flora during the first 10 days of life with untreated 
controls. In the untreated control group the overall colonisation began within the 
first 3 days of life and was of normal biodiversity, while in the group receiving 
the combination of three drugs the overall colonisation was delayed, a species 
level biodiversity was low, and rapid growth of staphylococci (mainly S. epi-
dermidis) and Candida spp. occurred.  
To avoid resistance Auriti et al (2009) shortened the course of antibiotic 
prophylaxis (ampicillin and netilmicin) and showed, that a single dose on ad-
mission was as effective as a three day course with no significant differences 
between the two groups in overall mortality and incidence of vertically acquired 
infections (23.9% vs 22.2%). 
 
 
2.4. Association between mucosal  
colonisation and invasive diseases 
 
2.4.1. Mucosal surfaces as a source of invasive disease 
In NICU by the end of the first week of life more than 40% and by Day 30 
almost all high risk neonates have mucosal colonisation with potentially 
pathogenic Gram-negative microorganisms which due to disturbed integrity of 
the barriers in sick neonates may result in invasive disease (Lin et al., 2008; 
Ambroise, 2009; Ogra, 2010; Smith et al., 2010). Genetical concordance of 
colonising and invasive strains has been demonstrated previously (Cartelle et 
al., 2004; Graham et al., 2007; Miranda et al., 2009). For example in 15 of 35 
(43%) cases of candidemia GIT colonisation preceeded and in 14 patients’ 
clonal relatedness of colonising and bloodstream isolates was confirmed (Sai-
man et al., 2000). Also, in 117 episodes of ceftazidime-resistant Gram-negative 
bacteraemia in 74.5% colonisation (oral swabs, urine sampling, tracheal 
aspirates, wounds) preceded invasive disease (Blot et al., 2005). 
The large intestine is a reservoir of Enterobacteriaceae, other Gram-negative 
bacilli (Foca et al., 2000; Donskey, 2004; Gupta et al., 2004; Duman et al., 
2005; Tapiainen et al., 2006; De La Cochetiere et al., 2007; Graham et al., 
2007; Srivastava et al., 2007), Candida spp. (Saiman et al., 2001; Donskey, 
2004; Hallstrom et al., 2004; Feja et al., 2005; Mendiratta et al., 2006; Manzoni 
et al., 2008; Miranda et al., 2009;) and of enterococci (Askin et al., 2005; 
Hufnagel et al., 2007). Mucosa may also serve as a source of opportunistic 
staphylococci and streptococci. For example NP constitutes an important 
ecological reservoir of microorganisms such as Streptococcus pneumoniae and 
S. aureus (Lima et al., 2010). In Taiwan it has been demonstrated that a neonate 
in a NICU may harbour MRSA strains in multiple sites for a long period  
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(>3 months), and colonisation serves as a significant risk factor for subsequent 
infection (OR: 19.86; 95% CI: 9.11–45.07). By the results of PFGE analyses 
colonised and clinical isolates were indistinguishable in 63 out of 68 episodes, 
highly related in 2, and distinct in 3 episodes (Huang et al., 2006a).  
As CoNS infections have been associated with skin colonisation, strategies 
to reduce infection rates have focused primarily on the insertion and main-
tenance of CvCs (Ibrahim et al., 2000; Mahieu et al., 2001; O'grady et al., 2002; 
Bizzarro et al., 2005; Brady, 2005; Inglis et al., 2007; Babazono et al., 2008). 
The biofilm forming capacity of CoNS is thought to be the main virulence 
factor (Von Eiff et al., 2002). However, mucosal colonisation by CoNS as an 
important source of bacteraemia is also suspected, suggesting that strategies to 
decrease mucosal colonisation are needed for effective infection control 
(D'angio et al., 1989; Costa et al., 2004). For example, genotypically similar 
CoNS strains have been isolated from different body sites in 12 of 13 paired 
BSI episodes (8 caused by S. epidermidis, 3 by S. hominis and 1 by  
S. intermedius) (Huang et al., 2006b). Also, molecular relatedness between  
S. epidermidis BSI and tracheal isolates from four mechanically ventilated 
infants (Betremieux et al., 1995) and BSI and nasal mucosal isolates in four 
patients (Valvano et al., 1988) have been documented. The assumption that 
mucosal sites can be a source of BSI has been further enabled by the fact, that in 
3 of 7 bacteraemic patients plasmid profiles of the catheter entry site and blood 
isolates of S. epidermidis were different (Valvano et al., 1988). 
 
 
2.4.2. Factors that predispose translocation 
Neonates, especially those with extreme prematurity are immunocompromised 
with host response shifted towards immune tolerance; they have decreased T-
cell function compared to adults. Lower cytokine production, diminished 
natural killer cell cytotoxicity, neutrophil migration, and complement pathway 
activity have all been described (Ambroise, 2009). Membrane protective IgA is 
missing from the respiratory and urinary tracts, and unless the newborn is 
breast-fed, is absent from the gastrointestinal tract as well (Srivastava et al., 
2007). Although secretory IgA can be detected as early as the first week after 
birth, significant salivary IgA levels are detected only by 4–6 weeks of life 
(Ogra, 2010). Neonatal leukocytes are less bactericidal and phagocytic, com-
pared to adult ones. The newborn has also low or non-existent level of anti-
bodies, IgM and IgE and IgG antibodies have been acquired from the mother. 
However, it is important to note that passive transfer of maternal antibodies 
does not take place until the 29th week of gestation. This has implications for 
preterm infants born between 25–29th week of gestation; they are susceptible to 
infection despite the mother’s antibody status. A slow rise of immunoglobulin 
levels to that of older children occurs after 3 months of age (Srivastava et al., 
2007).  
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Several factors contribute translocation of microorganisms from mucosal 
surfaces. First, neonates, especially preterms have an increased intestinal perme-
ability, mainly in first two days of life, which may lead to bacterial translocation 
to systemic organs and tissues (Westerbeek et al., 2006; De La Cochetiere et al., 
2007; Ambroise, 2009). Second, natural barriers, such as the acidity of the 
stomach or the production of pepsin and trypsin that maintain sterility of the 
small intestine, are not fully developed until 3–4 weeks after birth (Srivastava et 
al., 2007), especially in enterally fed preterms (De La Cochetiere et al., 2007). 
Third, in preterm neonates poor gastric empting and immature small intestinal 
motility may result in NEC (Neu, 2007). Although the development of GIT 
motility begins in the second trimester, it does not mature until the third tri-
mester, and migrating motor complexes which pass as wavers along the 
intestines are not present until by about 34 weeks of gestation age (GA) (Lin et 
al., 2008). Fourth, as mentioned above a newborn infant particularly the 
preterm, does not have a mature immune system and is often unable to mount 
an effective immune response (Kelly et al., 2000; Modi et al., 2000; Mussi-
Pinhata et al., 2005; Srivastava et al., 2007; Lin et al., 2008; Ambroise, 2009). 
 
 
2.4.3. The definition and aetiology of early sepsis onset and  
late onset sepsis in the neonatal intensive care unit 
Neonatal sepsis is defined as systemic inflammatory response syndrome 
occurring in the presence of or as a result of suspected or proven infection in the 
first 4 weeks of life (Goldstein et al., 2005) and is the most common neonatal 
infection in the NICU (45–55%) (Borghesi et al., 2008). The reported incidence 
varies from 3 per 1000 live births in Northen-Europe (Tessin et al., 1990); 6–9 
in US (Cohen-Wolkowiez et al., 2009) and 7–23 in Africa and 7–38 in Asia 
(Vergnano et al., 2005; Thaver et al., 2009). No population-based statistics 
describing situation in Estonia is available. The nosocomial infection rate in 
NICU has increased over the past decade; between 2% to 28% of babies 
admitted to NICU experience at least one episode of bacteraemia (Edwards et 
al., 2002; Clark et al., 2004; Phillips et al., 2008). Since neonatal sepsis is 
associated with increased mortality, prolonged length of hospital stay and 
neurodevelopmental impairment both the human and fiscal costs are high 
(Edwards et al., 2002; Stoll et al., 2002b; Stoll et al., 2003; Apostolopoulou et 
al., 2004; Clark et al., 2004; Zaidi et al., 2011). 
Neonatal sepsis can be classified into two sub-types depending upon whether 
the symptoms develop before 72 h of PNA (EOS) or later (LOS) (Karlowicz et 
al., 2000; Edwards et al., 2002; Stoll et al., 2002a; Clark et al., 2004; Ambroise, 
2009; Smith et al., 2010). Infants who develop BSI in the first few days of life 
typically acquire the agent from their mother during the intrapartum period, 
while LOS originates from community or nosocomial source (Mussi-Pinhata et 
al., 2001; Brady, 2005; Mishra et al., 2006; Schrag et al., 2006b). Other time-
limits have also been suggested: episodes diagnosed on the day of delivery are 
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very EOS (Ronnestad et al., 2005b), those diagnosed from day 2 to day 7 of life 
EOS (Schrag et al., 2002; Ronnestad et al., 2005b), and LOS is defined as 
microbiologically verified septicaemia occurring after the first week of life 
(Ronnestad et al., 2005a). Still, even authors supporting the last mentioned LOS 
classification accept, that in >50% of cases, EOS manifests within 6 h of birth, 
and most cases occur within 72 h (Schrag et al., 2002). 
The major agents of EOS and LOS in different countries are presented on 
Table 2 and 3. The most frequent isolates in EOS in developed countries are 
group-B streptococci (GBS) and E. coli, although administration of IAP has 
reduced the rate of GBS sepsis over the last two decades by 50–80% (Moore et 
al., 2003; Daley et al., 2004; Trijbels-Smeulders et al., 2007). Some surveil-
lance data suggest that this success has been achieved at the cost of increasing 
cases caused by E. coli (Joseph et al., 1998; Towers et al., 1998; Schuchat et 
al., 2000; Stoll et al., 2002a; Stoll et al., 2003; Cordero et al., 2004; Bizzarro et 
al., 2005; Vergnano et al., 2010). The most frequent microorganisms involved 
in LOS are CoNS, Enterobacteriaceae and nonfermentative bacteria, including 
Acinetobacter spp and Pseudomonas spp. 
Since the late 1980s, Gram-positive organisms have replaced Gram-negative 
ones as the most common bacteria causing sepsis in developed countries 
(Bizzarro et al., 2005; Hira et al., 2007; Mackenzie et al., 2007; Stoll et al., 
2002b; Stoll et al., 2003; Tarnow-Mordi et al., 2010; Vergnano et al., 2010). 
This change can be welcomed, as the mortality of Gram-negative (26–40%) and 
Candida sepsis (28–32%) is similar and significantly higher than that of Gram-
positive sepsis (9–10%) (Bizzarro et al., 2005; Costa et al., 2004; Edwards et 
al., 2002; Hira et al., 2007; Kayange et al., 2010; Ronnestad et al., 2005a; 
Ronnestad et al., 2005b; Stoll et al., 2002b; Zaidi et al., 2005). For example, in 
Australian neonatal units the mortality risk of sepsis caused by Gram-negative 
bacilli (RR=45.5; 95% 16.8–123.3) or S. aureus (RR=36.1; 95% CI 13.0–100.2) 
was significantly higher than that of sepsis caused by CoNS (Tarnow-Mordi et 
al., 2010).  
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Table 2. Causative agents in percentages of EOS in the different countries by the result 
of articles published within last decade 
 
Study 
St
ol
l e
t a
l.,
 2
00
2b
 
B
iz
za
rr
o 
et
 a
l.,
 2
00
5 
C
or
de
ro
 e
t a
l.,
 2
00
4 
R
on
ne
st
ad
 e
t a
l.,
 
20
05
b 
V
er
gn
an
o 
et
 a
l.,
 
20
10
 
G
he
ib
i e
t a
l.,
 2
00
8 
M
ah
m
oo
d 
et
 a
l.,
 
20
02
 
A
gn
ih
ot
ri
 e
t a
l.,
 
20
04
 
M
ill
ed
ge
 e
t a
l.,
 2
00
5 
Year 1998–
2000 
1989–
2003 
1986–
2002 
1999–2000 2006–
2008 
2002–
2006 
1996–
1999 
 1996–
2001 
Country USA USA USA Norway UK Iran Pakistan India Malawi 
Sepsis onset <72h D0–4 <48h D1 D2–7 ≤48h <D7 <1 week <D7 <D7 
CoNS 11 6 – – 54 20* 49 – – – 
S. aureus – 7 4 – 39 5 7 24 45 15 
GBS 11 49 36 21  50 1 2 – 16 
Other streptococci 8 – 2 –  6 – – – 10 
Enterococcus spp – 5 2 –  2 5 – 5 – 
Bacillus – 1 – –  4 – – – – 
Other Gram-
positives 
5 – – –  – – – – 13 
Listeria 2 – – 7  6 – – – – 
E. coli 44 24 36 64  18 10 11 12 11 
Klebsiella spp – – 3 – 8 – 17 38 19 11 
E. cloacae – – – –  – – 9 7 – 
Serratia spp – – – –  1 – – – – 
H. influenzae 8 5 14 –  3 – – – – 
Acinetobacter – 1 1 –  – 1 11 6 – 
Pseudomonas – 2 3 –  1 7 2 6 – 
Other Gram-
negatives 
8 1 – 7  3 2 3 – 24 
Candida spp 2 1 – 1  1 – – – – 
* data on CoNS is presented without 2006 
 
 
In greatest part of developing countries, Gram-negative rods (Agnihotri et al., 
2004; Amaya et al., 2010; Asghart et al., 2010; Zaidi et al., 2005), often pre-
senting with a more rapid clinical deterioration commonly associated with endo-
toxin production, shock and coagulation problems, are the major agents of neo-
natal sepsis (Clark et al., 2004). A review of 11471 bloodstream samples 
showed that Gram-negative rods were isolated from at least 60% of positive 
blood cultures in all the developing regions world-wide, with K. pneumoniae,  
E. coli, Pseudomonas spp, and Acinetobacter spp predominating (Zaidi et al., 
2005). 
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Table 3. Causative agents in percentages of BSI or LOS in the different countries by the 
result of articles published within last decade 
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Year 1998–
2000 
1989–2003 1986–
2002 
1999–
2000 
2006–
2008
2004–
2008 
1996–
2001 
2002–
2006 
1996–
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Country USA USA USA Nor-
way 
UK Poland Malawi Iran Pakistan 
Sepsis onset >72h D5–30 D>30 >48h >D7 >48h BSI D8–30 >D7 >D7 
CoNS 48 40 25 57 43 54* 47 – 70 – 
S. aureus 8 6 12 5 10 18 1 7 5 57 
GBS 2 4 4 1 9 8  19 – – 
Other streptococci – 1 2 – – 2  23 – – 
Enterococcus spp 3 7 14 5 1 16 1 – 3 – 
Bacillus – – 1 – – 8 – – – – 
Other Gram-
positive 
9 – – – 2 2 – 6 – – 
E. coli 5 9 7 6 2  2 7 14 7 
Klebsiella spp 4 9 10 6 8 9 14 5 6 14 
E. cloacae 3 2 3 3 – 9 9 – – 7 
Serratia spp 2 2 6 1 – 2 11 – – – 
Acinetobacter – – 1 – – 2 4 – – 12 
Pseudomonas 3 5 2 3 – 5 2 – 2 2 
Other Gram-
negatives 
1 3 3 – 10 10 2 – – – 
Candida spp 12 11 8 12 13 9 7 33 – – 
* data of CoNS is presented without 2006 
 
 
2.5. Relevance of mucosal surveillance cultures  
to predict LOS 
 
For decades clinicians and researchers have attempted to use surveillance 
cultures to predict invasive infections but the issue remains controversial. Two 
types of studies have been published – those looking at the predictive value of 
each individual mucosal sample (Evans, 1988; Bertrand et al., 2001; Miranda et 
al., 2009) and the others comparing colonised patients with non-colonised ones 
(Harris et al., 1976; Sprunt, 1985; Pierro et al., 1998; Shankar et al., 2001). The 
first method based on the correlation of mucosal invasive sample pairs is more 
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precise and scientifically sound as it allows estimating the predictive value of 
each individual sample.  
Three decades ago Harris et al. (Harris et al., 1976) and Sprunt et al. (1978) 
reported the clinical relevance of surveillance cultures in neonatal units. They 
showed that some changes in NP microbiota allow predicting infection occur-
rence. For example by Harris et al (1976) systemic infection developed only in 
those orotracheally intubated neonates who became colonised with potentially 
pathogenic microbes either before or after intubation. By Sprunt et al (1978) 
infections occurred only in the group of neonates with “abnormal” pharyngeal 
colonisation (18 infections in 115 neonates, whose predominating NP coloniser 
was other than α-hemolytic streptococci in a concentration of 104 or greater 
cfu/ml and made up more than 90% of a sample population). On the other hand, 
neonates with normal flora (α-hemolytic streptococci predominating) or with 
cultures showing low or no microbial titres did not become infected. However, 
the authors pointed out that the surveillance collection strategy was labour 
intensive and expensive.  
The question of whether an intensive surveillance strategy is cost-effective 
remains unanswered (Blot et al., 2005; Mcginigle et al., 2008), although others 
have also suggested that mucosal samples taken once or twice a week allow 
identifying patients at risk of nosocomial infection (Pierro et al., 1998; Silvestri 
et al., 1999; Shankar et al., 2001). Some previous studies looking at the sen-
sitivity and specificity of surveillance cultures in predicting invasive disease in 
the NICU setting have found them suboptimal (Evans, 1988; Choi et al., 2008). 
In these studies, the overall sensitivity, specificity, and positive predictive 
values (PPV) were 16 – 56%, 38 – 82%, and 5 – 7.7%, respectively. The poten-
tial issues of these studies could be the inclusion of all hospitalised neonates the 
majority of whom were at low risk for nosocomial infection (Evans, 1988) or 
looking at high number of different species; many of them with low potential of 
causing invasive disease (Choi et al., 2008). More recently Smith et al (2010) 
evaluated the sensitivity, specificity, and PPV of GIT surveillance cultures to 
predict BSI caused by gentamicin-nonsusceptible Gram-negative bacteria in 
VLBW infants and reported sensitivity, specificity and PPV values of 100%, 
98%, and 94% respectively. They found, that under these circumstances and 
considering specific risk factors, surveillance cultures are useful during the 
second to sixth week of life to guide empiric therapy for LOS.  
In adults admitted to intensive care unit (ICU) the sensitivity, specificity, 
PPV and negative predictive value (NPV) of 53.6%, 90.3%, 27.6% and 96.6%, 
respectively, has been reported for mucosal samples in the detection of further 
positive deep site cultures (Bertrand et al., 2001). Surveillance cultures may 
also provide important information on the drug resistance of Gram-negative 
pathogens and this information can improve empiric antibiotic therapy for 
patients subsequently developing BSI (Papadomichelakis et al., 2008; Baba et 
al., 2011). McGingle et al (2008) reviewed the data on morbidity, mortality and 
costs from sixteen articles regarding the use of active surveillance cultures in 
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intensive care units (ICU) to reduce MRSA. While the reduction of MRSA 
infection was proven, the overall quality of the evidence was poor; thus defini-
tive, evidence-based clinical recommendations cannot be made. 
 
 
2.6. Microbiological methods to study mucosal 
colonisation in neonates 
 
2.6.1. Sample collection 
Studies looking at the mucosal colonisation have collected samples from 
different sites with variable frequency. More often, depending on the aim of the 
study, first sample was taken on admission, the last one on discharge, and 
remaining samples were taken with the frequency of once or twice a week. The 
differences in timing make it difficult to compare results of one study to the 
other. The methods applied in different studies are further detailed in Table 4.  
 
 
Table 4. Different timing of sample collection has been used in studies looking at 
factors associated with early mucosal colonisation 
 
Reference R/NP County n= Sample collection  
Almuneef et al., 2001 R USA 239 on admission, once a W and on 
discharge 
Baltimore, 1998 NP USA 49 within 72h and W 2, 6, 12,18, 26 of 
PNA 
Bennet et al., 1982 R Sweden 22 3 during the 1st, 6 during the 2nd, 2 
during the-3th W; on 22 and 49 D 
Blakey et al., 1982 R/NP Australia 28 whithin 8H of admission, twice a W 
Bonnemaison et al., 2003 R France 30 within 12H and D 3,7 and 10 of PNA 
De Man et al., 2000 R/NP Netherlands 436 on admission and once a W thereafter 
Duman et al., 2005 R Turkey 118 after admission, altough 4 samples 
every 2 W 
Gewolb et al., 1999 R USA 29 on D 10, 20 and 30 of PNA 
Harris et al., 1976 NP USA 54 within 4H of intubation and daily while 
intubated 
Hallstrom et al., 2004 R Finland 140 from first stool and twice a W until 
discharge 
Jaureguy et al., 2004 R France 50 on D3 after birth 
Mammina et al., 2007 R Italy 210 Twice a W (Thursday and Friday) 
Mendiratta et al., 2006 R/NP India 203 within 24H; D 3,5,7; once a W until 
discharge  
Millar et al., 2008 R UK 221 W 2 of PNA and at discharge 
Penders et al., 2006 R Netherlands 1032 M 1of PNA 
Pierro et al., 1998 R/NP UK 94 at the start of PN and thereafter twice a W 
Saiman et al., 2001 R USA 2157 on admission, once a W until discharge 
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Reference R/NP County n= Sample collection  
Schwiertz et al., 2003 R Germany 29 Daily for 2 W and thereafter twice a W 
Sprunt et al., 1978 NP USA 223 twice a W 
Tapiainen et al., 2006 R Finland 32 from each stool in the first 2–7D PNA 
Tanaka et al., 2009 R Japan 44 daily for the first 5D, monthly for the 
first 2M 
Toltzis et al., 2001 R/NP USA 1180 Monday, Wednesday, Friday 
M – month; W – week; D – day; R – rectal samples; NP – nasopharyngeal samples;  
n=  –  number of participants 
 
 
2.6.2. Identification of microorganisms, detection of genetic 
relatedness between different microbes and microbial diversity 
Current knowledge of gut microbial ecology and diversity is almost exclusively 
based on the use of classic culture techniques (Baltimore et al., 1989; Pierro et 
al., 1998; Gewolb et al., 1999; De Man et al., 2000; Almuneef et al., 2001; 
Bonnemaison et al., 2003; Hallstrom et al., 2004; Mammina et al., 2007; Millar 
et al., 2008;) and the composition of intestinal microbiota of the neonate cannot 
yet be considered as clearly defined, as many bacterial species living in the gut 
are unculturable by conventional cultivation techniques (Morowitz et al., 2010; 
Mshvildadze et al., 2010a). By applying molecular techniques it has been 
shown that 105 of 325 isolated clones from infant faeces were unknown species 
(De La Cochetiere et al., 2007), and according to Mshidadze et al (Mshvildadze 
et al., 2010a) even 80% of microbes in the intestinal tract are very difficult if 
not impossible to culture by current methods. In addition, acquisition of un-
culturable bacteria expands rapidly after the third day of life (De La Cochetiere 
et al., 2007; Biasucci et al., 2010).  
Molecular approaches that identify microbes from small-submit gene 
sequences offer advantages over cultivation (Mshvildadze et al., 2010a). For 
example, an electrophoresis technique, PFGE, made it possible to separate large 
DNA fragments. This method has remarkable discriminatory power and repro-
ducibility, and has therefore become a widely applicable for comparative typing 
of almost all bacterial species (Van Belkum et al., 2007). PFGE and multi-
enzyme multiplex polymerase chain reaction (PCR) amplified fragment length 
polymprphism (AFLP) methods are closer described in chapter 4.3.3.3. For 
molecular analyses also 16S rRNA gene is typically chosen. The rRNA gene 
sequences comprise highly conserved sequence domains interspersed with more 
variable regions and simple profiling approaches such as DGGE, automated 
ribosomal intergenic spacer analysis (ARISA) and restriction fragment length 
polymorphism methods (RFLP) allow for an efficient evaluation of overall 
microbiota diversity. Methods, such as fluorescent in situ hybridization (FISH) 
and real time PCR are often complemented with quantitative tools (Mshvil-
dadze et al., 2010a). Also, microarray chip technology allows the assessment of 
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all bacterial species known to inhabit the human colon, but it is still very costly 
(Enck et al., 2009). Anyway, powerful novel sequencing approaches, including 
pyrosequencing, allow for an in depth analysis of even minor members of 
microbiota (Mshvildadze et al., 2010a). 
As previously described, molecular methods have been used to study human 
microbiota for only a decade and the available data are limited. These methods 
have been mostly applied for monitoring of microbial cross-colonisation 
(Almuneef et al., 2001; Toltzis et al., 2001; 2002; Cartelle et al., 2004; 
Mammina et al., 2007; Prelog et al., 2009; Sanchez-Carrillo et al., 2009;), 
translocation (Cartelle et al., 2004; Miranda et al., 2009) or their diversity 
(Schwiertz et al., 2003; Tanaka et al., 2009). This may, however, change in the 
near future, although in the last decade the data obtained by culture-independent 
techniques (FISH; DGGE; 16S rRNA cloning and sequencing, real time PCR) 
mostly support the results obtained by using selective cultures (Morelli, 2008).  
 
 
2.6.3. Antibiotic susceptibility testing 
Antibacterial resistance is spreading among a variety of clinically significant 
bacterial species. Therefore, the microbiology laboratory plays a key role in 
patient management by providing accurate data on which physicians can rely in 
treatment decisions (Turnidge et al., 2007). Laboratories can choose from among 
several conventional or novel methods for performance of routine antimicrobial 
susceptibility testing: the disk diffusion test, E-tests, broth microdilution, agar 
gradient, and rapid automated instrument methods (Jorgensen et al., 2005). Also 
molecular methods, such as mecA gene detection for determination of methicillin-
resistance of S. aureus, are used (Chambers, 1997; Dickinson et al., 2000). All 
these differ in cost, labour-intensity and accuracy, and are of course of different 
specificity. For this reason the choice of different methods in studies depends on 
the aims and amount of surveys, needed and performed.  
In colonisation studies where many susceptibility tests for different antibio-
tics are done mostly breakpoint susceptibility testing on selective medias with 
antimicrobial agents in certain concentrations  (Frebourg et al., 1999; Lidsky et 
al., 2002; Udo et al., 2008) or disc diffusion testing (Shi et al., 1996; Lindberg 
et al., 2004; Chiu et al., 2005; Bagattini et al., 2006; Dalben et al., 2008; Mitt et 
al., 2009; Lima et al., 2010) have been used. In most cases, E-tests are used 
only as an additional method for detailing minimal inhibiting concentration 
(MIC) values or for further detecting ESBLs (Ayan et al., 2003; Chiu et al., 
2005; Duman et al., 2005; Bagattini et al., 2006). As in the beginning of herein 
study the claims of Clinical and Laboratory Standards Institute (CLSI) were 
essential, the other criteria also exist. For example by the European Committee 
on Antimicrobial Susceptibility Testing (EUCAST) lower MIC values are 
recommend, and in comparison by CLSI, the higher level of resistance may 
occur. For example by CLSI vs EUCAST MIC values for ampicillin for 
Enterobacteriaceae ≥32 vs >8, respectively, have been recommended.  
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2.7. Summary of the literature 
 
Colonisation of mucosal surfaces with opportunistic microorganisms starts right 
after birth. On one hand mucosal colonisation by Gram-negative micro-
organisms is a normal process occurring over time but on the other hand it 
could also serve as a source for invasive infection (Cartelle et al., 2004; Graham 
et al., 2007; Miranda et al., 2009). Therefore a better understanding of the 
factors associated with the colonisation process might contribute to improved 
infection control-strategies and eventually improve the outcomes for critically 
ill neonates (Donskey, 2004; Miranda et al., 2009). Numerous studies have 
looked at factors associated with early mucosal colonisation and have identified 
several, like country of origin, maternal microbiota, PROM, route of delivery, 
GA, surrounding environment, feeding habits, and antibiotic use, as having a 
role. However, most of these studies have either included only a limited number 
of infants, have focused on gut colonisation alone, included healthy infants, or 
looked at only a few microbial species or risk factors at a time despite that the 
majority of factors are highly interrelated. In addition, studies in critically ill 
neonates admitted to NICU and especially those, looking at multiple factors and 
species simultaneously, are scarce. 
Fear of infection often leads to early use of empiric broad-spectrum anti-
biotics, a strategy that may select for resistant bacteria and Candida spp. 
(Gewolb et al., 1999; Bonnemaison et al., 2003; Fanaro et al., 2003). The use of 
ampicillin in intrapartum prophylaxis of group B streptococcal infection has 
been associated with the emergence of E. coli as a major causative pathogen of 
EOS in many countries and probably with an increase in ampicillin-resistance 
(Laugel et al., 2003; Stoll et al., 2002a) but the data are not conclusive 
(Jaureguy et al., 2004). On the other hand narrow spectrum penicillins like 
penicillin G have the least potential of interfering with normal gut colonisation 
(Bennet et al., 1982). Although, the negative impact of antibiotics to bowel 
colonisation is widely reported, the number of comparative studies, especially 
those reflecting the empiric use of the two mostly recommended regimens 
(penicillin G or ampicillin with gentamicin) for EOS, is still limited.  
Due to disturbed integrity of the barriers and immature immune response 
colonisation may lead to invasive disease in sick neonates; concordance of 
colonising and invasive strains has been demonstrated previously (Graham et 
al., 2007). For decades clinicians and researches have attempted to use 
surveillance cultures to predict invasive infections but the issue remains 
controversial. Surveillance cultures of the GIT, pharynx, and/or skin have been 
studied in an effort to identify infants who will develop infections. The 
surveillance cultures have been found to be relevant but their collection is 
labour intensive and expensive. Furthermore the sensitivity and specificity of 
surveillance cultures in predicting invasive disease in the setting of neonatal 
unit have found to be suboptimal (Evans, 1988; Choi et al., 2008). Still, some 
experts suggest that mucosal samples taken once or twice a week allow 
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identifying patients at risk of nosocomial infection (Pierro et al., 1998; Silvestri 
et al., 1999; Shankar et al., 2001). In addition, surveillance cultures may 
provide insight into the patients’ colonisation status and may guide physicians 
in antibiotic choice when infection occurs (Glynn et al., 2005). Hence, the role 
of surveillance cultures in predicting BSI needs to be proven, with special focus 
on specific high risk populations. 
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3. AIMS OF THE RESEARCH 
 
The general aim of the study was to compare how antibiotics commonly used 
for empiric therapy of EOS (ampicillin or penicillin both combined with 
gentamicin) influence the development of gut and NP microbiota and to define 
which of the abovementioned regimens should be preferred in terms of mucosal 
colonisation.  
The following specific aims were addressed:  
1. to characterize the prevalence and dynamics of mucosal colonisation by 
aerobic opportunistic bacteria and Candida spp. in neonates admitted to 
NICU with risk factor based suspicion of EOS; 
2. to identify independent perinatal, neonatal, and environmental factors 
influencing the colonisation process;  
3. to compare the influence of empiric EOS treatment with ampicillin and 
penicillin G (both combined with gentamicin) on early gut colonisation by 
aerobic, facultatively anaerobic and ampicillin resistant bacteria, accounting 
for other known risk factors interfering with the colonisation process; 
4. to identify the relatedness of microorganisms isolated from NP and rectum to 
isolates form sterile sites and thus characterize their potential for causing 
invasive disease; 
5. to define the value of twice a week collected surveillance cultures in 
predicting Gram-negative LOS in high risk neonates admitted to NICU. 
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4. PATIENTS AND METHODS 
This thesis is based on a prospective open label two centre cluster randomised 
study that compared the efficacy of penicillin G and ampicillin (both combined 
with gentamicin) in the empiric treatment of neonates with risk of EOS and 
evaluated the impact of these antibiotics on early gut colonisation. The study 
was conducted between August 2, 2006 and November 30, 2007 in the pae-
diatric and neonatal intensive care units of Tartu University Hospital and 
Tallinn Children’s Hospital. The analyses that were conducted are presented in 
Table 5.  
 
 
 
 
4.1. Ethics 
 
The study was approved by the Ethics Committee of the University of Tartu and 
registered at ClinicalTrials.gov identifier: NCT00487019.  
The study design was discussed with the Ethics Committee and an informed 
consent was not considered necessary because both antibiotic regimens are 
routinely used in the participating units. Similaer to the study in Netherlands 
(De Man et al 2000) our investigation can also be considered also a quality 
control of the hospital hygene practices, and not experimentation with human 
beings. Parents of the newborns were informed of all antibiotic treatments. 
Furthermore no additional interventions were conducted for study purposes only 
and for assessment the influence of different antibiotic regimens on the 
colonisation and the circulation of resistant microorganisms in NICU inclusion 
 
Table 5. Description of analyses of the thesis 
 
Analyses 
Number 
of 
subjects 
Collection site and number of samples Publication 
Risk factors of gut and NP 
colonisation 
276 Rectal 1242; NP 145; tracheal 60  III 
Comparative influence of 
empiric AB regimen on 
initial rectal colonisation 
276 Rectal 1242; NP 1145; tracheal 60 I 
Predictive value of 
surveillance cultures 
278 Rectal 1250; NP 1153; tracheal 60;  
sterile fluid samples 554 
II 
Detection of the related-
ness between mucosal and 
invasive strains: 
  I, II 
MRSA 11 Rectal 16; NP 1; tracheal 3; blood 5; breast milk 1; axilla 1; eye 1 
K. pneumoniae  47 Rectal 96; NP 56; tracheal 3; blood 5  
A. baumannii 7 Rectal 4; NP 4; blood 6 
E. cloacae  5 Rectal 3; NP 1; blood 5 
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of all affected patients were required. Finally the collection of surveillance 
cultures from all patients admitted to NICU was introduced by hospital 
infection control services prior commencing this study.  
 
 
4.2. Study setting, population and design 
 
4.2.1. Study setting 
Both participating units (later referred as unit A and unit B) are third level 
mixed referral PICUs admitting neonates either directly from the maternity or 
intermediate care units or from home. About 60–65% of all admissions are 
neonates cared for in a separate area. Both units have facilities for high fre-
quency ventilation, inhaled nitric oxide therapy and neonatal surgery. The 
paediatric intensive care unit (PICU) in Tartu University Hospital is divided 
into four and in Tallinn Childrenś Hospital into five rooms; the number of 
neonates in a room varies from three to six. The nursing staff/infant ratio in the 
units is 1:2, but can be 1:3 occasionally. Gloves, gowns, caps and masks are 
used routinely in all aseptic procedures. In general both units follow similar 
hospital infection prevention guidelines and strict antibiotic policy, in which 
narrow spectrum antibiotics and short courses are preferred. According to the 
infection control guidelines patients colonised with alert microorganisms are 
isolated in separate rooms and cared for by separate nurses. Both units practice 
early introduction of enteral feeding with preference given to breast milk. Breast 
milk is frozen but neither pasteurized nor fortified except in VLBW neonates 
after reaching enteral volume of 100 ml/kg. Formula if needed is prepared 
centrally; donor milk is not used.  
 
 
4.2.2. Study population 
Neonates were included in the study if they were younger than 72 hours, needed 
early empiric antibiotic treatment on clinical suspicion and/or due to risk factors 
of infection  according to the Centers for Disease Control and Prevention 
(CDC) criteria (i.e. maternal fever, chorionamnionitis, PROM more than 18h, 
preterm labour of <35 weeks of gestation) (Schrag et al., 2002) and were 
expected to stay in the unit for >24 hours. Patients who had received a different 
antibiotic regimen for more than 24h, had suspicion of meningitis, NEC, 
peritonitis or severe sepsis with a history of isolation of microorganisms 
resistant to the study regimen from maternal urinary tract or birth canal or had 
other situations where the treating physician considered a different antibiotic 
regimen necessary were excluded.  
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4.2.3. Study design and antibiotic treatment 
In the first period of the study (from August 2, 2006 to March 20, 2007) in unit 
A all patients received ampicillin (25 mg/kg 8–12 hourly) and in unit B peni-
cillin G (25,000 IU /kg 8–12 hourly), both in combination with gentamicin (4–
5 mg/kg 24–48 hourly, according to GA) (Metsvaht, 2010). After enrolling half 
of the patients required to prove clinical equivalence of the two antibiotic 
regimens the penicillins were switched (from March 21, 2007 to November 30, 
2007) so that in unit A penicillin G and in unit B ampicillin was used (Figure 1). 
Further patients receiving ampicillin with gentamicin or penicillin with genta-
micin will be called the ampicillin and penicillin group, respectively. If no 
clinical or laboratory signs of invasive infection were present and initial blood 
cultures remained negative, antibiotic therapy was stopped on Day 3.  
 
 
 
Figure 1. Study outline and reasons for exclusion (A – age on admission more than 72 
hours; B – no need for early empirical antibiotic treatment; C – different antibiotic regi-
men for more than 24 hours; D – need for different antibiotic regimen on admission; E – 
transfer from neonatal intensive care unit within 24 hours; F – no samples). NICU – 
neonatal intensive care unit. Number of cases is shown on y-axis. 
 
 
In case of clinical or culture proven infection initial antibiotic regimen could be 
continued if susceptible pathogens were involved or changed to a prespecified 
regimen depending on the antibacterial susceptibility of the isolate. For the 
empiric therapy of LOS cefuroxime, cefotaxime, ampicillin/sulbactam, or 
piperacillin/tazobactam alone or in combination with gentamicin was re-
commended. In neonates with BW below 800 g and central vascular catheter(s) 
in place vancomycin was added until infection caused by CoNS was ruled out 
by negative cultures. 
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4.2.4. Data collection 
The following maternal and perinatal characteristics were registered: maternal 
age, type and time of antibiotic treatment during pregnancy and delivery, 
presence of PROM for more than 18 h, multiple birth, mode of delivery, in-
cluding reason for caesarean section. 
For each patient the demographic characteristics and clinical data were 
collected as follows: BW; GA; duration of ALV; age on admission to PICU; 
ward; study period (divided into first and second) (Figure 1); duration of PICU 
stay; time, type and duration of initial and subsequent antibiotic regimens 
(carbapenems, third and fourth generation cephalosporins, and beta-lactamase 
resistant penicillins), duration of CvC and arterial catheter use.  
Feeding regimen was documented on Days 1, 3 and 7 with patients cate-
gorized into three groups based on the route of nutrition and the character of 
enteral feeds: (1) TPN when enteral calories constituted less than 10% of total 
daily calories; (2) breastfeeding when breast milk constituted more than 10% of 
enteral feeds and (3) formula feeding when formula constituted more than 89% 
of enteral feeds.  
 
4.3. Microbiological studies 
 
4.3.1. Pilot study 
Prior to commencing the main study (from October 21, 2005 to January 1, 
2006) a pilot study aiming to evaluate the influence of freezing on microbial 
recovery rates was conducted. In this study two rectal swabs (n=70) were 
collected from each subject (n=26) into a transport medium. One swab was sent 
directly to the microbiology laboratory for immediate culturing and species 
identification and the other was frozen at –20oC for a maximum of 22 days 
(median 14; interquartile range (IQR) 11–15). A total of 35 sample pairs were 
obtained. The recovery rate of frozen samples was good (86.4%). The sensi-
tivity of 100% (95% CI 79; 100), specificity of 81% (95% CI 54; 95), PPV of 
86% (95% CI 64; 96) and NPV of 14% (95% CI 4; 36) were observed. As 2 of 
the 3 cultures with a difference between frozen and fresh samples had been 
stored for more than two weeks we concluded that storing for a maximum of 
two weeks will not significantly influence the outcome.  
 
 
4.3.2. Sample collection and storage 
Rectal and NP specimens were collected with transport swabs (Nuova Aptaca, 
Canelli, Italy) on admission to PICU and then twice a week until discharge or 
Day 60 whichever occurred first. From patients receiving ALV tracheal aspirate 
instead of NP swab was collected. Samples were stored at –20°C for a maxi-
mum of two weeks and analysed in batches in the Department of Microbiology, 
University of Tartu. 
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Normally sterile body fluids (e.g. 0.5 ml blood, 0.2 ml cerebrospinal fluid if 
needed) were cultured preferably before administration of antibiotics on ad-
mission and then if clinical condition deteriorated and symptoms suggestive of 
neonatal sepsis, as detailed elsewhere, appeared (Metsvaht et al., 2010). 
Samples were processed immediately after collection in the microbiology 
laboratories of the Tartu University Hospital or North Estonia Medical Centre. 
All mucosal and invasive isolates were stored in skim-milk at –80ºC for further 
analysis, if needed.  
 
 
4.3.3. Microbiological analyses 
4.3.3.1. Identification of microorganisms 
The flowchart of mucosal sample testing is presented on Figure 2. Briefly, after 
thawing rectal swabs were directly plated onto blood agar, MacConkey agar for 
isolation of Gram-negative bacteria, and Sabouraud agar for isolation of yeasts. 
NP specimens were plated onto McConkey agar. The blood and MacConkey 
agar plates were incubated at 37oC in ambient air for 24 to 48 h and Sabouraud 
agar plates at 25oC for at least one week. Each morphologically different colony 
type was identified on species and genus level according to the CLSI criteria 
(CLSI, 2005). The Staphylococcus aureus strains were further tested by PCR 
for nuc genes using sequence specific primers (Brakstad et al., 1992; Khan et 
al., 2007), as presented in Table 6; detailed PCR procedure is described in 
chapter 4.3.3.2. 
 
 
Table 6. Sequences of adapters and primers of the molecular analyses 
 
Primer 
name 
Primer sequences      
(5’ → 3’) 
Adapter sequences  
(5’ → 3’) 
Recognition site Restriction 
enzyme 
Pxn * AGAGTCTGCCAGT
ACTAG 
CTAGTACTGGCAGAC
TCTGCCAGTA 
5’ T  CTAGA 3’ 
3’ AGATC  T 5’ 
XbaI 
Pst-at* GACTGCGTACATG
CAGAT 
CTCGTAGACTGCGTA
CATGCATGTACGCAG
TCTAC 
5’ CTGCA  G 3’ 
3’ G  ACGTC 5’ 
PstI 
nucF** GCGATTGATGGTG
ATACGGTT 
NA NA NA 
nucR** AGCCAAGCCTTGA
CGAACTAAAGC 
NA NA NA 
mecA*** AGTTGTAGTTGTC
GGGGTTT 
NA NA NA 
mecA*** AGTGGAACGAAGG
TATCATC 
NA NA NA 
* For AFLP. Adapted from van der Zee et al (2003). All oligonucletides were 
purchased from 5’ end of each oligonucleotide was phosphorylated. 
** For identification nuc gene (Brakstad et al., 1992; Khan et al., 2007) 
*** For identification mecA gene (Chambers, 1997; Khan et al., 2007) 
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Figure 2. Rectal and NP sample flow 
 
 
 
4.3.3.2. Antibiotic susceptibility testing 
All samples were also plated onto MacConkey agar with 16 μg/ml of ampicillin 
for the detection of Gram-negative AR strains. For staphylococci oxacillin-
resistance was determined using Mueller-Hinton agar plates containing 4% 
NaCl with 6 μg/ml of oxacillin for S. aureus and 2% NaCl with 0.75 μg/ml of 
oxacillin for CoNS (Huang et al.; 1993; CLSI, 2005). The S. aureus strains 
  
Conventional cultivation 
techniques API 
Molecular 
techniques 
Gram-negatives 
► McConkey agar  
API 20E 
(Biomé-
rieux,  
France) 
 PFGE: 
      ▼   K. pneumoniae 
 
Kliegler - glycose, lactose, 
gas  ► E. cloaceae 
 Simmonds – citrate   AFLP: 
 
SIM – indole, mobility, 
hydrogen sulfide   
K. pneumoniae 
 Urea  ►   
       ▼    
Enterobacteriaceae ► DNAase – Serratia     
Nonfermentative ► Oxidation-Fermentation test ► ► PFGE: 
      Acinetobacter 
Gram-positives ► Blood agar                
                               ▼    
Streptococci ► Catalase – negatiive     
Enterococci ► 
Catalase  – negative; 
Enterococcosel Agar     
KoNS ► Catalase  – positive ▼ ► 
API STAF 
(Marcy 
l’Etoile, 
France) 
  
S. aureus 
► 
Egg-Yolk Mannitol Salt 
agar  ► nuc-gene 
► 
Staphylococcus Latex test 
(Oxoid, UK) ►   
    ► 
mecA-gene 
(MRSA) 
Yeasts 
► 
Saboraud agar with 
antibiotics     PFGE                
(MRSA) 
► CHROMagarTMCandida;    
  
(BD BBL, Heidelberg, 
Germany) 
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were tested for methicillin-resistance by PCR detection of mecA gene using 
sequence specific primers as shown in Table 6 (Chambers, 1997; Khan et al., 
2007). PCR conditions comprised a thermal temperature 94°C for 3 minutes, 
followed by 30 cycles of 94°C for 30 seconds, annealing at 53°C for 20 
seconds, followed by a final extension for 5 minutes at 72°C.  
The ampicillin and gentamicin MIC values of all Gram-negative invasive 
isolates and of the first mucosal isolate of the same microorganisms from the 
same person were determined by E-tests (AB BIODISK; Sweden) on Mueller-
Hinton agar plates and evaluated according to the CLSI criteria.  
Microbiological culture techniques were not altered during the study.  
 
 
4.3.3.3. Detection of genetic relatedness between different 
microorganisms 
PFGE 
The PFGE analysis was performed for mucosal and invasive strain pairs of  
K. pneumoniae, E. cloacae and MRSA according to the manufacturer’s instruc-
tions (Genepath, Bio-Rad, France). Briefly, a colony was picked up from the 
blood agar plate, inoculated in 5 ml trypticase soya broth, incubated overnight at 
37o C in ambient air and pelleted at 12,000 rpm for 2 min. DNA was restricted 
with commercially available PFGE kits using SmaI (MRSA) and SpeI (Entero-
bacteriaceae) enzyme (Genepath, Bio-Rad, France). Electrophoresis was 
performed in the CHEF-DR II (Bio-Rad, France) with linear ramped pulse 
times of 5–35 s and at a voltage of 6 V/cm, at 12ºC for 20 h. The images of the 
gels were processed with the software Gene Tools (Syngene Ver 1,2, UK). For 
A. baumannii a previously described method using enzyme ApaI ( Zarrilli et al., 
2007; Arpac, 2009) was performed. The results were estimated discriminatory if 
at least ten-banding-pattern appeared; up to three band differences in PFGE 
were considered to represent clonally related strains (Tenover et al., 1995; 
Toltzis et al., 2002).   
 
AFLP 
For AFLP from each patient colonised with K. pneumoniae the first and last NP 
and rectal isolate was selected. If the baby was colonised by susceptible and AR 
strains the selection was performed the same way for both isolates. From those 
colonised for longer than three weeks an additional isolate was selected between 
the first and last sample.  
Multienzyme multiplex AFLP protocol developed by van der Zee et al (Van 
Der Zee et al., 2003) was used with few modifications. Briefly, bacterial DNA 
was digested with four different restriction enzymes and adapter oligonucleo-
tides were ligated to fragments simultaneously. After purification of DNA 
fragments, PCR targeting adapter sequences was performed. The PCR products 
were separated on agarose gel electrophoresis.  
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DNA was extracted from bacterial culture using QIAamp DNA minikit 
(Qiagen, Hilden, Germany) following manufactures instructions. Approxi-
mately 300 ng of genomic DNA was subjected to a restriction-ligation reaction 
in a final volume of 30 L. Restriction enzymes PstI, NheI, EcoRI and XbaI  
(20 U each; MBI Fermentas, Vilnius, Lithuania) were used in addition to 1 U of 
T4 ligase, 3 L of T4 ligase buffer, 15 nmol of ATP (all MBI Fermentas, 
Vilnius, Lithuania) and 20 pmol of each of the four ligation adapter oligo-
nucleotides (TAG Copenhagen A/S, Denmark), targeting the overhanging ends 
of XbaI and PstI restricted fragments. The restriction-ligation mixture was 
incubated at 37C for 3 h, followed by DNA precipitation with 2.5 M ammo-
nium acetate in 100 L cooled absolute ethanol. DNA was washed twice using 
70% ethanol and resuspended in 50 L TE-buffer (pH 8.0).  
According to van der Zee et al (Van Der Zee et al., 2003), PCR with the 
combination of two PCR primers, Pxn and Pst-at, has the best discriminatory 
power and band resolution compared to separate runs with both primers (Pxn or 
Pst-at). PCR was performed in a total volume of 25 L, using 0.5 U re-
combinant Taq DNA polymerase (MBI Fermentas, Vilnius, Lithuania), 
62.5 nmol MgCl2, 5 nmol of each deoxynucleotide (all from MBI Fermentas, 
Vilnius, Lithuania), 10 pmol of primers Pxn and Pst-at (Table 6) and 1 L of 
DNA. The reaction was carried out in the Eppendorf thermocycler under the 
following conditions: 4 minutes of preheating at 94C; 33 cycles of ampli-
fication at 94C for 1 minute, at 60C for 1 minute and at 72C for 2.5 minutes; 
ending by final elongation at 72C for 7 minutes. Twelve L of each PCR 
product was analysed on 1.5% (w/v) agarose gel stained with ethidium bromide. 
The band patterns on gel were analysed using GeneTools program (Syngene, 
Cambridge, UK).  
 
 
4.4. Definitions 
 
Neonatal sepsis (proven or clinical) was diagnosed in the presence of at least 
two clinical and two laboratory criteria as detailed elsewhere (Metsvaht et al., 
2010): hyper- or hypothermia, apnoea or bradycardia spells, increased oxygen 
requirement, feeding intolerance, abdominal distension, lethargy and hypotonia, 
hypertension, skin and subcutaneous lesions such as petechial rash, abscess, 
scleroderma; WBC count <5 or >20 X 109 /L; immature to total WBC ratio (I/T) 
>0.2; platelet count <100 x 109/L; CRP >10 mg/L.   
Early onset sepsis was defined as sepsis occurring within the first 72 h of 
life; all other cases were considered late onset sepsis ( Stoll et al., 2002a;, 
2002b; Hira et al., 2007). 
Neonates with the GA ≤28 weeks were considered extremely preterm, 29–
36 weeks late preterm, and ≥37 weeks term infants. 
Organisms were considered phenotypically similar if the same species of 
microorganisms were cultured and detected by similar biochemical properties at 
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different time points and/or from different sites. Phenotypically similar micro-
organisms from mucosa and sterile body fluids were called matching orga-
nisms. If results of PFGE analysis were available they overwrote phenotypic 
culture data.  
Genotypically similar organisms were defined according to PFGE if up to 
three band differences were considered to represent clonally related strains. For 
AFLP-PCR only fragments in the range of 200 to 2000 bp were included in the 
analysis and isolates showing >80% homology in pattern was considered 
clonally related strains.  
Prior mucosal colonisation was defined as the presence of microorganisms 
on mucosal surfaces for ≥2days but <14 days before the collection of positive 
normally sterile fluid cultures. 
Colonisation density (CD) was defined as the ratio of colonising days per 
100 PICU days. The number of colonising days was counted from the first until 
the last positive culture and extra two days were added to compensate for the 
sampling interval, which was 3 to 4 days. 
Invasive samples included blood and other sterile body fluids. 
 
 
4.5. Statistical analysis 
 
The software programs Sigma Stat for Windows 2.0 (Jandel Corporation, 
USA); R 2.6.2 (A Language and Environment, http://www.r-project.org), and 
EpiMax Table Calculator (Epidemiology and Lab Statistics from Study Counts, 
http://www.healthstrategy.com) were used for statistical analysis. Differences in 
proportions were compared using Chi-square test, odds ratios and/or Yates’ 
continuity correlation as appropriate. Normally distributed continuous variables 
were compared with Student’s t-test and non-normally distributed data with 
Mann-Whitney or Wald chi-square tests.  
 
 
4.5.1. Calculation of risk factors for mucosal colonisation  
by Gram-negative microorganisms 
A separate analysis was performed for each species and for the respective AR 
strain.  
First, an univariate logistic regression analysis was performed. All variables 
significant at a p-value of ≤0.1 were entered into multiple logistic regression 
model with backward stepwise removal in order of insignificance. To avoid 
confounding by simultaneous inclusion of highly interrelated variables only one 
was included. There was a high correlation between BW and GA (r = 0.933) 
and between the duration of NICU stay and PNA (r = 0.996). The GA was 
considered a better determinant of immaturity than BW (Almuneef et al., 2001; 
Kelly et al., 2000) and the duration of NICU stay more important than PNA in 
influencing mucosal colonisation.  
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Continuous variables like use of empirical antibacterial therapy, ALV, 
central venous and arterial catheters were studied by including binomial and 
duration characteristics. Wherever feasible continuous variables involving the 
impact of duration were given a priority. 
 
 
4.5.2. Comparing influence of penicillin G with gentamicin vs 
ampicillin with gentamicin on gut colonisation 
First, two treatment regimens were compared to each other in terms of the 
number of patients colonised and CD by using mixed models adjusted for 
participating unit and treatment period, as appropriate for cluster randomized 
study design. Next, for microorganisms in which empirical antibiotic regimen 
appeared a significant determinant of colonisation in primary analysis at a p-
value of ≤0.1, multivariate mixed effect models adjusted for other factors 
known to interfere with mucosal colonisation (GA, mode of delivery, maternal 
chorionamnionitis, PROM for more than 18 h before delivery, use of antenatal 
steroids and antibiotics, duration of ICU stay, type of feeding, presence of 
mechanical ventilation and culture proven EOS and use of carbapenems, third 
and fourth generation cephalosporins and beta-lactamase resistant penicillins) 
(Mackie et al., 1999; Fanaro et al., 2003; Thompson-Chagoyan et al., 2007) 
were developed.  
 
 
4.5.3. Calculation of sensitivity, specificity, positive and  
negative predictive values of mucosal samples 
For each mucosal-invasive sample pair an algorithm was generated as follows: 
(1) when both samples contained phenotypically similar organisms mucosal 
sample was considered “true positive” (TP); (2) when both samples were 
negative it was labelled “true negative” (TN); (3) positive mucosal samples that 
matched with negative blood culture or with positive blood culture of a different 
organism were considered “false positive” (FP); and (4) negative mucosal 
samples with positive blood cultures were considered “false negative” (FN). 
Separate analyses were conducted for rectal and NP samples as well as for the 
combined dataset. In the combined analysis if a sample of one site was TP and 
of the other site FN it was labelled TP or if a sample of one site was FP and of 
the other site TN it was labelled FP.  
The sensitivity, specificity, PPV and NPV were calculated for all Gram-
negatives and on species level according to the time frame of sample collection 
(2–6, 7–10 and 11–14 days prior to sepsis). For the per patient analysis odds 
ratios (OR) with 95% confidence intervals were calculated similar to per sample 
analyses. 
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5. RESULTS AND DISCUSSION 
 
5.1. Study population 
 
A total of 465 neonates were admitted to both units; 142 in unit A and 141 in 
unit B met the study inclusion criteria and 142 and 134, respectively, qualified 
for colonisation studies (Figure 1) The study population with half of the 
neonates having BW <1500g, half born via caesarean section, three quarters 
artificially ventilated and/or with indwelling catheters and a quarter with culture 
proven neonatal sepsis is characteristic for a third level NICU being in line with 
some previous studies (Perlman et al., 2007). With a few exceptions the 
population characteristics in both treatment groups and study periods were well 
balanced and similar in both units (Table 7). 
The colonisation studies were incorporated in an efficacy study that aimed to 
compare the efficacy of penicillin to ampicillin in the empiric treatment of EOS 
(Metsvaht et al., 2010). The cluster randomized design similar to De Man et al. 
(De Man et al., 2000) was chosen to evaluate possible effects of the NICU 
environment and study period on mucosal colonisation. We appreciate that this 
design has some limitations. First, not all admitted neonates but only those aged 
<72 hours and requiring treatment for suspected or proven EOS were included. 
Thus, we have missed at least 1/3 of admitted patients who could have been a 
source of microorganism circulating in the NICU. Also, the duration of each 
study regimen just over eight months is likely too short to trigger changes in the 
circulating microflora within a unit. Another disadvantage was not having a 
control group of antibiotic-naïve subjects. Such a group of neonates in a third 
level NICU would have been extremely difficult to recruit as almost all 
critically ill neonates are exposed to antibiotics (Lass et al. 2011). Recruiting 
controls with very different disease severity may have biased the comparisons.  
On the other hand the study was one of largest conducted on the topic with 
more than 1250 rectal and 1153 NP samples collected from 276 critically ill 
neonates. Also, collection of multiple data allowed investigation of 22 potential 
colonisation determinants in a multivariate manner in order to distinguish inde-
pendent effects. We believe that the advantages of the study design outweigh its 
few limitations.  
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5.2. Prevalence of mucosal colonisation by aerobic and 
facultatively anaerobic microorganisms 
Throughout the study the most frequent rectal colonisers were Gram-positive 
bacteria (77.8%), among which CoNS, accounting for 69.8%, clearly pre-
dominated (Table 8). These findings are in line with other recent studies 
showing that in modern era of neonatal care and especially in industrialized 
countries staphylococci are becoming more abundant than enterobacteria, the 
latter used to predominate prior to 1980ies (Adlerberth et al., 2006; Kelly et al., 
2007; Morelli, 2008). About half of the patients developed rectal (55.8%) or NP 
(42.8%) and 38.8% both sites’ colonisation with Gram-negative microorga-
nisms (Table 8). Except for E. coli Gram-negative colonisation was very much 
driven by the presence of AR strains; 73.4% of positive rectal and 60.2% of NP 
samples contained AR strains.  
As shown on Figure 3 the colonisation pattern was quite similar for a given 
bacterial species in the two studied mucosal sites. Similarly to previous studies 
(Lidsky et al., 2002) Enterobacteriaceae except Serratia spp. were more 
frequently colonising rectum than NP but Acinetobacter spp. were more com-
monly recovered in the NP. The most frequent Gram-negative coloniser in-
cluding AR strains was E. cloacae followed by K. pneumoniae, K. oxytoca and 
Acinetobacter spp.  
 
 
Figure 3. Rectal and NP colonisation with opportunistic Gram-negative microbes 
throughout the study. AR Enterobacteriaceae are shown in dark green bars and 
ampicillin-susceptible Enterobacteriaceae in light green bars. ORs with 95% CIs 
indicate significant differences between rectal and NP colonisation.  
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5.3. Dynamics of mucosal colonisation 
 
On admission to NICU on the first day of life about 1/3 of neonates were al-
ready colonised with Gram-positive microorganisms (mainly CoNS) and their 
predominance continued throughout the first 16 days (Figure 4). By Day 6 to 9 
more than 90% had colonisation by Gram-positive and about 30% with Gram-
negative AR microorganisms. These findings are very similar to previous 
studies conducted in NICUs in industrial countries although linear rather than 
sigmoid type increase has been shown by Almuneef et al. (Almuneef et al., 
2001) and Smith et al (Smith et al., 2010). 
 
 
 
Figure 4. Rectal colonisation in first 16 days of life. Gram-positives are presented in 
blue, Gram-negative es in red, Gram-negative AR in yellow, and yeasts in green line. 
 
 
In terms of individual species a steady increase in prevalence was observed for 
all enterobacterial species up to the 4th week of life, with the exception of 
Serratia spp and E.coli, the prevalence of which remained constantly around 
5% and 10%, respectively (Figure 5).  
In the first week of life K. pneumoniae and E. coli more often colonised 
rectum than NP (OR = 2.55; 95% CI 1.08 – 6.03 and OR = 2.19; 95% CI 1.11 – 
4.31, respectively) but later on no relevant differences between the two sites 
except for E. cloacae (OR = 2.28; 95% CI 1.26–4.13) in the second week were 
observed. AR E. cloacae and AR Klebsiella spp. increased steadily from Day 1 
levelling off at 15% (Haanpera et al.) to 20% (rectal) by week 4 to 5. These 
findings confirm the previous understanding that E.coli and Serratia spp. most 
likely originate from the mother while the other members of Enterobacteriacae 
arise from the hospital environment (Rotimi et al., 1977; Pietzak, 2004; Prelog 
et al., 2009). 
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Figure 5. The percentage of patients colonised by different species of Enterobacteria-
ceae during the first five weeks of the NICU stay. X-axis represents percentage of 
colonised patients. The rectal colonisation is shown on the left and NP on the right. 
Colonisation by AR strains is presented in darker and ampicillin susceptible strains in 
lighter colours. E. cloacae is shown in grey, K. pneumoniae in red, K. oxytoca in blue, 
E. coli in brown and Serratia spp in green bars. Asterisks indicate each case of LOS.  
 
 
Among nonfermentative microorganisms (Figure 6) no association with the 
duration of NICU stay was observed. On the second and third week Acineto-
bacter tended to colonise NP more often than the rectum and on the first week 
Pseudomonas was more frequent coloniser of the NP than rectum. 
Rectal colonisation by Candida spp. was observed in 49 (17.8%) patients led 
by C. albicans (n = 37) and followed by C. parapsilosis (n = 10), C. lusitaniae 
(n = 5) and C. tropicalis (n = 1). Four patients had C. albicans and C. parapsi-
losis concomitantly. Colonisation by C. albicans started at birth and increased 
steadily thereafter whereas a sharp rise in non-albicans Candida spp. was seen 
at the fifth week of NICU stay (Figure 3; publication III) confirming that 
C. albicans most likely is of maternal and non-albicans Candida spp. of hospital 
origin (Miranda et al., 2009; Saiman et al., 2001). 
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Figure 6. Timing of rectal and NP colonisation with nonfermentive Gram-negative 
microorganisms during the first 5 weeks of life. X-axis represents percentage of 
colonised patients. Pseudomonas is shown in green, Stenotrophomonas in blue and 
Acinetobacter in red bars. The significant differences between NP and rectal coloni-
sation are as follows: Pseudomonas – first week p=0.022; Acinetobacter – second week 
OR = 3.18; 95% CI 1.42 – 7.10, and third week OR = 5.02; 95% CI 1.37 – 18.42. 
Asterisks indicate cases of LOS and the causative agents are represented in the same 
colour as colonisers.  
 
 
5.4. Risk factors associated with mucosal colonisation 
 
In univariate regression analysis a total of 22 factors (3 environmental, 5 ma-
ternal and 14 neonatal) were associated with the colonisation by various 
opportunistic microorganisms at a p value of ≤0.1 (Table in Appendix; publi-
cation III). Further only the factors that remained associated with colonisation in 
multiple regression analysis are presented and discussed. 
 
 
5.4.1. Environmental factors – participating unit, treatment period 
and duration of stay in neonatal intensive care unit 
The duration of NICU stay was the most important factor influencing mucosal 
colonisation. It was associated with rectal and NP colonisation of Acinetobacter 
spp. and all Enterobacteriaceae except E. coli (Table 2 in publication III) and 
rectal colonisation of CoNS, S. aureus, Enterococcus spp. and yeasts (Table 9). 
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Depending on the species each day in NICU increased colonisation risk by 3% 
to 8%. Indeed PNA almost completely overlapping with the NICU stay in this 
study could also have influenced mucosal colonisation. When comparing NP 
carriage rates in healthy and age-matched hospitalized infants over the first 6 
months of life Baltimore et al (1989) suggested PNA’s primary effect in 
colonisation with Gram-negative microorganisms. However, we were unable to 
distinguish between their roles as due to strong correlation between the two 
only NICU stay was entered into the multiple regression model. We considered 
the duration of hospital stay a more important determinant of mucosal 
colonisation than PNA. 
We also observed some differences between rectal colonisation pattern 
between treatment periods and participating units (Table 8). As shown in Figure 
7 K. pneumoniae was extensively circulating in unit A, especially during the 1st 
period whereas only a few patients were colonised in unit B. Heavy colonisation 
in unit A was accompanied by an endemic occurrence of K. pneumoniae BSI 
lasting for more than 6 months. During this period altogether 23 neonates 
became colonised with genotypically related strains and five developed invasive 
disease. The clonal relatedness of invasive and colonising strains was confirmed 
by AFLP (Figure 7) and PFGE (Figure 8). Also a smaller outbreak of MRSA 
infection involving three patients occurred in unit B during the period of 
November 30 – December 28, 2006. These data further underline the role of 
hospital environment in mucosal colonisation process. 
Our results are not surprising as also previous studies have recognised 
hospital environment as one of the most important sources for colonisation by 
several Gram-negative organisms, including antibiotic-resistant strains, and 
MRSA and yeasts (Almuneef et al., 2001; Cartelle et al., 2004; Beggs et al., 
2006; Gregory et al., 2009; Heinrich et al., 2011). Microbes may spread via 
hands of health-care workers, air and/or contaminated water and/or environ-
mental surfaces (Huang et al., 1998b; De Man et al., 2001; Gupta et al., 2004; 
Bagattini et al., 2006; Amaya et al., 2010). Medical devices such as CvCs, 
urinary catheters and endotracheal tubes frequently used in the NICU are also 
well-known sources of mucosal colonisation and BSIs (Frebourg et al., 1999; 
Mahieu et al., 2001; O'grady et al., 2002; Srivastava et al., 2007). To study the 
role of the above mentioned environmental factors was clearly out of the scope 
of this study. 
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Figure 7. Clonal dissemination of K. pneumoniae in unit A. The horizontal arrow repre-
sents the progression of the study and vertical arrow represents the cumulation of 
patients colonised by K. pneumoniae in the corresponding study period. Above the red 
horizontal line the situation in unit A and below the line in unit B is presented. In March 
2007 the antibiotic regimens were changed between the units. All different genotypes 
are presented by different colours and letters. Genotypically related strains during the 
first outbreak are presented in yellow and those during the second outbreak in violet. 
Asterisks indicate BSIs caused by K. pneumoniae. 
 
 
These findings support the previous recommendations that NICU hygiene 
oriented interventions may enable to avoid or reduce colonisation by potentially 
pathogenic microorganisms and could eventually result in diminished numbers 
of invasive disease (Almuneef et al., 2001; Edwards et al., 2002; Lidsky et al., 
2002; Cartelle et al., 2004; Mammina et al., 2007; Millar et al., 2008; Phillips et 
al., 2008). For example, in US after a collaborative quality improvement pro-
cess wherein among the other activities improved hand cleaning and education 
of the entire staff to encourage maximal compliance with infection control 
practices, reduced nosocomial infection rate in the first year by 26% and in the 
second and third year by another 29% (Schelonka et al., 2006). Still, this study 
measured only reduction in infection rates, and did not monitor the mucosal 
colonisation. 
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Figure 8. Relatedness between of A. baumannii, K. pneumoniae, and E. cloacae strains 
isolated from rectal (R), nasopharyngeal (N) and blood (B) samples using PFGE 
analysis. M indicates marker. Each line shows different patient.  
 
 
Another measure suggested to reduce the number of hospital acquired infections 
is isolation and cohorting of patients, although some authors have pointed out, 
that evidence from randomized controlled trials is lacking (Traore et al., 2002; 
Cooper et al., 2004; Mohan et al., 2007). However, if the spread of a single 
strain is responsible for the outbreak of MRSA or MRSE, cohorting of infected 
and/or colonised patients might be useful as suggested (Mussi-Pinhata et al., 
2001; Traore et al., 2002; Mcdonald et al., 2007; Van Rossem et al., 2007; 
Gregory et al., 2009; Navarro et al., 2011).  
 
 
5.4.2. Perinatal factors – gestational age, mode of delivery, 
premature rupture of membranes 
We have shown that the GA played an important role in colonisation process. 
Term neonates were more likely colonised by E. coli (Table 2 in publication III) 
and CoNS (Table 9) compared with late preterm but not with the extremely 
premature babies. In terms of Gram-positives and yeasts the colonisation pattern 
of extremely preterm neonates was similar to late preterms, but the first men-
tioned group had higher risk of developing NP colonisation by K. pneumoniae 
as compared with both other age categories and by E. cloacae compared with 
term neonates.  
In terms of colonisation term neonates had almost four times greater chance 
to be colonised on Day 1–2 compared with late preterms (OR=4.27; 95% CI 
1.80–10.16). As term babies are more likely born via vaginal delivery than 
preterms this suggests that a vaginal tract could be a potential source of 
microorganisms (Bettelheim et al., 1974a; Bettelheim et al., 1974b; Bettelheim 
et al., 1974c; Goldmann, 1981; Tannock et al., 1990; Penders et al., 2006; Ogra, 
Acinetobacter Enterobacter Klebsiella 
baumannii
 
cloacae
 
pneumoniae
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2010). This is further supported by the fact that compared with neonates born 
via Caesarean section; those delivered vaginally had increased risk of mucosal 
colonisation by E. coli (Table 2 in publication III) and C. albicans (Table 9).  
Previously suggested reasons for later colonisation in preterms compared 
with term neonates include reduced maternal contact, different dietary intake, 
peristalsis and glandular secretions as well as the impaired immune response of 
intestinal mucosa (Kelly et al., 2000; Mshvildadze et al., 2010a; Wolfs et al., 
2010). Diminished host cell gene expression resulting in lower total counts of 
bacteria and limited numbers of species has also been proposed (Gewolb et al., 
1999; Thompson-Chagoyan et al., 2007).  
Similar to us previous studies showed that term neonates are more likely 
colonised with E. coli (Fanaro et al., 2003), and extremely preterms have 
greater risk of colonisation by K. pneumoniae, E. cloacae (Goldmann, 1981; 
Schwiertz et al., 2003) and Candida spp, especially non-albicans Candida spp 
(Saiman et al., 2001; Mendiratta et al., 2006; Manzoni et al., 2008). These data 
suggest that in extremely preterm infants colonisation depends rather on the 
endemic microorganisms present in NICU, while in term infants it is more 
affected by the mothersʼ microbiota (Almuneef et al., 2001; Mammina et al., 
2007; Millar et al., 2008). However, in the present study the association 
between GA and Candida colonisation was not significant in multivariate 
analysis indicating that low GA explains the greater colonisation by Candida 
spp. of preterms only partly. 
PROM was associated with increased risk of rectal colonisation by  
K. pneumoniae and NP colonisation by K. oxytoca, E. coli and Stenotro-
phomonas spp (OR=19.00; 95% CI 1.39; 260.21) (Table 2 in publication III). It 
is presumed that contact with intraamniotic fluid is associated first with NP 
colonisation. All above mentioned microbes (E. coli, K. pneumoniae and other 
Enterobacter spp) have been found in patients with PROM rising most likely 
from the ascending infection from perineum and vagina (Kayange et al., 2010). 
As PROM-related colonisation may be followed by a serious threat of 
immediate postnatal infection and intraamniotic bacterial infections may cause 
preterm birth (Asindi et al., 2002; Kenyon et al., 2003; Simhan et al., 2005; 
Kirchner et al., 2007; Levy, 2007;  Lafeber et al., 2008; Veleminsky et al., 
2008), avoidance of PROM ≥18 h is essential. 
 
 
5.4.3. Feeding regimen 
The dynamics of mucosal colonisation depending on the feeding habits is 
presented on Figure 9. Not surprisingly and similarly to previous studies we 
demonstrated that enteral feeding is an important determinant of colonisation 
process and that the use of TPN delays colonisation by Gram-negative bacilli 
(Smith et al., 2010). As shown, by Days 6–9 and 10–12 neonates fed with breast 
milk-containing regimen had six and nine times greater risk of colonisation with 
Gram-negative bacteria and six and seven times greater risk of colonisation with 
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Gram-negative AR strains compared to those on TPN, respectively. Differences 
between breast milk and formula feeding were minor; there was a greater 
colonisation risk by Gram-negative AR strains by Day 10–12 (OR=3.1; 95% CI 
1.08 – 8.86) in breast milk as compared with formula fed babies.  
Not surprisingly and consistent with previous studies feeding regimen 
affected rectal but not NP colonisation. Neonates receiving TPN were less likely 
colonised with K. oxytoca and E. coli (Table 2 in publication III), but more 
likely with C. albicans (Table 9) than those fed with breast milk, suggesting the 
likely maternal origin of these microorganisms (Berthelot et al., 2001; Martin et 
al., 2007). The association between TPN (more specifically intravenous lipids) 
and colonisation by C. albicans has been shown previously (Huang et al., 
1998a; Manzoni et al., 2008; Saiman et al., 2001). In one hand, TPN solutions 
are considered to be relatively good growth mediums (Fox et al., 1999; 
Kuwahara et al.2010), but on the other hand, it is not easy to explain how these 
microorganisms get into the GI tract. It may be explained by the fact that 
neonates receiving TPN have limited numbers of Gram-negatives (Smith et al., 
2010) leading to overgrowth of Candida spp obtained from their mothers or 
health-care workers.  
 
 
Figure 9. Comparison of dynamics of rectal colonisation between groups fed with the 
breast milk (presented by continuous lines) vs TPN (presented by dotted lines). The 
colonisation with Gram-positives is presented in blue, Gram-negatives in red, Gram-
negative ARs in yellow and with yeasts in green lines. The following significant diffe-
rences were observed: the rate of patients colonised with Gram-negatives and Gram-
negative AR strains is greater in breast milk-fed group vs TPN group on Days 6–9 
(OR=6.12; 95% CI 2.33–16.09 and OR=6.16; 95% CI 1.89–20.00, respectively), and 
Days 10–12 (OR=9.03; 95% CI 2.50–32.64 and OR=7.33; 95% CI 2.05–26.25, 
respectively). 
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However, in contrast to some other studies (Orrhage et al., 1999) we did not 
observe differences in gut colonisation between breast milk and exclusively 
formula fed neonates (Table 2 in publication III) suggesting that rather the route 
and not the content of food plays a critical role in the colonisation process. 
These results affirm that the spread of colonising microorganisms likely occurs 
via cross-colonisation including contamination of nasogastric tubes as 
demonstrated recently by Hurrell et al (2009) and underline once again the 
potential of hospital hygiene oriented interventions in preventing hospital 
acquired infections (Edwards et al., 2002; Cohen et al., 2003; Brady, 2005; 
Larson et al., 2005; Mcdonald et al., 2007; Borghesi et al., 2008; Phillips et al., 
2008; Gregory et al., 2009; Jarvis, 2010).  
The association between mucosal colonisation and invasive infection will be 
discussed in chapter 5.6.  
 
5.4.4. Medical devices  
(artificial lung ventilation and indwelling catheters) 
The presence of arterial lines was associated with increased risk of rectal and 
NP colonisation by K. pneumoniae and the presence of CvC increased the risk 
of rectal colonisation by Acinetobacter spp (Table 2 in publication III), entero-
cocci, and non-albicans Candida spp (Table 9). The mechanisms how in-
dwelling catheters are associated with mucosal colonisation are likely multi-
factorial. It may occur via horizontal transmission by the hands of NICU care 
givers (Saiman et al., 2000). Previous studies have shown that direct and 
indirect procedures in neonates are all associated with significant increase in 
hand colony count. For example, skin contact, respiratory tract care, contact 
with equipment and CvC device manipulation increased bacterial count of 
ungloved healthcare workers’ hands during 135 secons of care among neonates 
in the NICU of 21.2 CFU/min (p = 0.08), 20.4 CFU/min (p < 0.001),  
10.0 CFU/min (p = 0.004) and 10.0 CFU/min (p = 0.015), respectively. 
Altogether 13.8% and 1.8% of these microorganisms were Enterobacteriaceae 
and fungi, respectively (Pessoa-Silva et al., 2004). Even plain soaps may 
become contaminated and lead to hand colonisation by Gram-negatives (Sartor 
et al., 2000). On the other hand, colonisation by these microbes is facilitated by 
immaturity; serious general condition and prolonged hospital stay all associated 
with the use of indwelling catheters.  
The duration of ALV (in median of 80.6 hours; IQR 36.5–164 h) was associated 
with increased risk of NP colonisation by K. pneumoniae (Table 2 in publication 
III), and decreased risk of rectal colonisation by enterococci (Table 9). The 
relationship between tracheal intubation and NP colonisation remains presumptive, 
as an association between intubation, especially for more than 72 hours, and 
frequent NP colonisation by Entrobacteriaceae in NICU has been shown previously 
(Harris et al., 1976). Also, the presence of intubation has been identified as an 
independent risk factor for colonisation/infection by K. pneumoniae during an 
outbreak (OR=27.0; 95% CI 5.39 – 135.14) (Cartelle et al., 2004).  
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5.4.5. Influence of antibiotics used  
 for the empiric treatment of early onset sepsis 
Both antibiotic regimens (penicillin G + gentamicin and ampicillin + gentami-
cin) had similar effect on the dynamics of early gut colonisation with Gram-
negative microorganisms and Candida spp. except for the greater number of 
patients colonised by Acinetobacter spp on Days 13–16 in the penicillin 
compared with the ampicillin group (Figure 2B in publication 1). In terms of 
Gram-positive organisms, however, the two antibiotic regimens differed – peni-
cillin treatment resulted in significantly greater number of patients colonised 
with Enterococcus spp. at all time-points from Day 6 to 16 and by S. aureus 
between Days 3 to 5 compared to ampicillin (Figure 2A in publication 1).  
In the mixed effect model analysis the number of patients colonised with all 
Gram-negative organisms was similar in both treatment arms except of AR 
Acinetobacter spp., that was found only in the penicillin arm (0 vs 8; p = 0.008). 
Again, differences among Gram-positive colonisation were observed – com-
pared with penicillin ampicillin treatment was associated with twofold greater 
odds of colonisation by S. haemolyticus and six fold that of S. hominis, whereas 
the odds of colonisation by Enterococcus spp. and S. aureus were about a half 
and one third of that seen in the penicillin arm, respectively (Table 10). 
In terms of CD the penicillin and ampicillin treatments were more distinct 
than in cumulative per patient colonisation – the mean CDs in multivariate 
analyses of K. pneumoniae (difference +6.6) and AR Serratia spp. (+3.7) were 
greater in ampicillin as compared with penicillin arm and those of AR 
Acinetobacter spp. (–2.5) in the penicillin as compared with the ampicillin arm. 
Among Gram-positive bacteria the CDs followed similar trends as in the per 
patient analysis; ampicillin was associated with higher mean CDs of S. 
haemolyticus (difference +11.4) and S. hominis (+6.4) but lower CDs of 
Enterococcus spp. (–13). In univariate analysis ampicillin was also associated 
with lower CDs of S. epidermidis (–8.5) but in multivariate analyses this 
remained of borderline significance (p = 0.0725). In addition, in multivariate 
analysis ampicillin treatment was associated with higher CD of Candida spp.  
(p = 0.02). Although colonisation by S. aureus was different between treatment 
arms in per patients analysis, in CD analysis this did not reach significance at 
the p value of < 0.05 (p = 0.054) (Table 10).  
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In contrast to a previous EOS study (De Man et al., 2000), comparing amoxi-
cillin plus cefotaxime regimen to penicillin plus tobramycin, as well as some 
studies on intrapartum antibiotic prophylaxis (Mcduffie et al., 1993; Joseph et 
al., 1998; Levine et al., 1999; Almuneef et al., 2001; Stoll et al., 2002a; Laugel 
et al., 2003; Cordero et al., 2004; Bizzarro et al., 2008), we failed to prove our 
main hypothesis that ampicillin as an antibiotic with broader Gram-negative 
coverage than penicillin selects for AR Enterobacteriaceae except for the 
greater CD of AR Serratia spp. However, our findings support those of Jauré-
guy et al. (Jaureguy et al., 2004) who in an intrapartum prophylaxis study failed 
to demonstrate that amoxicillin selects for beta-lactam resistant enterobacteria. 
At present in most countries all Enterobacteriaceae other than E. coli have 
become uniformly resistant to ampicillin (Bennet et al., 2002; Jain et al., 2003; 
Mitt et al., 2009) and thus it is not surprising that ampicillin and penicillin have 
similar influence on gut colonisation with Gram-negative bacteria.  
A more serious problem emerging during penicillin containing regimen was 
the greater number of patients colonised with S. aureus, a well-recognized and 
frequent opportunistic pathogen in NICU (Milledge et al., 2005; Elwan et al., 
2009). It has been shown previously that compared with untreated subjects 
ampicillin in combination with gentamicin reduces faecal colonisation of S. 
aureus (Bennet et al., 1982). The results of herein study are not surprising as the 
vast majority of S. aureus isolates are penicillin resistant nowadays ( Livermore, 
2000; Hawkey, 2008) but may still be susceptible to ampicillin.  
The shift in colonisation by CoNS species so that penicillin treatment is 
associated with greater colonisation of S. epidermidis and lower colonisation by 
S. haemolyticus and S. hominis than ampicillin is more difficult to explain and 
to our knowledge has not been described before. It is likely that these different 
species of staphylococci compete for the colonisation niche with each other. 
The different colonisation pattern may still have clinical implications as 
mucosal colonisation is an important source of CoNS in invasive infections 
(Costa et al., 2004). In addition, differences in the pathogenicity between CoNS 
species have been demonstrated so that 50% to 71% of S. epidermidis but only 
35% of S. haemolyticus and 26% of S. hominis strains are capable of slime 
production, the latter being associated with invasive disease (Hall et al., 1990; 
Drozenova et al., 2000; Arslan et al., 2007; Koksal et al., 2009). The relevance 
of differences in gut colonisation observed in this study is further supported by 
the clinical findings showing a trend towards greater prevalence of LOS caused 
by S. epidermidis in the penicillin as compared with the ampicillin arm (7.6 vs 
2.7 per 100 patient days, respectively). See section 5.6.1. 
 
 
5.4.6. Influence of other antibiotics 
In an univariate analysis shown in Appendix Table in publication III all addi-
tionally administrated antibiotic classes were associated with increased rectal 
colonisation by non-albicans Candida spp. In addition, carbapenems predisposed 
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to colonisation by K. pneumoniae and NP colonisation by K. oxytoca and broad 
spectrum beta-lactams by K. oxytoca and E. cloacae. However, none of these 
associations remained significant in risk factor adjusted multivariate analysis.  
These findings contrast some previous studies showing that the use of broad 
spectrum antibiotics leads to outselection of specific organisms like Candida 
spp. and antibiotic resistant strains (Garcia-Rodriguez et al., 2002; Jain et al., 
2003;  Chiu et al., 2005). However, one should note that this controversy could 
in part be explained by different study conditions and analyses used. So studies 
monitoring antibiotic use as single factor (Burman et al., 1993), or monitoring 
multiple factors but not applying multivariate analyses  (De Man et al., 2000; 
Duman et al., 2005), or looking at the influence of antibiotics in an outbreak 
period (Cassettari et al., 2009) have reported an association between antibiotic 
therapy and resistance occurrence. On the other hand, studies applying multi-
variate analyses have not confirmed this association (Mammina et al., 2007; 
Millar et al., 2008). The selection of resistant strains is a lengthy process likely 
not observed in studies with short duration or using antibiotics for a limited 
number of days as ours (Jaureguy et al., 2004; Millar et al., 2008; Auriti et al., 
2009; Puopolo et al., 2010).  
 
 
5.5. Factors associated with colonisation  
by ampicillin resistant strains 
 
As shown in Table 3 in publication III, the risk factors of colonisation with AR 
microorganisms were largely similar to those seen in all strains. While rectal 
colonisation by AR K. oxytoca more likely occurred in term babies AR  
K. pneumoniae was three times more often isolated in extremely immature as 
compared with late preterm babies. Breast milk feeding increased the risk of 
colonisation by AR K. oxytoca. Early empiric ampicillin therapy was associated 
with increased risk of NP colonisation by AR E. cloacae. Mode of delivery did 
not influence colonisation by AR strains, but PROM > 18h increased risk of NP 
colonisation by AR K. pneumoniae, K. oxytoca, and E. coli. Intrapartum anti-
biotic use favored rectal colonisation by AR K. pneumoniae.  
The role of antibacterial therapy in inducing colonisation by resistant 
Enterobacteriaceae has been shown in several studies (Garcia-Rodriguez et al., 
2002; Jain et al., 2003; Chiu et al., 2005). However, more recently this effect 
has been questioned (Karami et al., 2006; Millar et al., 2008). As discussed 
above overinterpreting associations between short-term antibiotic use and 
resistance development may rise from analyses including only a limited number 
of risk factors and not considering others with major impact, like duration of 
NICU stay, maternal antibiotic use during pregnancy and/or invasive procedures 
or population characteristics. For example, the AR rates of microbes in the 
intestinal flora of healthy subjects are much greater in developing than in the 
developed countries – 96.8% in India or South Africa (Amyes et al., 1992; 
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Shanahan et al., 1995) vs 42% in the UK (Shanahan et al., 1994). This could 
explain the relationship between antibiotic use and resistance development in a 
Brasilian study (Cassettari et al., 2009). Similar to general colonisation early 
mucosal colonisation by resistant strains is more likely associated with trans-
mission of microbiota from other patients than reflection of the emergence of 
resistance due to antibiotics; the NICU environment itself is a reservoir of 
resistant Gram-negative bacilli (Toltzis et al., 2002; Mammina et al., 2007; 
Millar et al., 2008).   
 
 
5.6. Associations between mucosal colonisation and 
development of LOS 
 
5.6.1. Prevalence and aetiology of LOS 
A total of 75 culture proven LOS cases in 53 neonates occurred during the 
study. Similar to other studies in industrialised countries (De Man et al., 2000; 
Stoll et al., 2002b; Bizzarro et al., 2005; Ronnestad et al., 2005a) the majority 
of cases (59%) were caused by Gram-positive organisms. Gram-negatives and 
Candida spp. represented 36% and 6%, respectively (Figure 10). A greater 
number of LOS cases caused by S. epidermidis occurred in the penicillin 
compared with the ampicillin group (2.7 vs 7.6 per 1000 patients days, RR 0.32; 
95% CI 0.19–0.55). However, in multivariate model adjusted for other risk 
factors of infection the difference between the two treatments became non-
significant (p = 0.08).  
 
 
Figure 10. Distribution of causative agents of LOS. Numbers in the chart indicate the cases.  
Gram-negative sepsis occurred at a median on Day 13 (IQR 9 – 21); E. cloacae sepsis 
was the earliest (median on Day 8; IQR 5 – 14) and K. oxytoca the latest (median on 
Day 30; IQR 22.5 – 39). Sepsis caused by CoNS occurred at a median on Day 8  
(IQR 5 – 13), by S. aureus on Day 7 (IQR 5 – 10.5), and by Candida spp on Day 21 
(IQR 13.75 – 49.5). Further only Gram-negative organisms are analysed and discussed. 
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5.6.2. Relatedness of colonising and invasive strains 
In 22 of 27 Gram-negative LOS cases mucosal and invasive strains were pheno-
typically similar and in 16 of those 22 colonisation with the respective strain 
preceded invasive disease. The median duration of prior colonisation with a 
matching strain was 10.5 days (range 2 to 36) for Enterobacteriacae and seven 
days (range 2 to 29) for nonfermentative microorganisms. Of 16 patients 
colonised with the phenotypically similar microorganism prior to LOS nine 
were colonised with several GN strains (number ranging from 2 to 6). All 
invasive infections were monoinfections. Patients with mucosal colonisation, 
except with E. cloacae and Serratia spp., were more likely to develop invasive 
infection than those without (Table 11).  
 
 
Table 11. Association between mucosal colonisation by a specific microorganism and 
LOS caused by the same organism 
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E. cloacae 76 5 3 4.11 /          0.55–35.96 1 
0.66 /          
0.28–6.15 
K. pneumonia 51 6 5 24.57 /          2.69–587.93 4 
9.57 /          
1.45–77.74 
E. coli 49 3 3 34.55 /       2.03–20474.48 3 
34.55 /         
2.03–20474.48 
Acinetobacter spp 47 7 5 13.63 /       2.41–105.29 2 
2.01 /          
0.26–12.20 
K. oxytoca 46 3 3 37.41 /       2.20–22188.59 3 
37.41 /         
2.20–22188.59 
Serratia spp 31 1 1 24.34 /       0.81–16921.25 1 
24.34 /        
0.81–16921.25 
Stenotrophomonas spp 12 1 1 69.52 /       2.19–49681.68 1 
69.52 /        
2.18–49681.68 
P. aeruginosa 7 1 1 125.31 /      3.69–92781.90 1 
125.31 /        
3.69–92781.90 
*  chance to be infected in patients who had colonisation by particular microbe during 
hospital stay vs noncolonised neonates 
** chance to be infected in patients who had colonisation by particular microbe prior 
LOS 
 
 
The genetic relatedness between mucosal and colonising strains was studied for 
K. pneumoniae (4 patients), E. cloacae (3 patients) and A. baumannii (5 pa-
tients); all studied sample pairs were genetically related (Figure 8). This affirms 
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the findings of previous studies suggesting that the large intestine and NP are 
important reservoirs for Enterobacteriaceae and other Gram-negative bacilli 
causing invasive disease (Foca et al., 2000; Cartelle et al., 2004; Gupta et al., 
2004; Graham et al., 2007). 
 
 
5.6.3. Value of mucosal site cultures  
in predicting invasive disease 
Two analyses – per sample and per patient – were conducted. The results of per 
sample analysis are presented in Table 2 in publication II. As shown the overall 
sensitivity (37% vs 11%) and PPV (3.5% vs 0.8%) in per sample analyses were 
greater for Enterobacteriaceae compared to nonfermentative organisms, 
respectively and at Days 2–6 compared to Day 7–10 and 11–14 prior to invasive 
disease (sensitivity: 2–6 Days 50% vs 16%; 7–10 Days 26% vs 7%, 11–14 Days 
31% vs 8%, and PPV: 2–6 Days 24% vs 1%, 7–10 Days 3% vs 0.5% and 11–14 
Days 3.5% vs 1%, respectively).  
In the per patient analyses overall sensitivity, specificity, PPV and NPV of 
59%, 42%, 10% and 91%, respectively were greater than the ones in an 
individual sample analysis. The by species and per samples analysis indicated 
the best sensitivity (above 60%) in K. oxytoca, E. coli and P. aeruginosa (Table 
12). Still, most likely due to the small sample size, the 95% CI intervals varied 
widely although the specificity exceeded 92% for all organisms. In addition, 
high NPV (above 98% for all species) enabling to identify patients with low risk 
of LOS, was observed.  
Our results resemble the findings reported in adult ICUs indicating that if 
colonised patients and specific organisms instead of a single sample and all 
organisms are considered, the sensitivity and specificity of mucosal cultures in 
predicting invasive disease is acceptable and might aid in guiding selection of 
empiric antimicrobial treatment. At least as important should be considered the 
prevention of the spread of difficult to manage or multidrug resistant organisms 
such as P. aeruginosa (Bertrand et al., 2001; Blot et al., 2005; Smith et al., 
2010). However, it is important to emphasize that during NICU stay (at least in 
this study) most patients are colonised with several microorganisms and this 
method does not allow discriminating which colonising strain would become 
invasive.  
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In multivariate mixed model analysis we demonstrated that greater number of 
true positive samples prior to invasive disease and lower PNA improve the 
accuracy of prediction – OR 4.66; 95% CI 2.28–9.55; p<0.0001 and OR 0.94; 
95% CI 0.88–1.00; p=0.047, respectively. 
Our results suggest that in high risk patients admitted to 3rd level NICU the 
value of surveillance cultures in predicting invasive disease is suboptimal. 
Fairly similar data have been reported in general NICU patients with a sensi-
tivity of 16% and 56%, specificity of 38% and 82%, and PPV of 5% and 7.5% 
shown by Choi et al (2008) and Evans et al. (1998), respectively. Similar to 
these authors we also showed that the predictive value of surveillance cultures 
collected shortly prior to invasive disease is better (2–6 days in our study) than 
those taken at more distant times ( Evans, 1988; Choi et al., 2008).  
Still, the predictive value of mucosal cultures was especially poor in 
infections caused by nonfermentative organisms and more specifically in cases 
of A. baumannii (Table 12). Although here the ratio of infection to colonisation 
was 2:7 (Table 11) in most cases invasive disease preceded mucosal colo-
nisation. A. baumannii is a known hospital acquired microorganism with which 
outbreaks are not uncommon (Zarrilli et al., 2007; Curtis, 2008; Shete et al., 
2009). The most compromising group are patients with prior risk factors; the 
fact that mucosal colonisation does not precede infection suggest that infection 
develops immediately after transmission. Thus, in A. baumannii infection sur-
veillance cultures are of little value in selecting appropriate antibacterial agents 
but may be relevant in recognising potential cross-colonisation and avoiding 
further spread of infection.  
77 
6. GENERAL DISCUSSION 
 
To our best knowledge this is the first prospective study comparing the effect of 
two widely used antibiotic regimens – penicillin and ampicillin, both combined 
with gentamicin – on initial mucosal colonisation in neonates with suspected 
EOS. The role of other potentially interfering factors was also explored. 
 
 
6.1. Complexities of conducting studies on mucosal 
colonisation in neonates 
 
One of the most essential issues when studying mucosal colonisation is the 
selection of laboratory methods. Variations in methodology also partly explain 
the different results obtained in previously conducted studies. 
 
 
6.1.1. Selection of laboratory methods 
The laboratory work in colonisation studies is labour consuming and needs a 
significant amount of coordination between laboratories. In this study several 
methods were used in order to simplify laboratory work with minimal loss in 
quality. First, the samples were processed in one laboratory in batches that 
required their transport and freezing for a maximum of two weeks at –20° C. 
We appreciate that freezing may influence survival of microorganisms but 
according to our pilot data the rate of potentially lost organisms for the storage 
period used, did not exceed 14%. In the circumstances of limited human and 
laboratory resources the processing of swabs in batches once a week was 
considered a reasonable alternative to simplify laboratory work.  
Second, when measuring antibacterial susceptibility for the resource saving 
reasons we used screening for resistant organisms by plating samples on the 
culture media with antibiotic concentration one dilution lower than CLSI 
resistance breakpoint. Again we may have lost some organisms with borderline 
resistance but if that happened it should have been seen in both study arms and 
the number of such organisms was most likely not very high.  
Third, antibiotic susceptibility testing were performed according to the CSLI 
criteria in which Enterobacteriaceae are considered resistant if the MIC was 
>32 mg/L. More recently the EUCAST criteria with the resistance breakpoint of 
8 for Enterobacteracae were established. This may change interpretation and 
increase rates of antibiotic resistance in the future. Although comparative 
studies on the topic are still limited. 
Fourth, only classic culture based techniques were employed as at the time 
of initiating these studies they were the only readily available methods. How-
ever, we appreciate that in recent decade various molecular methods like RT-
PCR, pyrosequencing, microarray chip technology, FISH etc, have emerged and 
have revealed the presence of uncultivable microorganisms like Akkermansia 
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muciniphila and Ruminococcus obeum and others in human GIT microbiome 
(Derrien et al., 2004; Zoetendal et al., 2002). We believe that with molecular 
methods becoming more affordable to researches (which is already happening), 
future studies looking into the development of neonatal microbiota should either 
be complimented by or relay entirely on the PCR or sequence based methods.  
 
 
6.1.2. Statistical approach 
When studying complex issues like the development of mucosal colonisation 
and factors that influence it the selection of most appropriate statistical methods 
is of utmost importance. Numerous previous studies on the topic have drawn 
their conclusions by using simple statistical approach comparing different cate-
gorical values to each other although those factors are interrelated (Baltimore et 
al., 1989; Pierro et al., 1998; Toltzis et al., 2001; Bennet et al., 2002; Hallstrom 
et al., 2004; Jaureguy et al., 2004; Mendiratta et al., 2006). Even if multivariate 
analysis has been employed the studies have looked at only one or two micro-
organisms or included a small number of risk factors in the analysis (Cartelle et 
al., 2004; Cassettari et al., 2009; Penders et al., 2006; Saiman et al., 2001). 
Therefore it is not surprising that conflicting results on influence of antibiotics 
on mucosal colonisation have been reported.  
For example, in studies monitoring antibiotics as a single factor (Burman et 
al., 1993), or monitoring multiple factors but not applying multivariate analysis 
(De Man et al., 2000; Toltzis et al., 2001; Duman et al., 2005) an association 
between antibiotic therapy and resistance occurrence has been reported. On the 
other hand, in studies applying multivariate analysis, this association has not 
been confirmed (Cartelle et al., 2004; Mammina et al., 2007; Millar et al., 
2008). Similarly, in a study by Schrag et al (2006a) univariate analysis found a 
significant association between the use of antibiotic prophylaxis and infection 
caused by AR E. coli; but this association was not confirmed in multivariate 
analysis adjusted for other risk factors. Analogous results were shown by Huf-
nagel et al (2007), who compared the results of Chi-square test and multivariate 
logistic regression in monitoring the association between prepartum antibiotic 
treatment and neonatal colonisation by multidrug-resistant enterococci. These 
data affirm the understanding that colonisation in neonates is influenced by 
multiple factors and this fact needs to be taken into account. 
We believe that one of the strengths of our study is the complex statistical 
approach. In order to evaluate the influence of different antibiotic regimens on 
mucosal colonisation by aerobic and facultatively anaerobic microorganisms 
during NICU stay we included a total of more than 2300 Gram-negative and 
almost 1200 Gram-positive isolates and evaluated a total of 22 factors that have 
been described to influence mucosal colonisation in previous studies (Fanaro et 
al., 2003; Westerbeek et al., 2006; Thompson-Chagoyan et al., 2007). Due to 
the cluster-randomised study design all analyses were first adjusted for study 
centre and treatment period and multivariate approach avoiding inclusion of 
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highly interrelated factors was employed in all analyses. Thus, our conclusion 
that differences between penicillin and ampicillin containing regimens do not 
involve Enterobacteriaceae but affect colonisation with Gram-positive micro-
bes adequately reflects the true differences between the studied antibiotic 
regimens.  Furthermore, we believe that given the wide variety of potential risk 
factors entered into our mixed model analysis, a comprehensive description of 
their interplay has been achieved. However, one should still appreciate that 
these conclusions are valid for the population under study and may not be 
relevant to all neonates admitted to NICU.  
 
 
6.2. What are the most important factors influencing 
mucosal colonisation by opportunistic microorganisms  
in neonates? 
 
The following independent colonisation risk factors were identified: parti-
cipating unit, duration of NICU stay, GA, feeding regimen, mode of delivery, 
PROM >18 h and use of indwelling catheters. Our results suggest that in 
neonates admitted to NICU right after birth the predominant microbiota is 
acquired from the hospital environment, although host characteristics (like GA) 
also play a role. In contrast, healthy neonates spending only few days in the 
hospital become colonised predominantly by E. coli and Candida albicans, 
microorganisms known to be acquired from the mother (Saiman et al., 2001; 
Eggesbo et al., 2010; Mendiratta et al., 2006).  
With some exceptions, such as nonfermentative organisms more commonly 
colonising NP mucosa and rectal cultures more frequently yielding Entero-
bacteriaceae or feeding habits affecting colonisation of gut but not NP, we 
found that the colonisation pattern and the interfering risk factors for gut and 
NP are quite similar for a given bacterial species. This suggests that when 
performing colonisation studies extrapolations from one site to the other are 
feasible and in the interest of saving resources only one site (most likely gut as 
more abundant site of microbial colonisation) could be studied (Goldmann, 
1981; Ogra, 2010). 
The NICUs environment as a source of colonisation is not surprising since 
opportunistic microorganisms K. pneumoniae, E. cloacae, Serratia spp., 
Acinetobacter spp., P. aeruginosa, and MRSA are known to circulate in hospi-
tals and cross-colonise via contaminated equipment and/or hands of medical 
personnel (Hira et al., 2007; Mcdonald et al., 2007; Srivastava et al., 2007). As 
in our study the patients were admitted to NICU during the first hours after 
birth, and first days of PNA are likely critical for the development of GI tract 
microbiota, it is important to avoid as possible the colonisation by microbes got 
from the hospital (Srivastava et al., 2007; Mshvildadze et al., 2010a). 
In line with others we showed that gut and NP mucosa are potential sources 
of invasive disease; patients colonised with Klebsiella spp., Serratia spp., 
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Stenotrophomonas spp., Pseudomonas spp., and E. coli had greater odds of 
developing invasive disease as compared to those without colonisation. In order 
to avoid colonisation with opportunistic organisms with greater pathogenic 
potential (e.g. MRSA, Klebsiella spp., E. coli, E. cloacae, Pseudomonas spp., 
Candida spp.) specific measures should be targeted in preventing cross-
colonisation and spread of these microorganisms. However, while environ-
mental factors like nutrition habits and hygienic conditions in NICU are easier 
to change, little can be done to host related ones (e.g. GA and BW). 
Although the duration of NICU stay is felt to be an immutable factor, early 
discharge can be achievable for a number of infants by avoiding nosocomial 
infections, a known risk factor prolonging hospital stay (Merritt et al., 2003; 
Hira et al., 2007). Furthermore longer hospital stay is associated with higher 
likelihood of colonisation by resistant microbes (Toltzis et al.; 2001Mammina 
et al., 2007). The findings, that the duration of NICU stay was the most com-
mon factor influencing mucosal colonisation and outbreaks of K. pneumoniae 
and MRSA were unit-dependent, definitely support the recommendations that 
hygiene oriented interventions may avoid or reduce colonisation by potentially 
pathogenic microorganisms and could eventually result in diminished numbers 
of invasive disease (Saiman, 2002; Schelonka et al., 2006; Srivastava et al., 
2007).  
Another important factor in colonisation process, though hard to prevent, is 
too low GA. Colonisation with microorganisms that are also the main causative 
agents of LOS in neonates, like E. coli, K. pneumoniae, E. cloacae and CoNS 
(Stoll et al., 2002b; Bizzarro et al., 2005; Vergnano et al., 2010), was in-
fluenced by GA. Reasons why GA plays a crucial role in mucosal colonisation 
are multiple. It has been speculated that preterms are separated from the mother 
for prolonged period allowing colonisation by environmental rather than by 
maternal microflora (Schwiertz et al., 2003; Sanders et al., 2010). Also preterm 
neonates have higher exposure to other risk factors such as prolonged hospital 
stay, indwelling catheters, and prolonged use of antibiotics (Stoll et al., 2002b; 
Stoll et al., 2003; Curtis et al., 2008). So, to avoid colonisation by bacteria 
circulating in NICU maternal-infant contact could be reinforced, however, this 
may not be feasible in critically ill ventilated neonates. One should also bear in 
mind that mothers, especially those hospitalized during pregnancy may carry 
more virulent or antibiotic resistant strains (Toltzis 2001). 
The fact that the route of feeding as well as the character of enteral feeds are 
essential for early gut but not NP colonisation is not surprising. We like others 
have shown that preterm infants receiving TPN have delayed colonisation with 
almost all microorganisms but especially with Gram-negative bacilli (Smith et 
al., 2010). However, the differences between breast milk and formula feeding 
were minor, including only greater colonisation risk by Gram-negative AR 
strains by Day 10–12 among breast milk compared with formula fed babies. 
Compared to those, receiving TPN, breast milk fed babies were more likely 
colonised by E. coli and K. oxytoca, likely of maternal origin. However, in 
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feeding process possible contamination of milk bank or equipment used for 
enteral feeding should be considered. Outbreaks, caused by Enterobacteriaceae 
(including K. oxytoca and E. coli) or Pseudomonas aeruginosa (Donowitz et al., 
1981; Berthelot et al., 2001; Gras-Le Guen et al., 2003; Hurrell et al., 2009; 
Sanchez-Carrillo et al., 2009) transmitted via contaminated feeding equipment, 
have been described. Whether avoidance of enteral feeding will affect the rates 
of invasive disease is less clear. Although the protective role of early human 
milk feeding in avoiding episodes of neonatal sepsis in preterm infants has been 
demonstrated in large studies (El-Mohandes et al., 1997; Hylander et al., 1998; 
Ronnestad et al., 2005a; Neu, 2007) the results of the review of nine studies 
from various countries indicated that the advantage of breast milk over formula 
is not conclusively proven (De Silva et al., 2004). Drawing any firm conclu-
sions of the issue remains also beyond the scope of the current study.  
The finding that route of delivery influenced colonisation by opportunistic 
microorganisms was expected. Our results confirm that colonisation by E. coli 
and C. albicans is mostly of maternal origin as vaginally delivered neonates are 
more likely colonised than those born via Caesarean section. On one hand, 
vaginal delivery is the normal route of birth, but on the other hand colonisation 
by C. albicans could lead to invasive infections. Especially poor outcome of 
these infections in extremely premature babies have been shown (Stoll et al., 
2002b; Pappas et al., 2009), although vaginal delivery in this group is not 
frequent. However, we suggest that prevention of Candida infection should 
include multiple measures and not be limited to fluconazole prophylaxis alone 
in extremely preterm babies. So, colonisation monitoring during pregnancy is 
essential. 
Even more serious problems may be associated with intraamniotic bacterial 
infections related to PROM that may cause preterm birth followed by a serious 
threat of immediate postnatal infections. We showed an association between 
PROM and rectal colonisation with K. pneumoniae but not with other micro-
organisms. More importantly PROM was the premier predictor for colonisation 
by almost all AR resistant Enterobacteriaceae, studied, suggesting that when 
EOS or LOS develops in a neonate born to a mother with PROM, empiric 
antibiotic treatment should also cover AR organisms. 
 
 
6.3. Do antibiotics promote colonisation by  
potentially pathogenic members of Enterobacteriaceae and 
Candida spp. or ampicillin-resistant strains? 
 
Previous studies have shown that broad spectrum antibiotics (e.g. ampicillin, 
cephalosporins) when used in the empiric treatment of EOS lead to increased 
rates of colonisation by potentially pathogenic members of Enterobacteriaceae 
and Candida spp. and will select for antibiotic resistant strains (Wong-Beringer 
et al., 2002; Bonnemaison et al., 2003; Duman et al., 2005; Glynn et al., 2005). 
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We showed that ampicillin as a broader spectrum antibiotic than penicillin 
influenced gut colonisation, but not in the way we hypothesized when planning 
the study. In terms of Gram-negative microorganisms and Candida spp. the 
number of colonised patients in both treatment arms was similar but greater 
CDs of K. pneumoniae, AR Serratia spp. and Candida spp. were seen in the 
ampicillin and that of AR Acinetobacter spp. in the penicillin arm.  
The issue whether short courses of antibiotics induce colonisation by resis-
tant Enterobacteriaceae or other resistant organisms has been recently ques-
tioned (Karami et al., 2006; Millar et al., 2008; Hall et al., 2011). Likely 
colonisation by resistant strains is rather accompanied by long-term antibiotic 
strategies in a specific unit, as usually resistant strains are isolated from 
numerous patients on antibacterials and they become part of the flora of the unit 
(Baltimore, 1998). It is likely that the selection of resistant strains is a lengthy 
process not observed in studies of short duration or using antibiotics for a 
limited number of days as in ours (Jaureguy et al., 2004; Millar et al., 2008; 
Auriti et al., 2009; Puopolo et al., 2010). At present in most countries all entero-
bacterial species other than E. coli have become uniformly resistant to ampi-
cillin and the resistance of E. coli is also increasing (Cordero et al., 2004; 
Kayange et al., 2010). Still, one should bear in mind that our study was con-
ducted in a country with low antibiotic resistance (Lõivukene et al., 2006) 
including low prevalence of ESBL producing microorganisms in the NICU 
setting (approximately 2%) (Mitt et al., 2009). Future studies should identify 
whether our data are applicable to countries with higher resistance rates, as a 
recent study from Brazil found that 87% of patients colonised with ESBL 
producing K. pneumoniae had received previously a penicillin containing regi-
men, whereas the rate among non-colonised patients was 29%; the respective 
results for ampicillin receiving patients were 13% and 9%. Unfortunately the 
study was too small to be conclusive (Cassettari et al., 2009).   
We found only limited associations between mucosal colonisation and the 
use of additional broad spectrum antibiotics or its duration in multivariate 
analyses, although associations between the administration of carbapenems, 
betalactamases with β-lactamase inhibitors, and III and IV generation cepha-
losporins and rectal colonisation by nonalbicans Candida, and administration of 
cephalosporins and betalactamases with β-lactamase inhibitors and NP colo-
nisation mostly by both susceptible and resistant strains of K. oxytoca were 
observed in univariate analysis. Of note the influence of other antibiotics on gut 
colonisation remained beyond the primary scope of this study and the finding 
could be biased by small numbers of patients receiving each individual 
antibiotic.   
Another controversial issue was mucosal colonisation by Candida spp. 
Earlier studies have shown that broad spectrum antibiotics including ampicillin 
but not penicillin outselect Candida spp. which then could lead to invasive 
disease, especially in ELBW infants (Bennet et al., 2002; Bonnemaison et al., 
2003). We found similar numbers of patients colonised with Candida spp. in 
83 
both treatment arms but ampicillin treated patients had greater CD than those 
receiving penicillin indicating that when colonisation occurs its duration after 
ampicillin treatment is longer than after the use of penicillin. Still, the as-
sociation between antibiotic treatment and Candida colonisation/infection 
remains a controversial issue as demonstrated in some though not in all studies 
(Bonnemaison et al., 2003; Clark et al., 2004; Donskey, 2004; Brecht et al., 
2009). Nosocomial spread and cross colonisation especially in ELBW babies 
cannot be excluded.  
Although we did not demonstrate significant differences in AR Gram-
negative or Candida colonisation between the two empiric antibiotic regimens 
one should bear in mind that the relatively short duration of the study (each 
regimen lasted for 8 months) may have been too limited to trigger changes in 
the circulating microflora, especially as the selection of resistant strains is likely 
a lengthy process. We hypothesize that not antibacterial therapy itself but poor 
hospital hygiene will enable the circulation and transmission of multiresistant 
strains which then require the use of broad spectrum antibacterial agents and 
result in longer NICU stay and in turn greater potential for colonisation by 
resistant organisms. Early colonisation by resistant strains seen in about 40% of 
subjects in this study is likely another proof of cross colonisation that can be 
avoided by improving hospital hygiene rather than changing antibacterial 
guidelines. 
 
 
6.4. Which empiric antibiotic regimen should  
be preferred in terms of mucosal colonisation? 
 
The most significant argument in the decision whether to prefer ampicillin or 
penicillin is based on preferring either enterococci and S. aureus or S. haemo-
lyticus and S. hominis. Considering translocation and subsequent BSI, CoNS 
infection is often indolent rather than fulminant and the mortality rate is low, 
although fatalities have been reported. In a recent study conducted in England 
and Wales (Depani et al., 2011), staphylococcal infections, primarily CoNS, 
were more commonly noted among deaths in extremely preterm neonates. Still, 
the mortality rates of BSI caused by S. aureus remain much higher, although not 
as high as caused by Gram-negative bacilli (Tarnow-Mordi et al., 2010).  
The fact that ampicillin is associated with greater colonisation by entero-
cocci than penicillin has been shown previously (Miedema et al., 2000; Bennet 
et al., 2002). The role of this difference, however, is less clear. Enterococci are 
rarely associated with EOS or LOS (1 – 16% of LOS in previous studies and 
1.4% in our study) (Cordero et al., 2004; Bizzarro et al., 2005; Ronnestad et al., 
2005a; Vergnano et al., 2010). More interestingly recent in vitro data indicate 
that some strains of E. faecalis could suppress the proliferation of intestinal 
pathogens and thus have a potential to prevent infection and induction of 
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inflammation (Wang et al., 2008) suggesting potential benefit rather than harm 
of enterococcal colonisation.  
A more serious problem is larger colonisation by S. aureus, a well-known 
agent of HAIs with a potential of inducing allergies (Lundell et al., 2007). How-
ever, S. aureus infections in NICU are not very common (Depani et al., 2011). 
In this study they were as infrequent as enterococcal infections (1.4%). Still, 
clonal transmission of MRSA has become an increasing problem in NICUs 
around the world (Shiojima et al., 2003; Singh et al., 2003; Regev-Yochay et 
al., 2005; Mcdonald et al., 2007; Gregory et al., 2009; Heinrich et al., 2011). 
Although during this study an epidemic of MRSA infection occurred in one but 
not in the other unit, the association between penicillin and greater colonisation 
by S. aureus remained significant after adjusting for participating unit and study 
period. Whether ampicillin treatment has an advantage over penicillin in 
preventing colonisation by MRSA needs further studies. 
The shift in colonisation by CoNS so that ampicillin treatment was as-
sociated with greater colonisation of S. haemolyticus and S. hominis than peni-
cillin is more difficult to explain and to our knowledge has not been described 
before. It is likely that different species of staphylococci compete for the 
colonisation niche but we are not aware of any studies on the subject. The 
relevance of differences in gut colonisation observed in this study is further 
supported by the trend towards higher prevalence of LOS caused by S. haemo-
lyticus in the ampicillin compared with penicillin arm (7 vs 4). Differences in 
the virulence between CoNS species have been demonstrated with 71% of S. 
epidermidis but only 35% of S. haemolyticus and 26% of S. hominis strains 
being capable of slime production, the latter being associated with invasive 
disease (Drozenova et al., 2000; Arslan et al., 2007; Koksal et al., 2009). 
Thus, the interference with the initial mucosal colonisation should not be a 
limiting factor in choosing between ampicillin and penicillin for the empiric 
treatment of EOS although one should bear in mind that some clinically less 
important differences between these two agents occurred. We suggest that the 
selection should be made mainly according to the local distribution of EOS 
causing microorganisms and their antibiotic susceptibility. The equal effecti-
veness and safety of two these antibiotic regimens was previously published by 
Metsvaht et al (2010). Anyway, ampicillin for extremely preterms is more 
recommended, as in this group higher mortality rates in penicillin arm occurred. 
 
 
6.5. When if at all are surveillance cultures useful? 
 
In this study, conducted in neonates at high risk of health care associated infec-
tions we demonstrated that prior mucosal colonisation with Gram-negative 
microorganisms except E. cloacae, Serratia spp and Acinetobacter spp. in-
creases the risk for invasive disease. Thus it will be tempting to use the results 
of mucosal cultures in guiding the selection of empiric antibiotic therapy and 
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due to extra pain and distress avoid taking blood cultures in critically as much 
as possible. Surveillance cultures, in turn, are labour intensive and require 
significant amount of laboratory resources. 
In concordance with other studies (Evans, 1988; Choi et al., 2008) we 
showed that the predictive value of surveillance cultures in general is sub-
optimal – the sensitivity on sample level was 27% and on patient level 59%; the 
specificity being only slightly better, 66% and 42%, respectively. Furthermore, 
a study in adult ICU has shown that regular screening sample collection has also 
a downside as therapy guided by these may result in overuse of antibiotics with 
consequent increase in costs, antibiotic resistance and probably superinfections 
(Warren et al., 2005). 
Colleting rectal or NP swabs may have some value in cohorting colonised 
patients (Friedman et al., 2008) or selecting appropriate antibacterial therapy 
during outbreaks of hospital acquired infections. Monitoring of alert micro-
organisms and reinforcing infection control measures like isolation of colonised 
patients may help to interrupt horizontal spread and avoid outbreaks of hospital 
acquired infections (Bertrand et al., 2001; Regev-Yochay et al., 2005; Mam-
mina et al., 2007; Mcdonald et al., 2007; Anderson et al., 2008; Heinrich et al., 
2011).  
The issue which patients should be isolated and cohorted is less clear. In 
principle, isolation needs should be determined by the mode of transmission and 
by the pathogen involved. Newborns are nonmobile and often cared for in incu-
bators, so there is no direct contact between patients. Under these circumstan-
ces, for contact transmission, involved in most nosocomial Gram-negative and –
positive pathogens as well as Candida spp., care measures focusing on pre-
vention of vector-related (i.e. contaminated hand or equipment) transmission 
have likely the greatest potential. Some previous studies have questioned the 
clinical and economical value of surveillance cultures as part of such strategies. 
For example, to prevent the spread of MRSA, Gregory et al (2009) cultured 
samples from nares and rectum weekly over 7 years and cohorted colonised or 
infected patients. As a results MRSA in the NICU was not permanently 
eradicated although $ 1 500 000 was spent. One potential explanation for this 
failure was the inability to locate and eliminate the source of MRSA. So, to 
ensure success, a more complex approach is probably needed. Also, no evidence 
has been found to either support or refute the use of patient isolation measures 
in neonates with Candida colonisation or infection (Mohan et al., 2007). 
Thus mucosal surfaces are an important source of infection but routine and 
non-targeted surveillance cultures are not efficient in predicting LOS in NICU 
patients. However, mucosal sampling targeted for specific organisms (e.g 
Klebsiella spp., E. coli, Stenotrophomonas and Pseudomonas) may offer an 
opportunity to improve infection control measures and selection of empiric 
antibiotic regimen. 
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6.6. Limitations of the study 
 
Several limitations which we believe did not significantly interfere with our 
conclusions should be noted. First, involvement of two units only (although 
these cover the entire 3rd level NICU population in Estonia) did not allow ac-
counting for the variability potentially occurring in multicentre settings. Second, 
not all admitted patients but only those require empiric antibiotic treatment with 
ampicillin or penicillin plus gentamicin were recruited, excluding 40% of NICU 
admissions. Third, the short duration of the study and each antibiotic regimen 
did not allow addressing long term changes in circulating microbiota. Fourth, 
the lack of antibiotic treatment free control group made it impossible to assess 
the influence of any antibacterial treatment on development of gut microbiota; 
although one should mention that antibiotic naive group in third level NICU is 
almost non-existent (Lass et al., 2011). Fifth, environmental cultures as well as 
maternal colonisation were not evaluated. 
     In addition, in both arms 35% neonates received additional broad spectrum 
antibiotics which could interfere with gut colonisation process and may have 
affected our conclusions on the impact of penicillin and ampicillin on mucosal 
colonisation. Still, our population closely mirrored the one admitted to NICU 
where the majority of infected neonates receive more than one antibiotic 
regimen during their stay. Exclusion of these patients from the analysis would 
have introduced a major population bias with the sickest babies at highest risk 
of adverse colonisation being left out. We believe that the use of other anti-
biotics did not influence the overall conclusions as in both treatment arms their 
frequency as well as the type of drugs used, was similar. Also, risk factor 
adjusted multivariate analysis allowing correction for possible confounders, 
including broad spectrum antibiotics, was applied.  
 
 
6.7. Future research 
 
In this study we focused on the collection of potentially pathogenic opportu-
nistic organisms and did not look at the non-pathogenic bacteria like Lacto-
bacilli, Bifidobacteria and Bacteroides. However, we appreciate their enormous 
role in mucosal colonisation that may be interfered by all risk factors identified 
in this study. Therefore, further detailed studies are needed. Also, quantitative 
cultures which may reveal additional information, when development of 
invasive disease is concerned, were not performed. The stool samples from 
ELBW babies were collected and are analysed separately by using qRT-PCR 
(Drell et al., 2009).  
The results of herein study showed that neonates acquire opportunistic 
microbes frequently from the hospital environment but collection of cultures 
from environment or hospital staff was beyond the scope of our study. A better 
understanding of the circulation of microorganisms in the NICU may offer the 
possibility to improve infection control measures. 
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As in our study one antibiotic regimen was given only over a maximum of  
8 months, this period may have been too short to trigger changes in the 
circulating microbiota. Long term effects of various antibiotics should be 
addressed in future surveillance studies. Also further research should clarify our 
understanding of the clinical relevance of differences in early gut colonisation 
by various CoNS species and enterococci. Better knowledge about the sources 
of CoNS BSI is of ultimate importance, as it remains the most frequently en-
countered HAI in preterm neonates, associated with significant cost in both 
human and material resources.  
Several studies but not all provide compelling evidence that prophylactic 
administration of certain Lactobacillus and Bifidobacterium probiotics reduces 
LOS (Dani et al., 2002; Bin-Nun et al., 2005; Lin et al., 2005). Thus, operating 
with probiotics in infant nutrition can only be justified once we have developed 
a detailed understanding of their action, not only short but also in the longer 
term (Salminen et al., 2006; Kelly et al., 2007; Sanders et al., 2010).  
We also performed an analysis to identify risk factors of invasive disease. 
However, most likely due to relatively small numbers of Gram-negative 
infections in this study (n = 27) the 95% CI of associated risk factors were 
extremely wide. Larger studies should be conducted to identify risk factors of 
invasive disease caused by opportunistic microorganisms.  
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7. CONCLUSIONS 
 
1. The first colonisers in neonates admitted to NICU with risk factors of EOS 
were Gram-positive bacteria, among which CoNS clearly predominated 
throughout the study. By the end of first week more than 90% of patients were 
colonised with Gram-positive and about 30% with Gram-negative AR micro-
organisms. Colonisation by Gram-negatives in NP and rectal area were similar, 
but Enterobacteriaceae except Serratia spp. were more frequently colonising 
rectum than NP but Acinetobacter spp. were more commonly recovered in the 
NP. The most frequent Gram-negative coloniser including AR strains was  
E. cloacae followed by K. pneumoniae, K. oxytoca and Acinetobacter spp. The 
frequent opportunistic colonisers were also frequent causative agents of LOS.  
 
2. The mucosal colonisation by E. coli, K. oxytoca and C. albicans is mainly 
influenced by maternal and early perinatal factors, while K. pneumoniae,  
E. cloacae, MRSA and non-albicans Candida spp. are predominantly affected 
by the hospital environment and prematurity. Risk factors (e.g. duration of 
NICU stay, unit, GA, route of delivery) influencing NP and rectal colonisation 
including AR strains are similar and species-specific and are closely inter-
related making extrapolations from one site to the other feasible. 
 
3. In patients with risk factors for EOS the impact of ampicillin (a broader 
spectrum antibacterial agent compared with penicillin) on mucosal colonisation 
with Gram-negative microorganisms including AR strains may have been over-
estimated. The main differences between these two agents are as follows:  
a. Patients receiving ampicillin containing regimen are less frequently 
colonised with S. aureus and Enterococcus spp. but more often colonised 
with S. haemolyticus and S. hominis than those treated with penicillin.  
b. Patients receiving ampicillin have greater CDs of K. pneumoniae, AR 
Serratia spp. and Candida spp. but lower CDs of AR Acinetobacter spp. 
than those receiving penicillin. 
c. The colonisation of Candida spp. and all other Gram-negatives are 
similar in both groups.  
 
Thus, the avoidance of unwanted initial gut colonisation should not be a limi-
ting factor in choosing between ampicillin and penicillin for the empiric treat-
ment of EOS. We suggest that the selection should be made mainly according to 
the local distribution of EOS causing microorganisms and their antibiotic 
susceptibility. Host-related factors like the degree of prematurity should also be 
considered.  
 
4. Prior mucosal colonisation with Gram-negative organisms other than  
E. cloacae, Serratia spp., Acinetobacter spp. and MRSA may lead to invasive 
disease. However, the sensitivity, specificity and PPVs of mucosal surveillance 
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samples in predicting invasive disease is moderate for Enterobacteriaceae and 
suboptimal for non-fermentative micro-organisms.   
 
5. Routine and non-targeted surveillance cultures are not efficient in predicting 
LOS in NICU as they are of low diagnostic accuracy, expensive and time 
consuming. Targeted for specific organisms (e.g MRSA, Klebsiella spp.), 
surveillance cultures may prove to be useful especially during outbreaks of 
nosocomial infections. They may offer an opportunity to improve infection 
control measures, to cohort patients and to select the most appropriate empiric 
antibiotic regimen.  
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9. SUMMARY IN ESTONIAN 
 
Varase sepsise riskiga vastsündinute limaskestade  
kolonisatsioon ja selle osatähtsus invasiivse infektsiooni 
prognoosimisel 
Inimese seederakti mikrofloora on mitmekesise koostisega dünaamiline ja tasa-
kaalustatud ökosüsteem (Mackie et al.,1999; Morelli, 2008; Mshvildadze et al., 
2010a). Üsasiseselt on loote seedetrakt mikroobivaba ning esmane limaskestade 
kokkupuude mikroobidega toimub sünnituse ajal ja vahetult peale sündi (Srivas-
tava et al. 2007; Mshvildadze et al., 2008). Tavaliselt on esmased koloniseerijad 
oportunistlikud aeroobsed ja fakultatiivselt aeroobsed mikroobid (Almuneef et 
al., 2001; Rautava et al., 2002; Hallstrom et al. 2004; Morelli, 2008; Enck et 
al., 2009; Ogra, 2010). Ühest küljest valmistavad nad soole ette nn kasulikele 
anaeroobsetele mikroobidele nagu Bacteroides spp., Bifidobacterium spp. ja 
Clostridium spp. (Morelli, 2008; Srivastava et al., 2007; Thompson-Chagoyan 
et al., 2007) ning neil on positiivne mõju immuunsuse väljakujunemisel. Samuti 
mõjutavad nad lapse organismi arengut ning ka üldist tervislikku seisundit 
hilisemas eas. Teisest küljest võivad needsamad mikroobid translotseeruda keha 
steriilsetesse piirkondadesse ja põhjustada infektsiooni, seda eriti enneaegsetel 
ja immuunkomprimeeritud lastel (Cartelle et al., 2004; Donskey, 2004; Graham 
et al., 2007; Miranda et al., 2009).  
Limaskestade kolonisatsiooni mikroobidega mõjutavad mitmed erinevad 
sünnieelsed, -aegsed ja -järgsed tegurid, nagu ema tervis, sünniviis, gestatsiooni 
aeg, sünnikaal, antibakteriaalne ravi, toit, keskkond jne. Kui ajaliste tervete laste 
esmane kolonisatsioon pärineb peamiselt ema mikrofloorast (Mackie et al., 
1999; Morelli, 2008), siis intensiivravi osakondades viibijatel on selle allikaks 
suures osas haigla keskkond (Saiman, 2002; Srivastava et al.2007). Samas on 
haiglas ringlevad tüved sageli virulentsemad ja ka ravimresistentsed (Ayan et 
al., 2003; Bagattini et al., 2006; Mears et al., 2009, Millar et al., 2008; Sim-
monds et al., 2009).  
Siiski on teadmised oportunistlike mikroobide varast kolonisatsiooni mõju-
tavate faktorite mõjust ja nende omavahelistest seostest ebapiisavad, kuna vara-
semates uuringutes on peamiselt jälgitud kas üksiku konkreetse mikroobi 
kolonisatsiooni või vaid mõnede riskifaktorite mõju (DeMan et al., 2000; Ber-
nard et al., 2001; Asindi et al., 2002; Cartelle et al., 2004; Hallstrom et al, 
2004). Kolonisatsiooni mõjutavate faktorite omavahelisi seoste ja nende oluli-
suse uurimist takistab enamasti väike uuritavate arv (Bennet et al., 1982; Ge-
wolb et al., 1999; Bennet et al., 2002; Bonnemaison et al, 2003; Taipiainen et 
al., 2006) või vaid univariantse statistika kasutamine (Baltimore et al., 1989; 
Bennet et al., 2002; Jaureguy et al., 2004). Täpsemad teadmised mikrofloora 
kujunemisest ja seda mõjutavatest teguritest intensiivravi osakondades aitaksid 
parandada infektsioonikontrolli strateegiaid ja mõjutada kolonisatsiooni teket 
lapse tervisest lähtuvalt (Donskey, 2004; Miranda et al., 2009). 
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Kuna enneaegsetel ja nõrgestatud immuunsüsteemiga vastsündinutel on suur 
oht mikroobide translokatsiooniks ja infektsiooni kujunemiseks, on empiiriline 
antibakteriaalne ravi laialt kasutusel. Käesoleval ajal on peamiselt soovitatavad 
kaks ravirežiimi: ampitsilliin või penitsilliin koos gentamütsiiniga (Schrag et 
al., 2002; Metha, 2005; Joung, 2008). On leitud, et ampitsilliin, kui laiema 
toimespektriga antibiootikum mõjutab küll enam Gram-negatiivset mikrofloo-
rat, kuid samas soodustab ravimresistentsete enterobakterite teket ning koloni-
satsiooni pärmseentega (DeMan et al., 2000; Bonnemaison et al., 2003; Stoll et 
al., 2005). Teisest küljest on penitsilliinil normaalsele mikrofloorale säästvam 
toime (Bennet et al., 1982). Ampitsilliini + gentamütsiini ja penitsilliini + 
gentamütsiini kliinilist efektiivsust jälgiv uuring tõestas, et mõlemad ravimi 
kombinatsioonid on sarnase efektiivsuse ja ohutusega (Metsvaht et al., 2010). 
Samas vastavad kaht režiimi võrdlevad uuringud mikrofloora seisukohast puu-
duvad.   
Aastakümneid on klinitsistid ja teadlased püüdnud prognoosida sooletrakti, 
neelu või naha järelvalvekülvide järgi sepsise teket. Need katsed on andnud 
enamasti statistiliselt ebarahuldavaid tulemusi, kuid teatud olukordades osu-
tunud siiski kasulikuks. Kolm aastakümmet tagasi hindasid Harris (1976) ja 
Sprunt (1978) kaasautoritega sel otstarbel võetud järelevalve külve kulukaks ja 
aeganõudvaks, kuid puudub ülevaade nende kulukusest käesoleval ajal (Blot et 
al., 2005; Mcginigle et al., 2008). On teadlasi, kes soovitavad kord või kaks 
nädalas koguda järelevalvekülve haiglainfektsiooniriskiga patsientide välja-
selgitamiseks (Pierro et al 1998; Silvestri et al., 1999; Shankar et al., 2001). 
Kahe varasema vastsündinute intensiivravi osakonnas läbiviidud uuringu tule-
muste järgi olid siin kogutud järelvalvekülvidel madal sensitiivsus (16% – 
56%), spetsiifilisus (38% – 82%) ja positiivne prognostiline väärtus (PPV) 5% – 
7,7%) (Evans, 1988; Choi et al., 2008). Hiljuti Smith kaasautoritega (2010) 
poolt läbiviidud uuringus, millega püüti prognoosida gentamütsiin-resistentsete 
Gram-negatiivsete mikroobide poolt põhjustatud sepsist väikese sünnikaaluga 
lastel, olid samad arvtulemused tunduvalt paremad; vastavalt 100%, 98%, and 
90%. Nii kõrged väärtused lubvad arvata, et kasutati patsiendi-, mitte aga 
külvidepõhist analüüsi. Seega on järelevalvekülvide sepsist prognoosiv väärtus 
siiani ebaselge.  
 
 
Uurimistöö eesmärk 
 
Uurimistöö peamiseks eesmärgiks oli selgitada, kuidas vastsündinute varase 
sepsise empiiriliseks raviks kasutatavad ravirežiimid (ampitsilliin ja penitsilliin 
kombinatsioonis gentamütsiiniga) mõjutavad varast laste rektaalset ja ninaleelu 
kolonisatsiooni oportunistlike mikroobidega ja kumba nest seoses eelnenuga 
tuleks eelistada.  
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Konkreetsed eesmärgid: 
 iseloomustada vastsündinute intensiivravi osakonnas viibivate vastsündinute 
limaskestade varast kolonisatsiooni aeroobsete oportunistlike bakterite ja 
Candida spp. esindajatega; 
 selgitada, millised perinataalsed, neonataalsed ja keskkonna faktorid seda 
eeskätt mõjutavad;  
 võrrelda kahe varase sepsise empiiriliseks raviks kasutatava ravirežiimi 
(penitsilliin või ampitsilliin koos gentamütsiiniga) mõju aeroobse, fakulta-
tiivselt aeroobse ja ampitsilliin-resistentse rektaalse mikrofloora kujune-
misele teiste võimalike kolonisatsiooni mõjutavate faktorite foonil; 
 hinnata seost kolonisatsiooni ja infektsioone põhjustavate mikroobitüvede 
vahel; 
 hinnata kaks korda nädalas kogutud järelvalvekülvide prognostilist väärtust 
sepsisesse haigestumisel.  
 
 
Materjal ja meetodid 
 
Uuring viidi läbi prospektiivse, kahekeskuselise, klaster-randomiseeritud avatud 
uuringuna Tallinna Lastehaigla ja Tartu Ülikooli Kliinikumi laste- ja vast-
sündinute intensiivravi osakondades 02.08.2006 kuni 30.11.2007. Uuringu 
esimesel perioodil kasutati ühes keskuses ampitsilliini koos gentamütsiiniga ja 
teises penitsilliini koos gentamütsiiniga. Peale seda, kui mõlemas osakonnas oli 
materjal kogutud pooltelt vastava ravirežiimiga lastelt (vajalik laste arv saadi 
võimsusanalüüsi alusel), ravirežiimid osakondades vahetati. Uuringusse kaasati 
276 (prognoosi uuringusse 278) vastsündinut, kes olid osakonda saabudes noo-
remad kui 72 tundi, vajasid sepsise kahtluse või riskifaktorite olemasolu tõttu 
empiirilist antibakteriaalset ravi ning viibisid osakonnas vähemalt 24 tundi.  
Limaskestade kolonisatsiooni hindamiseks koguti nina-neelu ja perirektaalne 
kaabe patsiendi osakonda saabumisel ja edaspidi kaks korda nädalas (esmas-
päev ja neljapäev) kuni osakonnas viibimise lõpuni või kuni 60-da ravipäevani. 
Tampoone materjaliga säilitati –20 °C juures ja külvati kord nädalas veri-, 
MacConkey ja Sabouraud agarile ning MacConkey agarile, kuhu oli lisatud  
16 µg/ml ampitsilliini. Veri- ja MacConkey agarit inkubeeriti 37 °C juures 24–
48 tundi ja Sabouraud agarit 25 °C juures kuni nädal. Igast morfoloogiliselt 
erinevalt kasvanud pesast saadud mikroobid värviti Grami järgi ja identi-
fitseeriti kasutades erinevaid söötmeid ja biokeemilisi meetodeid (API 20E ja 
API STAF). S. aureus ja MRSA määrati nuc- ja mecA-geeni olemasolu järgi. 
Veri võeti haiglasse saabumisel ja edasi kahtlusel invasiivsele infekstioonile 
ning selle uuringud viidi läbi TÜ Kliinikumi laboris. Translokatsiooni (K. pneu-
moniae, E. cloacae, Acinetobacter spp., MRSA) ja puhangutüvede (K. pneu-
moniae) klonaalsuse selgitamiseks kasutati molekulaarseid meetodeid, vastavalt 
pulssvälja geel-elektoforeesi (PFGE) ja amplifitseeritud fragmendi pikkuse 
polümorfismi (AFLP).  
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Kolonisatsiooni riskifaktorite selgitamiseks registreeriti järgmised perina-
taalsed parameetrid: ema vanus, antibakteriaalne ravi raseduse ja sünnituse ajal, 
lootevete puhkemine varem kui 18 tundi enne sünnitust, mitmiksünd ja sünni-
viis. Igalt patsiendilt koguti järgmised andmed: sünnikaal, gestatsiooni vanus, 
kopsude kunstliku ventilatsiooni rakendamine ja selle kestvus, intensiivravi 
osakonda saabumise vanus ja seal viibimise aeg, osakond, uuringu periood, 
empiiriline antibakteriaalne ravi ja selle kestvus, lisavajadus laia toimespektriga 
antibakteriaalne ravi järele ja selle kestvus (karbapeneemid, kolmanda ja 
neljanda põlvkonna tsefalosporiinid ja beeta-laktamaas resistentsed penitsil-
liinid), tsentraalsete intravenoossete veeni- ja intraarteriaalste kanüülide kasu-
tamine ja selle kestvus ning lapse toitmise viis (täielik parenteraalne toitmine, 
rinnapiim, piimasegu).  
Kolonisatsiooni riskifaktorite selgitamiseks kasutati ühest ja mitmest logis-
tilist regressiooni. Selgitamaks kahe erineva empiirilise ravirežiimi mõju 
kolonisatsiooni tekkele ja kolonisatsioonitihedusele (kolonisatsioonipäevi 100 
voodipäeva kohta) kasutati osakonnale ja uuringuperioodile kohandatud mit-
mest multifaktoriaalset hierarhilist segamudelit. Järelevalvekülvide väärtuse 
hindamiseks sepsise prognoosimisel arvutati eraldi nii külvipõhine kui ka 
patsiendipõhine sensitiivsus, spetsiifilisus ning PPV negatiivne prognostiline 
väärtus (NPV).  
 
 
Tulemused 
 
Varase empiirilise antibakteriaalse ravi mõju  
seedetrakti kolonisatsioonile 
 
Esmased seedetrakti koloniseerijad mõlemas ravigrupis olid Gram-positiivsed 
mikroobid, neile järgnesid Gram-negatiivsed ja pärmid. Kahe erineva ravigrupi 
(ampitislliin koos gentamütsiiniga vs penitsilliin koos gentamütsiiniga) vahel 
esinesid mõningad erinevused. Nimelt oli penitsilliini saanud grupis rohkem:  
(1)  enterokokkidega koloniseerunud vastsündinuid nii 6.–9. elupäeval (OR = 
2,99; 95% CI 1,23–7,25) kui ka 13.–16. elupäeval (OR = 3,33; 95 % CI 
1,29–8,63);  
(2)  S. aureus’ga koloniseerunuid 3.–5. elupäeval (p = 0,012) ja  
(3)  Acinetobacter spp-ga koloniseerunuid 13.–16. elupäeval (6 vs 0; p=0,009) 
ning sama mikroobi ampitsilliin-resistentsete tüvedega koloniseerunuid  
10.–12. (6 vs 0; p=0,045) ja 13.–16. (4 vs 0; p=0,046) elupäeval.  
Vastupidiselt meie hüpoteesile kolonisatsioon ampitsilliin-resistentsete tüve-
dega kahe ravirežiimi vahel oluliselt ei erinenud. 
Kahe erineva ravirežiimi ja kolonisatsiooni tekke vahelise seose jälgimisel 
selgus, et ampitsilliinravi grupis võrreldes penitsilliinraviga oli enam koloni-
seerunuid S. haemolyticus’e (erinevus +0,7; p=0,039) ja S. hominis’ga (+1,9; 
p=0,003) kuid vähem enterokokkide (–1,2; p<0,001) ja S. aureus’ga (–1,9; 
p=0,006). 
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Ampitsilliini grupis oli statistiliselt suurem koloniseeritud päevade arv 100 
voodipäeva kohta K. pneumoniae (erinevus +6,6 päeva; p = 0.012), ampitsilliin-
resistentsete Serratia spp (+3,6; p = 0,012), S. haemolyticus’e (+11,4; p = 
0,001), S. hominis’e (+6,3; p = 0,001) ja Candida spp’ga (+6,1; p=0,020), kuid 
väiksem S. epidermidis’e (–7,1; p = 0,073), Enterococcus spp (–13,0; p = 
0,001), ampitsilliin-resistentse Acinetobacter spp (–2,5; p = 0,001) ja piiri-
pealselt ka S. aureus’ga (–2,8; p=0,052). 
 
 
Limaskestade kolonisatsiooni mõjutavad riskifaktorid 
 
Uuringu käigus koguti 276lt antud uuringusse kaasatud patsiendilt 1250 rek-
taalset ja 1205 ninaneelu kaabet, milledes vastavalt 55,8% ja 42,8% esinesid 
Gram-negatiivsed mikroobid. Rektaalsetest isolaatidest 73,4% ja nasofarün-
geaalsetest 60,2% olid ampitsilliin-resistentsed. 49-l (17,8%) patsiendil ilmnes 
rektaalne kolonisatsioon Candida spp-ga. 
Kasutades mitmest logistilist regressiooni hinnati 22 riskifaktori (millest 3 
olid seotud keskkonnaga, 5 emaga ja 14 vastsündinuga) mõju rektaalse ja nina-
neelu mikrofloora kujunemisele. Leiti, et erinevatel faktoritel on sarnane 
mikroobispetsiifiline mõju kahele erinevale piirkonnale. Siiski esines ka kahe 
erineva piirkonna (ninaneel, rectum) valikuline mõju mikroobsele kolonisat-
sioonile. See väljendus statistiliselt 1,5–2,5 korda suuremas šansis rektaalseks 
(võrreldes ninaneeluga) kolonisatsiooniks enterobakteritega (va Serratia spp) ja 
väiksemas šansis (OR=0,52; 95% CI 0,30–0,89) kolonisatsiooniks Acineto-
bacter spp’ga.  
Kõige rohkem mõjutas oportunistlike mikroobidega kolonisatsiooni pat-
siendi haiglasviibimise kestus. Olenevalt mikroobiliigist suurendas iga haiglas-
veedetud päev kolonisatsiooniriski 5–8% võrra. E. coli, K. oxytoca ja C. albi-
cans’i kolonisatsiooni mõjutasid peamiselt emaga seotud või varased neo-
nataalsed riskifaktorid. Näiteks oli rinnapiimaga toidetutel võrreldes paren-
teraalset toitmist saajatega üheksa korda suurem šanss rektaalseks kolonisat-
siooniks E. coli (OR=8,90; 95% CI 2,27–34,70) ning vastavalt viis ja kuus 
korda suurem šanss K. oxytoca nii tundlike kui ampitsilliin-resistentsete tüve-
dega (vastavalt OR=5,00; 95% CI 1,57–15,92 ja OR=5,81; 95% CI 1,65–20,44). 
Vastupidiselt omas parenteraalne toitmine võrreldes rinnapiimaga suuremat 
riski kolonisatsiooniks C. albicans’ga (OR=2,91; 95% CI 1,02–8,26).  
Ka oli vaginaalse sünnituse järgselt võrreldes keisrilõikega üle kahe korra 
suurem šanss kolonisatsiooniks C. albicans’ga (OR=2,27; 95% CI 1,06–4,86) ja 
samuti soodustas vaginaalne sünd nii rektaalset kui nasofarüngeaalselt koloni-
satsiooni E. coli’ga (OR= 4,44; 95% CI 1,97–10,00 ja OR=2,69; 95% CI 1,01–
7,18). Lootevete varase puhkemise korral oli vastavalt neli ja viis korda suurem 
šanss ninaneelu kolonisatsiooniks K. oxytoca nii tundlike kui ka ampitsilliin-
resistentsete tüvedega (OR=4,33; 95% CI 1,54–12,21 ja OR=4,83; 95% CI 
1,44–16,18) ning neli ja kuus korda suurem šanss E. coli nii tundlike kui ka 
ampitsilliin-resistentsete tüvedega (OR=4,43; 95% CI 1,66–11,78 ja OR=5,94; 
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95% CI 1,58–22,42). Ajalised lapsed (gestatsiooniaeg ≥37) võrreldes enne-
aegsetega (gestatsiooniaeg 29–36 nädalat) koloniseerusid rektaalselt sagedamini 
E. coli (OR=3,13; 95% CI 1,18–8,27) ja K. oxytoca resistentsete tüvedega 
(OR=3,13; 95% CI 1.02–9,57). 
Kolonisatsioon K. pneumoniae, E. cloacae ja mitte-albicans-Candida spp. 
pärines peamiselt haigla keskkonnast ja/või oli seotud lapse enneaegsusega. 
Näiteks oli suurem šanss koloniseeruda K. pneumoniae ja E. cloaceae’ga nii 
rektaalselt kui ka nasofarüngeaalselt nii tundlike kui ka ampitsillin-resistentsete 
tüvedega peamiselt ühes osakonnas. Samuti soodustas E. cloacae (OR=8,48; 
95% CI 1,04–68,89) ja K. pneumoniae (OR=9,00; 95% CI 1,93–42,08) naso-
farüngeaalset kolonisatsiooni sügav enneaegsus (gestatsiooniaeg ≤28 vs 
≥37nädalat). Päevade arv, mil kasutati tsentraalseid veenikateetreid, tõstis 
rektaalse kolonisatsiooni šanssi K. pneumoniae (OR=1,06; 95% CI 1,01–1,12) 
ja mitte-albicans-Candida’ga (OR=1,06; 95% CI 1.00–1,13). 
 
 
Järelvalvekülvide prognostiline väärtus vastsündinute intensiivravi 
osakondades 
 
Järelevalvekülvide väärtust Gram-negatiivsete mikroobide poolt tekitatud hilise 
sepsise tekke ennustamiseks hinnati 278-lt patsiendilt kogutud 1250 rektaal-, 
1153 ninaneelu ja neile lisatud 60 mikroobse kasvuga trahhea materjali alusel. 
Neid võrreldi 555 steriilsetest kehavedelikest (514 verest, 36 liikvorist, 5 
mujalt) võetud materjaliga. Kokku analüüsiti 2108 limaskesta ja invasiivsete 
külvide paari. Gram-negatiivseid mikroobe isoleeriti 171 (62%) patsiendil; 
kusjuures kasv esines 55,4% rektaal-, 48,4% nina-neelu ja 5,8% invasiivsetes 
külvides. Erinevate hinnatud liikide hulk ühel patsiendil oli 1 – 8 (mediaan 3).  
Kolonisatsiooni ja infektsiooni seoste leidmiseks jälgiti 27-l Gram-negatiiv-
sete sepsisega patsiendil (mediaan tekkeks oli 13.-elupäev) identsete mikroo-
bide esinemist limaskestadel. 22-l juhul koloniseerusid hilist sepsit põdevad 
lapsed fenotüüpiliselt sarnaste tekitajatega, kusjuures kolonisatsioon esines 2–
36 päeva enne sepsist. Genotüüpiline koloniseeruvate ja sepsist põhjustavate 
tüvede sarnasus (K. pneumoniae, E. cloaceae, A. baumannii) kinnitati pulss-
välja geelelektroforeesiga. 
Üldine järelvalvekülvide prognostiline väärtus oli madal – sensitiivsus, 
spetsiifilisus, NPP ja PPV vastavalt 27%, 66%, 4% ja 94%. Võrreldes mitte-
fermenteerivate mikroobidega olid enterobakteritel kõrgemad sensitiivsuse 
(37% vs 11%) ja PPV (3,5% vs 0,8%) näitajad. Samuti olid enterobakterite 
väärtused kõrgemad kõigil uuritud ajahetkedel. Parim oli sensitiivsus kui 
kolonisatsioon tekkis 2–6 päeva enne sepsist. Mitmese segamudelite analüüsi 
kasutamisel selgus, et sepsise prognoosimist aitab parandada positiivsete 
järelvalvekülvide suurem arv enne infektsiooni (iga positiivse külvi kohta OR= 
4.66; 95% CI 2.28–9.55; p=<0,0001) ja patsiendi väiksem eluiga (iga elupäeva 
kohta OR=0,94; 95% CI 0,88–1.00; p=0.047). 
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Klonaalne seos limaskestade kolonisatsiooni põhjustavate ja infektsiooni-
tüvede vahel leidis eriti kinnitust ühes osakonnas esinenud K. pneumoniae ja 
teises osakonnas esinenud kahe väiksema MRSA puhangu ajal. Esimesena 
mainitud mikroobi poolt tingitud puhang kestis rohkem kui kuus kuud. Sel 
perioodil koloniseerus sama mikroobitüvega 23 patsienti, kellest viiel ilmnes 
vereringe infektsioon. 
 
 
Järeldused 
 
 Esmased varase sepsise kahtlusega intensiivravi osakonnas viibivate vast-
sündinute limaskestade koloniseerijad olid Gram-positiivsed bakterid, mille-
dest kogu uuringu vältel domineeris KoNS. Esimese elunädala lõpuks oli üle 
90%-i uuritavatest koloniseerunud Gram-positiivsete ja ligi kolmandik 
Gram-negatiivsete ampitsilliin-resistentsete mikroobidega. Rektaalne ja 
nina-neelu kolonisatsioon Gram-negatiivsete mikroobidega oli sarnane, kuid 
enterobaktereid, va Serratia spp., leidus rohkem rektaalselt ja Acinetobacter 
spp. esindajaid isoleeriti rohkem nina-neelust. Sagedasemad nii tundlikud 
kui ka ampitsilliin-resistentsed Gram-negatiivsed mõlema limaskesta koloni-
seerijad olid E. cloaceae, K. pneumonia, K. oxytoca ja Acinetobacter spp. 
Sagedasemad oportunistlikud koloniseerijad olid ka sagedasemad vereringe 
infektsiooni põhjustajad.   
 Limaskestade kolonisatsiooni E. coli, K. oxytoca ja C. albicans’ga mõjuta-
vad peamiselt emapoolsed ja perinataalsed faktorid ning kolonisatsioon K. 
pneumoniae, E. cloaceae, MRSA ja mitte-albicans-Candida’ga on peamiselt 
tingitud haigla keskkonnast ja lapse enneaegsusest. Riskifaktorite mõju (näi-
teks haiglas viibimise aeg, osakond, gestatsiooni vanus, sünniviis) sooletrakti 
ja nina-neelu kolonisatsioonile nii antibiootikum-tundlike kui ka ravim-
resistentsete tüvede osas on sarnane, omavahel tihedalt seotud ja mikroobi-
spetsiifiline ning seetõttu on neid võimalik üldistada mõlemale piirkonnale. 
 Võrreldes ampitsilliini kui laiema toimespektriga antibiootikumi mõju 
penitsilliiniga, kui neid kasutatakse empiiriliselt varase sepsise ohu korral, 
võib väita, et esmamainitu toimet Gram-negatiivsele mikrofloorale ja ravim-
resistentsete tüvede tekkele on ilmselt ülehinnatud. Peamised erinevused 
nende režiimide osas olid järgmised: 
a. Ampitsilliinravi korral võrreldes penitsilliiniga koloniseeruti rohkem S. 
haemolyticusʼe ja S. hominisʼga, kuid vähem S. aureus’e ja entero-
kokkidega.  
b. Ampitsilliinravi saavad patsiendid võrreldes penitsilliinravi saavatega 
omasid suuremat kolonisatsioonitihedust K. pneumoniae, ampitsilliin-
resistentse Serratia spp. ja Candida spp.ʼga, kuid neil oli väiksem 
kolonisatsioonitihedus ravimresistentse Acinetobacter spp.ʼga. 
c. Kolonisatsioon Candida spp. ja eelpool mainimata Gram-negatiivstete 
mikroobide osas oli mõlemas ravigrupis sarnane. 
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Seega empiirilise ravi mõju uurimisel soovimatu mikrofloora kujunemisele ei 
tohiks keskenduda vaid kahe erineva ravirežiimi (ampitsilliin ja penitsilliin koos 
gentamütsiiniga) eelistamise tõestamisele. Ravimrežiimi eelistus peaks pigem 
baseeruma lokaalsel olukorral: millised on vastava osakonna sagedasemad 
infektsioonitekitajad ja nende ravimtundlikkus. Samuti tuleks arvestada enne-
aegsust ja muid lapsest sõltuvaid faktoreid. 
 Eelnev limaskestade kolonisatsioon Gram-negatiivsete mikroobidega (va E. 
cloacae, Serratia spp., Acinetobacter spp.) ja MRSA-ga võib viia invasiivse 
infektsiooni väljakujunemisele. Siiski on järelevalvekülvide sensitiivsus, 
spetsiifilisus ja PPV ennustamaks invasiivse infektsiooni teket enterobak-
terite korral mõõdukas, kuid mittefermenteerivate mikroobide jaoks sub-
optimaalne.   
 Regulaarselt kogutud järelevalvekülvid on väheefektiivsed, samas ka küllalt 
kulukad ja aeganõudvad ennustamaks intensiivravi osakondades viibivatel 
vastsündinutel sepsise teket. Järelvalvekülve on mõttekas koguda teatud 
spetsiifiliste mikroobide poolt põhjustatud haiglainfektsioonide puhangute 
korral (nt. MRSA, Klebsiella pneumoniae). See aitaks parandada infekt-
sioonikontrolli meetmeid ja oleks abiks empiirilise ravi valikul.  
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